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Arboviruses are transmitted to vertebrates by arthropod vectors such as mosquitoes 
or ticks. The replication of Semliki Forest virus (SFV) (Togaviridae; Alphavirus) in 
vertebrate cells is well established and triggers cell death. SFV infection of Aedes 
albopictus mosquito cells was characterised. Virus growth curves were compared in 
three cell lines. Infection of U4.4 cells was persistent and did not affect growth of the 
culture. In contrast, infection of C6/36 and C7-10 cells resulted in a static culture 
with no cell division and no cell death. The response of U4.4 cells was characterised 
in greater detail using viruses containing fluorescent or luciferase markers within the 
replicase or structural open reading frame of the virus genome. Activation of the 
STAT/IMD pathway prior to SFV infection significantly reduced virus driven 
luciferase expression and virus production. Activation of the Toll pathway prior to 
SFV infection had no effect. However, activation of Toll in addition to STAT/IMD 
had a cumulative effect on luciferase expression and virus production.  viRNAs were 
characterised by Illumina Solexa sequencing. Two percent of the small RNA species 
found in virus infected cells were derived from virus RNA. These were 
predominantly 21 nt long and mapped along the entire SFV genome and genome 
complementary RNAs. Generation of these viRNAs was not random. Some areas 
produced high frequencies and others no or very few; hot and cold spots respectively. 
There were no correlations between viRNA frequency and base pairing or secondary 
structures predictions. Cold spot-derived viRNAs were more effective than hot-spot 
viRNAs in inhibiting virus replication. Similar results were observed in Aedes 
aegypti-derived cells. Attempts were made to investigate the source of these viRNAs 
using a virus containing an IRES element which had been reported to prevent virus 
replication in insect cells but which did not efficiently do so in this study. A virus 
containing the RNAi inhibitor p19 was characterised and shown to increase virus 
production. 
Techniques for infecting mosquitoes via a blood meal feed were established. No 
infection was observed with virus replicon particles carrying a fluorescent marker 
gene. Infection was established using virus containing p19 
Chapter 1  Introduction 
1 
 
Table of contents 
Chapter 1: Introduction ................................................................................................ 3 
Medical and veterinary importance of arboviruses .................................................. 4 
Alphavirus ............................................................................................................ 6 
Flaviviruses ........................................................................................................ 10 
Bunyaviruses ...................................................................................................... 14 
The mosquito Aedes albopictus: classification, geographical distribution life cycle 
and disease association ........................................................................................... 15 
Classification and geographical distribution ...................................................... 15 
Mosquito life cycle ............................................................................................. 16 
Disease associations ........................................................................................... 18 
Alphaviruses: classification, geographical distribution, morphology and replication 
cycle ....................................................................................................................... 18 
Classification and geographical distribution ...................................................... 18 
Morphology ........................................................................................................ 19 
Replication cycle of alphaviruses....................................................................... 19 
Dissemination of alphaviruses in mosquitoes ........................................................ 22 
Pathogenesis of Semliki Forest virus (SFV) .......................................................... 23 
Alphavirus reverse genetics ................................................................................... 25 
Innate immunity in mammals ................................................................................ 30 
Toll-Like Receptors (TLR) ................................................................................ 30 
Toll immune pathways ....................................................................................... 31 
The c-Jun N-terminal kinases (JNKs) signal transduction pathways ................ 32 
Retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5
 ............................................................................................................................ 32 
Chapter 1  Introduction 
2 
 
Protein Kinase R ................................................................................................ 34 
Endoribonuclease (RNase L) ............................................................................. 36 
RNA interference (RNAi) .................................................................................. 36 
Apoptosis ........................................................................................................... 37 
Interferon (IFN) system...................................................................................... 38 
Innate immunity in insects ..................................................................................... 40 
Toll pathway....................................................................................................... 41 
Immune deficiency (IMD)/ JUN N-terminal kinases (JNKs) signal transduction 
pathways ............................................................................................................. 44 
Janus kinases (JAK) & signal transducers and activators of transcription 
(STAT) ............................................................................................................... 47 
Apoptosis ........................................................................................................... 48 
RNA interference (RNAi) in insects .................................................................. 48 
Effect of alphaviruses on the innate immune response .......................................... 52 
Hypothesis .............................................................................................................. 56 
Aims and objectives ............................................................................................... 56 
AIM .................................................................................................................... 56 
OBJECTIVES .................................................................................................... 56 
  
Chapter 1  Introduction 
3 
 
Chapter 1: Introduction 
Arboviruses are some of the most common pathogens impacting on human and 
animal health worldwide.  In many cases, virus transmission relies on successful 
replication and dissemination within susceptible vector tissues. Different mosquito 
species such as Aedes albopictus, Aedes aegypti and Anopheles gambiae are common 
vectors for different arboviruses.  However, we are just beginning to understand how 
mosquito vectors respond to arbovirus infections.  Although, there are mechanisms 
and pathways conserved between insects and mammals, insects lack the fundamental 
anti-viral systems of vertebrates.  In vertebrates, the immune system can be divided 
into innate and adaptive immunity.  Adaptive immunity relies on the production of 
specific antigen receptors and acquisition of memory.  Prior to the development of 
specific responses, a rapid and non-specific system detects and determines the 
biological context of antigens.  These tasks are achieved by the innate immune 
system.  The innate immune system detects foreign antigens by a set of structurally 
and functionally diverse receptors (Choe et al., 2002; Kurt-Jones et al., 2000; Michel 
et al., 2001; Söderhäll & Cerenius, 1998; Wyers et al., 1995). These receptors trigger 
mechanisms such as phagocytosis, expression of pro-inflammatory genes and 
interferons in vertebrates (Klotman & Chang, 2006).  However, there is no adaptive 
immune system in insects.  Extensive studies in Drosophila melanogaster have 
shown only an innate immune system (Hoffmann, 2003).  It is generally assumed 
that all insect species utilise a similar system.  To date, the systems identified in 
Drosophila, the Toll and IMD pathways, defend against fungi and bacteria.  The 
nature of innate defences against viruses remains less clear.  As mosquitoes are 
vectors for transmitting many medically important virus diseases including: dengue 
fever (DF) and dengue hemorrhagic fever (DHF), yellow fever, Rift Valley fever 
(RVF), and West Nile fever (Black et al., 2002), therefore understanding the 
interaction between insects and viruses is not only important fundamental biological 
knowledge but also has relevance to human and veterinary medicine.  
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Medical and veterinary importance of arboviruses 
Arboviruses (arthropod-borne viruses) are viruses that are maintained in nature 
through transmission between vertebrate hosts by blood feeding arthropods. The 
commonly known blood feeding arthropod vectors include mosquitoes, psychodids 
(moth and sand flies), ceratopogonids (midges), and ticks. Transmission occurs when 
the infected arthropod takes a blood meal from a susceptible vertebrate host. There 
are over five hundred different arboviruses registered in the international catalogue 
of arboviruses at the division of vector-borne infectious diseases (DVBID) under the 
Centers for Diseases Control and Prevention (CDC).  The members of three families: 
the Togaviridae (genus Alphavirus), Flaviviridae and Bunyaviridae pose important 
human health problems worldwide (Table 1.1). These viruses are maintained in non-
human vertebrates (birds and rodents and sometimes horses) and transmitted by 
mosquitoes and mosquitoes or ticks. In many cases, transmission to humans occurs 
when the virus escapes the natural cycle often through a secondary vector to a 
secondary host (dead end host) (Figure 1.1). Infected humans occasionally develop 
clinical illnesses such as mild febrile illness, arthralgia and encephalitis. More severe 
cases include neurological damage, the development of hemorrhagic fever and death. 
Arthopod vector Virus family Human diseases 
Mosquito Bunyaviridae La Crosse encephalitis, Rift Valley fever 
 Flaviviridae Japanese encephalitis, St Louis encephalitis, West Nile 
fever, Dengue fever, Yellow fever 
 Togaviridae Eastern equine encephalitis, Western equine 
encephalitis, Venezuelan equine encephalitis, 
Chikungunya, O’nyong-nyong fever, Ross River fever 
Tick Bunyaviridae Crimean-Congo haemorrhagic fever 
 Flaviviridae Tick-borne encephalitis, Powassan encephalitis, Omsk 
haemorrhagic fever 
 Reoviridae Colorado tick fever 
Table 1.1 Arboviruses of medical importance in different families. 
Most arboviruses are RNA viruses of the families Bunyaviridae, Togaviridae and Flaviviridae 
with exceptions such as CTF of the double stranded RNA virus family Reoviridae.  




Figure 1.1: Enzootic cycle of arboviruses. 
Arboviruses are maintained in complex life cycles involving a nonhuman vertebrate host and 
arthropod vector(s). These cycles remain intact until the virus escapes via a secondary vector or 
vertebrate host as the result of some ecologic change. Infected humans and domestic animals can 
develop mild febrile illness and occasionally viral encephalitis. Infection in humans usually leads 
to a dead end for the virus because “dead end hosts” do not usually contribute to the transmission 
cycle. 
Arboviruses have been recognised as the leading cause of encephalitis worldwide 
since 1985 (Ho & Hirsch, 1985) . The outburst of arboviral infections often occurs 
during warmer seasons when it is most favourable for mosquitoes to breed. This 
reflects the importance of transmitting vectors for transmission. For example, 
incidence of yellow fever is often high during the rainy season in both South 
America and Africa. This reflects the importance of understanding the vector as one 
of the major keys to control the transmission cycles of all mosquito-borne diseases.  
Infections are mostly asymptomatic, a minority of patients develop mild febrile 
illness or viral meningitis (Tsai, 1991). Although only a minority develop 
encephalitis with arbovirus infection, the fatality rate in this group can be up to 70%.  




The genus Alphavirus contains approximately 30 members, which were estimated to 
have diverged a few thousand years ago (Powers et al., 2001). Not all alphaviruses 
are pathogenic to humans, only some are highly infectious and cause clinical 
diseaseswhich ranges from mild to severe.  Alphaviruses can be divided into New 
World and Old World viruses characterised by their distinctive ways of interacting 
with their respective hosts and differences in their pathogenicity, tissue and cellular 
tropism, cytotoxicity and interaction with the cell. The New World virus infections 
are predominantly associated with encephalitis, whereas the Old World virus 
infections are associated with polyarthritis and rash (Powers et al., 2001; Weaver & 
Reisen, 2010).  
Sindbis virus (SINV) is one of the most studied alphaviruses. It is named after the 
northern Egyptian district where the virus was first isolated from a mosquito in 1952 
(Taylor et al., 1955). The virus is present in Europe, Africa, Asia and Australia and 
transmitted between birds by Culex species mosquitoes (Jupp et al., 1986; Tesh, 
1982).  SINV has been isolated from blood of migratory birds, but it does not cause 
mortality or sickness in them. The virus is naturally transmitted to humans by 
mosquitoes of the genera Culex and Culiseta, in laboratory studies it can also be 
transmitted by Aedes species (Taylor et al., 1955). In Europe, outbreaks have been 
recorded since the early 1980s in Sweden, Finland, and the adjacent Karelia area of 
Russia. Clinical disease caused by SINV is called Ockelbo disease in Sweden, 
Pogosta disease in Finland, and Karelian fever in Russian Karelia. The most recent 
outbreak occurred in Finland in 2002 (Kurkela et al., 2005). Pogosta disease was first 
recognised in Finland in 1974, and since then epidemics have taken place every 7 
years. Nucleotide sequencing of the viruses isolated from these locations indicated 
that these viruses are geographically distinct genotypes (Norder et al., 1996). During 
the acute phase of infection in humans, symptoms consist of fever, headache, fatigue, 
followed by progressive musculoskeletal pain, swollen joints, arthritis, inflamed 
tendons and rash. The joint symptoms can be incapacitating in the acute phase of the 
disease. Recovery usually takes a period of weeks, and joint pains may persist for 
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several years in one-third of the patients (Niklasson et al., 1988). No vaccines against 
SINV and SINV-related viruses are presently available. 
Eastern equine encephalitis (EEE) is caused by the alphavirus EEEV, transmitted to 
humans and equines by the bite of an infected mosquito. It was first isolated in 1933 
after an equine epizootic in New Jersey and Virginia (TenBroeck & Merrill, 1933). 
EEEV occurs along the eastern seaboard of the United States and has a wide range of 
avian and mammalian hosts including turkeys, emus, whooping cranes, partridges, 
pheasants, horses and humans. Infection is more dangerous to horses but mostly 
asymptomatic for humans. However, in some cases, infected humans can develop 
sudden onset of fever, general muscle pains, and a headache of increasing severity. 
These individuals often progress to more severe symptoms such as seizures and 
coma. One in three who develop clinical encephalitis will die from the disease and 
those who recover often suffer permanent brain damage. Infection is often lethal for 
pheasants and horses whilst rapidly fatal for whooping cranes, turkeys and emus. 
Outbreaks of EEE were observed from May 2008 to August 2009 in Brazil. The 
disease occurred in 93 farms affecting 229 equids with a case fatality rate of 72.92% 
(Silva et al., 2011).  EEEV is maintained between birds and the mosquito Culiseta 
melanura (Armstrong & Andreadis, 2010). The virus is thought to escape its natural 
cycle through other mosquito vectors Coquilletidia perturbans and Aedes sollicitans 
which feed on birds and mammals.  
Western equine encephalitis virus (WEEV) is an alphavirus that causes western 
equine encephalitis in horses and humans in western parts of the USA and Canada. It 
was first isolated in 1930 from a horse with encephalitis. Like other viral 
encephalitis, most WEEV infections in humans are asymptomatic or present as mild, 
nonspecific illness. Patients with clinically apparent illness usually have a sudden 
onset with fever, headache, nausea, vomiting, anorexia and malaise, followed by 
altered mental state, weakness and signs of meningeal irritation. Infants under 1 year 
old are affected more severely than adults and may be left with permanent sequelae 
(5 - 30% of young patients). The case mortality rate is about 3%. The enzootic cycle 
of WEEV is maintained between passerine birds and culicine mosquitoes, in 
particular Culex tarsalis (Kenney et al., 2010). 
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Venezuelan equine encephalitis (VEE) caused by VEEV, an alphavirus like EEEV 
and WEEV viruses, is a disease ranging from mild febrile illness to encephalitis or 
death in horses and humans. It is an important veterinary and public health problem 
in Central and South America because it is one of the most pathogenic members of 
the genus. This virus is a complex of antigenically related but epidemiologically and 
ecologically distinct viruses. Epizootic viruses emerge at unpredictable intervals of 
time; infect a large number of mosquito species, producing extensive outbreaks in 
equines and humans. It was estimated that 200,000 human cases and more than 
100,000 equine deaths in the outbreak in 1969 in centra Colombia (Weaver et al., 
2004). In 1995, 90,000 humans were estimated to have been infected by a VEE 
epidemic in Venezuela and Colombia. A recent outbreak of VEE in 2004 caused at 
least one fatal case in Panama (Quiroz et al., 2009). On the other hand, sylvatic 
VEEV subtypes are transmitted continuously in forest and swamps, causing sporadic 
human infections (Oberste et al., 1998) . VEEV infection in humans is less severe 
than EEEV and WEEV, but has a 20-40% case fatality rate in horses and high 
mortality in experimentally infected dogs, rodents and coyotes. These viruses are 
maintained in cycles involving forest dwelling rodents and the mosquito Culex 
melanoconion (Anishchenko et al., 2006). 
Chikungunya is a disease caused by CHIKV, a member of the Alphavirus genus. It 
was first identified in Newala province (Tanzania) in 1953 (Robinson, 1955). The 
disease is transmitted by the vector mosquito Ae. albopictus (Vazeille et al., 2007). 
Between the 1960s and the 1980s, the virus was isolated from numerous countries in 
Central, Southern and West Africa as well as many areas of Asia (Powers et al, 
2000). The outbreak which took place in Madras had 400,000 estimated cases in 
1964, and there were 40,000 to 70,000 paediatric cases in the Bangkok outbreak in 
1962 (Halstead et al., 1969). In 2005 and 2006, a Chikungunya outbreak occurred on 
the French island of Reunion in the Indian Ocean. During this outbreak, there were 
244,000 cases and 237 deaths were reported (Bonn, 2006; Renault et al., 2007). 
Madagascar, Mauritius and the Seychelles were also affected.  An outbreak occurred 
in the following year in India, in which more than 1.25 million suspected cases were 
reported (GAR, WHO). In 2007, Chikungunya was transmitted locally in a small 
outbreak in Italy; about 200 cases were reported from two small towns in Ravenna 
Chapter 1  Introduction 
9 
 
province (Vazeille et al., 2008). The spread of CHIKV into Europe is thought to have 
resulted from importation by infected travellers returning from areas with high 
incidence rates.  Infection with CHIKV is not usually fatal but can cause fever, 
headache, fatigue, nausea, vomiting, muscle pain, rash, and joint pain. Acute 
Chikungunya fever typically lasts a few days to a few weeks. More importantly, after 
recovery from acute infection some patients suffer from incapacitating joint pain, or 
arthritis which may last for weeks or months (Yazdani & Kaushik, 2007). Epidemics 
have been reported in East and South Africa since 1952 with 50% polyarthritis in 
reported cases. Recurrent joint pain can last for years in 30-40% of those infected 
and this is thought to be the result of immune mediated swelling of joints similar to 
the pain caused by the related alphavirus Ross River virus (RRV) (Morrison et al., 
2006).  The case fatality rate has been estimated to be 1 in 1,000, with most deaths 
occurring in neonates, immunocompromised adults and the elderly (Gérardin et al., 
2008). Although CHIKV is a member of the Old World viruses, it causes 
meningoencephalitis in neonates and haemorrhagic diseases. However, unlike other 
encephalogenic alphaviruses, which infect neurons, CHIKV infects the stromal cells 
of the central nervous system (CNS) (Schwartz & Albert, 2010). The virus is 
maintained naturally between monkeys or baboons and the mosquito Ae. aegypti. 
Transmission of CHIKV to humans usually occurs through the bite of infected Ae. 
aegypti, however, Ae. albopictus has been associated with all the recent outbreaks. 
An analysis of CHIKV genetic sequences was carried out and revealed independent 
mutation events in the CHIKV genome which provided selective advantage for 
transmission by Ae. albopictus mosquitoes (de Lamballerie et al., 2008; Tsetsarkin et 
al., 2007). Ae. albopictus has been shown to acquire blood exclusively from human 
hosts, this suggested the amplification and transmission were enhanced by this 
mosquito species (Muñnoz et al., 2011).  CHIKV initially replicates in the skin 
following transmission and then disseminates to the liver and joints through the 
bloodstream (Robin et al., 2010).  In tissue culture experiments, the virus replicates 
in various human cell lines and causes wide spread apoptotic cell death in epithelial 
cells, endothelial cells, fibroblasts, monocyte-derived macrophages and Hep-2 
hepatic cells (Sourisseau et al., 2007). CHIKV has also been shown to infect a broad 
range of non-human cell lines including Vero cells, chick embryo cells, BHK21 and 
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L929 fibroblast-like cells (Glasgow, 1966; Hahon & Zimmerman, 1970; Rinaldo Jr 
et al., 1975; Simizu et al., 1984). 
O’nyong-nyong virus (ONNV), which causes O’nyong-nyong fever is closely related 
to CHIKV and serologically classified in the Semliki Forest virus complex (see 
below). The symptoms of infection resemble Chikungunya fever: joint pains, rash 
and lymphadenitis. Clinical symptoms appear in 40% of patients. The virus circulates 
locally in East Africa at a low level and transmission is maintained by local malaria 
vectors Anopheles funestus and Anopheles gambiae (Bessaud et al., 2006). The first 
outbreak was recorded in 1959 in Uganda.. This spread rapidly in East Africa, south 
to Mozambique, and Malawi, and west to Senegal (Williams et al., 1965). The 
outbreak lasted for three years and was estimated to have caused two million cases. 
The epidemic re-emerged again in 1996-1997 in southern Uganda (Kiwanuka et al., 
1999).  
Ross River fever is a disease endemic to Australia, Papua New Guinea, and the 
South Pacific caused by Ross River virus (RRV). Infections in humans often lead to 
20-60% of the patients developing fever, and 83-98% develop polyarthralgia. Joint 
pain may persist for several months. The joint pain is caused by immune-mediated 
swelling of joints (Morrison et al., 2006). In RRV-infected mice, inflammatory 
macrophages infiltrate muscles and joints, and treatment of mice with macrophage-
toxic agents (silica) prior to RRV infection completely abrogated disease symptoms 
(Lidbury et al., 2000). The virus was first described in outbreaks during 1928 and 
1956 and subsequently isolated from Aedes vigilax in 1963. A large epidemic 
outbreak occurred in 1979 and 1980 involving Fiji, New Caledonia, Samoa, and the 
Cook Islands. In Australia between 1991 and 2000, there were 4,745 reported cases 
each year on average (Harley et al., 2001).  
Flaviviruses 
West Nile fever is caused by West Nile virus (WNV), a member of the Flaviviridae. 
Infection can cause encephalitis in both humans and horses. The virus is naturally 
maintained between birds and mosquitoes and was first isolated from a patient in 
Uganda in 1937 (Smithburn et al., 1940). It can be found in Europe, Africa, the 
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Middle East, Asia, Australia and more recently in the US (Hayes, 2001). WNV can 
infect cells from humans, primates, swine, ticks and mosquitoes. Intracerebal 
injection of WNV to mice, hamsters, rhesus monkeys and bonnet macaques leads to 
fatal encephalitis. Encephalitis caused by WNV is unusual, as only 1% of infections 
are associated with clinical disease including encephalitis. Encephalitis can be fatal 
in both children and adults. Many small outbreaks have occurred in Israel, India, 
France, Egypt, Russia, Belarus, Ukraine, Romania, the Czech Republic, and the 
United States. Since 1996 a large outbreak affected Bucharest and surrounding areas 
of southern Romania; 800 clinical cases were recorded with a case fatality rate of 
1.8% for patients with meningitis and 15% for encephalitis. Between 1998 and 2000, 
infection of horses occurred in Italy, southern France and New York (Trock et al., 
2000), and there were outbreaks of human disease in the Democratic Republic of 
Congo and Russia (Lvov et al., 2000). The disease was identified for the first time in 
the US in 1999 where it caused 62 clinical cases and seven deaths in Queens, New 
York, and surrounding areas (Lanciotti, 1999), and another 18 cases with two deaths 
in the following year. Since then the virus had spread to all states of US except 
Hawaii, Alaska and Oregon. Subsequent outbreaks took place every year from 2002 
to 2008 with an average of 4,115 cases and 159 deaths per year reported by the CDC. 
At least 30% of those cases were considered severe involving meningitis or 
encephalitis.  
Yellow fever is a mosquito-borne disease caused by yellow fever virus, a prototype 
virus of the Flaviviridae family first isolated in 1927 (Stokes et al., 1928). There are 
five distinct strains, three in Africa and two in South America. The virus is 
maintained between non-human primates and tree hole mosquitoes (Haemagogus 
spp. in the Americas and Aedes africanus in Africa) in the jungles of South Central 
America and Africa. Humans can acquire yellow fever from jungle mosquitoes and 
transmit it to other humans through urban adapted mosquitoes Aedes aeypti. Yellow 





(Patterson, 1992). Since 1905, yellow fever has only been recorded to occur in 
tropical South America and sub-Saharan Africa. From 1987 to 1991, there were 
18,735 reported cases and 4,522 deaths worldwide (Nasidi et al., 1989; Robertson et 
al., 1996). Between 1990 and 1999, there were 11,297 cases worldwide (83% in 
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Africa) and 2,648 deaths were officially recorded by the World Health Organization 
(WHO). Incidence of yellow fever is often high during the rainy season in both South 
America and Africa. The virus is maintained over the dry season by vertical 
transmission in mosquitoes (Aitken et al., 1979). According to WHO, there are an 
estimated 200,000 cases of yellow fever, causing 30,000 deaths, worldwide each 
year.  In America, Ae. aegypti has adapted to become an urban inhabitant and it is a 
concern that yellow fever could erupt in explosive outbreaks. Fortunately, Ae. 
aegypti has low vector competence for yellow fever virus. Patients infected with 
yellow fever virus suffer from headache, backache, muscle ache, haemorrhagic fever 
and hepatic, renal and myocardial failures (Monath, 2001). Like other arboviral 
diseases, infection is usually asymptomatic with a low chance of developing severe 
disease, but the case fatality rate of diseased patients ranges from 15% to over 50% . 
Dengue fever (DF), one of the most important tropical diseases, is caused by four 
distinct but closely related dengue virus (DENV) serotypes and occurs in tropical and 
sub-tropical regions. The virus is transmitted by Aedes mosquitoes, mainly Ae. 
aegypti. On average, 5-10% of Ae. aegypti found within a household are infected 
with dengue virus and 10-20 females maybe found per room and each female has the 
propensity to probe several persons before completing a blood meal. Ae. albopictus 
only plays a secondary role in interhuman transmission of dengue. There are 2.5 
billion people at risk of infection, and according to CDC there are as many as 100 
million people infected every year including 100-200 travellers from the United 
States, Europe and Australia. Human infection with dengue virus can result in severe 
flu-like illness, and sometimes a potentially lethal complication called dengue 
haemorrhagic fever (DHF). DHF is a leading cause of serious illness and death 
among children in some Asian countries. Based on findings of serological surveys, 
there is a high risk of developing DHF when subsequent infection happens with a 
serotype different from the previous infection. For example, DENV-1 was introduced 
to Cuba in 1977 and 44% of the population was infected. Only mild disease was 
reported. Then DENV-2 was brought into Cuba four years later leading to an 
estimated 10,000 incidences of DHF (Guzmán et al., 1990; Kouri et al., 1989). In 
many areas of the world, two or more serotypes co-circulate. Dengue infections are 
mostly prevalent in Southeast Asia, where all four serotypes are continuously in 
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circulation. The transmission of DENV has been recorded all over the tropical 
regions of the world including: sub-continental India, southern China, Taiwan, the 
Oceanic islands, Queensland in Australia, the Seychelle Islands, coastal Kenya, 
Somalia, Sudan, Saudi Arabia, Yemen, Central America, the Caribbean region, and 
South America. It is believed that pre-existing heterotypic, non-neutralising antibody 
that binds with DENV would facilitate the entry of the virus into cells of the 
monocytic line which leads to positive feedback in production of cytokines and 
chemical mediators, resulting in vascular permeability (Gubler, 1998). The 
symptoms of DHF included rapid onset of capillary leakage accompanied by 
thrombocytopenia, altered haemostasis and damage to the liver. There are not yet any 
vaccines developed to prevent infection with DENV.  
St. Louis encephalitis caused by St. Louis encephalitis (SLE) virus, Flaviviridae, is 
the leading cause of epidemic flaviviral encephalitis and the most common mosquito-
transmitted human pathogen in the United States (Tsai, 1991). SLE virus is 
maintained between birds and Culex mosquitoes and distributed throughout the 
Southern US.  In average, there have been 193 cases reported per year since 1964. 
However, less than 1% of infections show clinical symptoms and the majority of 
infections remain undiagnosed. Patients can develop a symptoms ranging from a 
simple febrile headache to meningoencephalitis, with an overall case-fatality ratio of 
5-15 %. The disease is generally milder in children than in adults, but in those 
children who do have disease, there is a high rate of encephalitis. The elderly are at 
highest risk for severe disease and death.  
Japanese encephalitis (JE) caused by Japanese encephalitis virus (JEV), Flaviviridae, 
is one of the most important endemic encephalitides; it occurs mostly in Asia (50,000 
patients annually). JE is also asymptomatic in most people; however symptomatic 
individuals have a high fatality rate (15,000 deaths annually) and half of the 
survivors have neurological sequelae (Misra & Kalita, 2010). The virus is maintained 
between waterbirds and culicine mosquitoes and transmitted to man by Culex 
mosquitoes, primarily Cx. tritaeniorhynchus. 




La Crosse (LAC) encephalitis is caused by La Crosse virus, Bunyaviridae. The virus 
was first isolated from the brain of a child who died of encephalitis in La Crosse 
County, USA (Thompson et al., 1965). LAC virus is naturally cycled between the 
mosquito, Aedes triseriatus, and vertebrate hosts (commonly chipmunks and tree 
squirrels). The virus is maintained over the dry season by vertical transmission in 
mosquitoes (Watts et al., 1975).  There are about 75 cases reported in the United 
States per year on average since 1963. Most infections occur in children under 16 
years of age. LAC encephalitis initially displays nonspecific symptoms such as fever, 
headache, nausea, vomiting and lethargy. Severe disease occurs most commonly in 
children under the age of 16 and is characterized by seizures, coma, paralysis, and a 
variety of neurological sequelae after recovery. Death from LAC encephalitis occurs 
in less than 1% of clinical cases. 
Rift Valley fever (RVF) is an endemic disease in Eastern and Sub-Saharan Africa 
affecting domestic animals (sheep, buffalo, cattle, goats and camels) and humans. 
The disease is caused by RVF virus, a member of the genus Phlebovirus in the 
family Bunyaviridae. The virus is maintained in a natural cycle between livestock 
and insect vectors (Aedes mosquitoes and sandflies). The disease was first reported in 
1900. Major outbreaks occurred in Kenya in 1950 (resulting in the death of 100,000 
sheep), Egypt in 1977 and 1993 (both animals and humans) and Saudi Arabia and 
subsequently Yemen in 2000 (Abu-Elyazeed et al., 1996; Ahmad, 2000; Davies, 
1975; Meegan, 1979). The infection has a mortality rate of 10 - 30% in sheep, cattle 
and goats and is associated with abortion and almost 100% mortality in pregnant 
animals (Madani et al., 2003). Infection in humans can occur through insect vectors 
or direct contact with infected animals. Infection in humans is usually asymptomatic 
but occasionally causes a mild febrile illness. However, a small number of patients 
(1%) develop fatal haemorrhagic fever, shock, encephalitis, liver necrosis and ocular 
complications. Approximately 1-10% of affected patients may suffer vision loss (Al-
Hazmi et al., 2003).  
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The mosquito Aedes albopictus: classification, geographical 
distribution life cycle and disease association 
Classification and geographical distribution 
Mosquitoes make up the family Culicidae in the order Diptera. At present, there are 
about 3,523 species of Culicidae classified in two subfamilies and 113 genera. The 
two subfamilies are Anophelinae and Culicinae. Anophelinae contains three genera 
and Culicinae contains 110 genera and two groups of incertae sedis (of uncertain 
taxonomic position, broader relationships are unknown or undefined). Aedes 
mosquitoes are one of the incertae sedis groups under subfamily Culicinae (Harbach, 
2011; Reinert et al., 2005).  
There are 12 species within the genus Aedes. Ae. aegypti and Ae. albopictus are well 
known for their adaptability, aggressiveness, blood feeding requirement and viral 
disease associations. Ae. albopictus is also known as the Asian tiger mosquito 
because of its origin and its black and white stripes (Figure 1.2). It is geographically 
distributed in warm and humid parts of the world and areas that have been urbanised 
including: China, Japan, Vietnam, Singapore, Indonesia, Indian Ocean Islands, the 
islands of La Réunion and Mauritius, Madagascar, south-eastern Brazil, Florida, and 
Puerto Rico. (Bagny et al., 2009; Braks et al., 2003; Chan et al, 1971; Cox et al, 
2007; Delatte et al., 2008; Higa et al., 2010; Ishak et al., 1997). Ae. albopictus has 
also become established in European countries such as: France, Spain (2004), Italy 
(1990), Greece, Belgium, Montenegro, Albania, Bosnia and Herzegovina, Croatia, 
Israel, Montenegro, Serbia, Slovenia, Switzerland, The Netherlands and Germany 
(Delaunay et al., 2009; Eritja et al., 2005; Pluskota et al., 2008; Roiz et al., 2008; 
Romi, 2001; Samanidou-Voyadjoglou et al., 2005). In the United States, the species 
was first discovered in Florida in 1986 and it has rapidly become the most common 
mosquito throughout the US. Ae. albopictus is often introduced to European 
countries by the importation of used tyres which retain water during transportation. 
Ae. Albopictus is a competent vector for numerous arboviruses, and its geographical 
distribution has continuously expanded and even replacing Ae. aegypti in some parts 
of the world (Gould & Higgs, 2009; de Lamballerie et al., 2008). 





Figure 1.2: Ae. albopictus 
A) An unfed female Ae. albopictus. B) A freshly fed Ae. albopictus. These pictures were taken 
by James Gathany, and are available at Centers for Disease Control and Prevention's Public 
Health Image Library (PHIL). 
Mosquito life cycle 
There are four stages to the mosquito life cycle: egg, larva, pupa and adult (Figure 
1.3). In Ae. aegypti the key biological process to initiate egg production, 
vitellogenesis (synthesis of yolk protein precursors), is in an arrested state before a 
female mosquito takes a blood meal. The repression on yolk protein precursor genes 
(YPPs) is lifted once blood feeding has taken place (Attardo et al., 2003) . Male 
mosquitoes only feed on plant nectar, not requiring a blood meal. A female mosquito 
can lay several hundred fertilised eggs on the surface of water in treeholes, or other 
water-holding containers. Eggs can be clustered or dispersed depending on the 
species of the mosquito. Mosquito larvae hatch from the eggs within 24 hours. The 
larvae feed on algae, bacteria, and other micro-organisms. Domesticated larvae kept 
in an insectary can be fed on commercial chicken liver powder. The larvae take 7-14 
A 
B 
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days before moulting into pupae. Mosquito pupae spend 1-4 days transforming into 
adult mosquitoes (metamorphosis) and then leave the pupal case. 
 
Figure 1.3: Ae. albopictus life cycle 
A female mosquito produces eggs after a blood meal has been taken (left). Several hundred eggs 
are laid on the surface of water in water-holding containers. Ae. albopictus eggs are black and 
dispersed (top), distinct from eggs of Culex spp. which form an egg raft. Larvae of mosquitoes 








 instars. During this 
stage they actively feed and grow larger. It takes up to a week for the larvae to be fully developed 
and moult into the pupal stage (bottom). Feeding does not take place during the pupal stage. The 
pupa remains in the water for no more than a few days until the adult emerges from the pupal 
case on the surface of the water.  




The disease association and the vector competence of a mosquito are often 
established by the following observations. i) isolation of infectious virus from wild-
caught mosquito samples, ii) infection of the mosquito by feeding on a viraemic host, 
iii) virus transmission by subsequent bites, iv) association of infected mosquito with 
confirmed cases in an epidemic region.  
Ae. albopictus is a vector of dengue viruses in Asia. In the United States, at least six 
arboviruses including WNV, EEEV, Keystone virus, Tensaw virus, Cache Valley 
virus, and Potosi virus have been isolated from this species. Of these six viruses, 
West Nile virus, Eastern equine encephalitis virus and Cache Valley viruses are 
known to cause disease in humans. As mentioned above, Ae. albopictus was 
responsible for the outbreak of Chikungunya in the French Indian Ocean islands in 
2005 (Schaffner, 2000) and in Italy in 2007 (Romi et al., 1999). The feeding patterns 
of Ae. albopictus (acquire blood exclusively from human hosts) makes this species of 
major importance in the amplification and transmission of infectious viruses to 
humans. 
 
Alphaviruses: classification, geographical distribution, morphology 
and replication cycle 
Classification and geographical distribution 
Alphaviruses belong to the Togaviridae family. Viruses in the Togaviridae family 
are enveloped positive-strand RNA viruses. In Latin, toga means cloak, indicating 
that viruses in this family are enveloped. Alphavirus and Rubivirus are the two 
genera in the Togaviridae family. This family was originally much larger and 
included flaviviruses, pestiviruses and some other viruses that had not been well 
characterised. They were originally grouped together by their size, the characteristics 
of their genome (single stranded non-segmented RNA), the ability of their RNA to 
be infectious and their transmission strategy via mosquito vectors. With the advance 
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in knowledge of virus genome structure and replication strategies, the Flaviviridae 
family was established apart from the Togaviridae family. The Alphavirus genus 
consists of 28 different members. Rubella virus is the only member of the genus 
Rubivirus (Strauss & Strauss, 1994). Alphaviruses are classified into seven distinct 
antigenic complexes based on the sequences of their E1 envelope glycoproteins. The 
complexes are VEE complex, WEE complex, Semliki Forest complex, Sindbis-like 
virus complex (SIN), Middelburg complex (MID), Barmah Forest complex (BF), and 
Ndumu complex (NDU) (Powers et al., 2001) . Members of the Alphavirus genus are 
globally distributed. Viruses from the VEE and EEE groups are found in America, 
Brazil and Peru. Sindbis virus and its group members are distributed in Africa, Asia, 
Europe, Australia, Brazil and the USSR. The SFV group viruses are distributed 
mainly in Africa and Australia. 
Morphology 
Alphaviruses contain a single positive strand of RNA which contains two open 
reading frames (ORFs) encoding nine functional proteins. The viral genome, 11-13 
kb, is surrounded by an icosahedral capsid (T=4 symmetry) composed of 240 copies 
of a single capsid protein. The capsid is then enveloped in a lipid membrane derived 
from the infected host cell. Alphaviruses have two or three glycoproteins E1, E2 and 
E3 (species dependent) that associate to form a single spike, each virion contains 80 
spikes. The C-terminus of the glycoprotein E2 is attached to the capsid and its 
membrane spanning domain anchors on the envelope membrane forcing the envelope 
to surround tightly and take on the shape of the capsid. The E1 protein is essential for 
membrane fusion between the viral envelope and the target membrane (Knipe, 1996). 
Replication cycle of alphaviruses 
Alphaviruses infect host cells via receptor-mediated endocytosis. Virus particles 
attach to the host cell surface receptor through the receptor-binding domain of the E2 
glycoprotein (Strauss & Strauss, 1994). The host receptor involved in viral 
attachment remains unclear. One study reports that SFV has affinity for major 
histocompatibility antigen of humans (HLA-A and –B) and mice (H2-K and D) 
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(Helenius et al., 1980, 1978), though this has never been confirmed. Sindbis virus 
attaches to cells via laminin and heparin sulphate receptors (Klimstra et al., 1998; 
Wang et al., 1992).  
Following endocytosis, the endocytosed vesicle fuses with an endosome and then a 
lysosome. The acidic environment of the lysosome induces a low-pH-dependent 
conformational change in the glycoprotein spike complex which facilitates 
membrane fusion between the virus envelope and the lysosome membrane to allow 
the release of the nucleocapsid into the cytoplasm (Kielian, 1995). It has been 
proposed that passing through the acidic endosome destabilises the nucleocapsid, and 
reveals ribosomal binding sites on the capsid (Singh & Helenius, 1992). Ribosomes 
bind to the capsid resulting in release of viral RNA into the cytoplasm (Wengler, 
1984, 1987). 
The naked alphavirus genome is a single positive-strand of RNA with two ORFs 
(11.7 kb for SINV and 11.5kb for SFV). The viral genome has the features of a 
mature messenger RNA found in eukaryotes, containing a 5’ terminal cap and a 3’ 
terminal poly-A tail, and it encodes nine functional proteins. The 5’ two thirds of the 
genome encodes four non-structural proteins (nsP 1, 2, 3 and 4). The four nsPs are 
translated as one or two large polyproteins (some viruses have an opal termination 
codon after nsP3 which can be read through). The nsPs are the components for viral 
replication. The 3’ one-third of the genome encodes for the viral structural proteins, 
capsid, p62(E3+E2), 6K and E1, under the control of a subgenomic 26S promoter. 
These polyproteins are essential to make new virus particles and they are co- or post-
translationally processed into individual proteins (Strauss & Strauss, 1994). 
After the viral RNA genome has been released into the cytosol, it serves directly as 
mRNA resulting in the synthesis of a polyprotein containing nsP1 to nsP3 or nsP1 to 
nsP4 known as P123 or P1234 respectively. The polyprotein is processed into 
individual mature proteins by the catalytic activity of the C-terminal domain of nsP2, 
which is a papain-like protease domain (Vasiljeva et al., 2001).  The processing of 
the non-structural polyprotein is highly regulated to promote different stages of the 
viral replication process.  In SFV, the first cleavage takes place between nsP3 and 
nsP4 in trans, resulting in the release of nsP4 and formation of the early replication 
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complex (nsP123 and nsP4). This early replication complex is essential for 
synthesising the negative-strand RNA from the positive viral genome (Vasiljeva et 
al., 2003).  There is a lag period following each cleavage event and the next cleavage 
is between nsP1 and nsP2 in cis, then between nsP2 and nsP3 in trans (Figure 1.4A). 
Once nsP1 is processed from the polyprotein or nsP2 is separated from nsP3, the 
early replication complex loses its ability for making negative strand. 
 
The four processed nsPs form the mature replication complex which synthesises full-
length 42S genome (positive strand RNA) and 26S sub-genomic RNAs. The 
transcription of positive strand RNA can either start at the 3’ end so that the complete 
strand is transcribed or it can start at a subgenomic promoter located at the 3’ of the 
structural protein genes.  The mature replication complexes are anchored to 
membranous structures of endosomal and lysosomal origin known as cytoplasmic 
vacuoles (CPVs). On the external surface of CPVs are numerous invaginations called 
Figure 1.4: Early and late 
processing pathways of SFV 
P1234.  (A) processing pathway 
during early infection produces a 
functional replication complex. This 
is essential for the production of the 
genome complimentary RNA. (B) 
processing pathway during late 
infection which inhibits the 
formation of new replication 
complexes and synthesis of minus-
strand. RNA Figure adapted from 
Vasiljeva et al, 2003 with 
permission. 
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spherules. The synthesis of viral RNA takes place in these spherules.  At a late stage 
of infection, due to abundant processed nsPs in the cytosol, newly produced non-
structural polyproteins (nsP1-4) are being cleaved in trans between nsP2 and nsP3. 
This inhibits the formation of early replication complexes (nsP1-3+4) and the 
synthesis of negative-strand RNA (Figure 1.4B). 
Translation of the sub genomic RNA leads to the production of the structural 
polyprotein NH2-capsid-p62(E3+E2)-6K-E1-COOH. The capsid protein has 
autoprotease activity and it cleaves itself from the polyprotein. The remaining 
polyprotein is then translocated to the endoplasmic reticulum (ER) by a signal 
sequence located on the p62 protein. Another signal sequence on the 6K protein 
leads to the translocation of E1 to the ER lumen. p62 and E1 are transmembrane 
proteins which are released from the polyprotein by signal peptidase and transported 
from the ER through the Golgi apparatus to the cell surface. During the 
transportation through the secretory pathway, p62, E3 and E2 are cleaved and 
modified (Melancon & Garoff, 1987). These processed glycoproteins are then 
anchored into the cell membrane while the viral genome is being packaged by capsid 
proteins. 
Virus particle assembly starts from the encapsidation of the genomic RNA. The 
capsid protein binds and encapsulates the genomic RNA from a packaging sequence 
in nsP2 for SFV and nsP1 for SINV (Frolova et al., 1997). Then the nucleocapsid 
interacts with the cytoplasmic tail of transmembrane E2 spike proteins. New virus 
particles are released via budding mediated by structural protein 6K (Loewy et al., 
1995). The exact mechanism remains unclear, but 6K-deficient SFV does not form 
new virus particles. 
Dissemination of alphaviruses in mosquitoes 
To begin the alphavirus life cycle in a mosquito, a haematophagous mosquito has to 
ingest viraemic blood from a vertebrate host. Once the viraemic blood has reached 
the mosquito midgut, the virus must establish a productive infection in midgut 
epithelial cells by overcoming the midgut infection barrier (Bosio et al., 2000). 
Following the replication in midgut epithelium, the virus progeny exits the infected 
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cell either by budding or through apoptotic cell death. The virus must pass through a 
midgut escape barrier before it infects secondary tissue such as muscle surrounding 
the alimentary tract, the fat body, haemocytes, nerve tissue, and finally the salivary 
glands (Myles et al., 2004). The virus is then shed into the ducts of the salivary 
gland. Once the virus enters the saliva, the virus has completed its extrinsic 
incubation and the mosquito can transmit the virus to a new host through a 
subsequent bite. The molecular and cellular biology of alphavirus replication in 
mosquito cells have not been studied in detail but are generally presumed to be 
similar to the well-described process in mammals. 
Pathogenesis of Semliki Forest virus (SFV) 
SFV is an alphavirus naturally found in sub-Saharan Africa and it was first isolated 
in Uganda in 1942 from the mosquito Aedes abnormalis (Smithburn & Haddow, 
1944). However, it is spread predominately by Aedes africanus and Ae. aegypti 
mosquitoes. SFV infections have been repoted in horses, monkeys and human 
(Mathiot et al., 1990; Robin et al., 1974). There is only one reported case of human 
death from infection with SFV; a scientist who was working with the Osterrieth 
strain of SFV (Willems et al., 1979). An outbreak of SFV was reported in Central 
African  Republic in 1987, with 22 isolations of SFV made from serum samples 
collected from 22 paitients presenting with fever, severe persistent headache, 
myalgia (muscle pain), and arthralgia (Mathiot et al., 1990). 
There are various strains of SFV including the strain L10, V13, Osterrieth, A8, A7, 
A7(74), SFV4 (molecular clone of prototype), and MRS MP 192/7. Four of these 
strains, L10, prototype, A7 and A7(74) have been studied most extensively. The 
strains L10 and prototype are virulent in adult mice and A7 and A7(74) are avirulent 
in adult mice. Whether they are virulent or avirulent, all strains of SFV are 
neuroinvasive and virulent in neonatal mice (Bradish et al., 1971; Fazakerley et al., 
2002; Glasgow et al., 1991; Smithburn & Haddow, 1944). The strains that have been 
cloned and sequenced are prototype, SFV4, L10, and Viet Nam strains (Garoff et al., 
1980; Glasgow et al., 1994; Santagati et al., 1995, 1998; Takkinen, 1986; Tan et al., 
2008; Tarbatt et al., 1997). 
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The cell lines which are commonly used to study SFV infection are Chicken embryo 
fibroblasts (CEF) and baby hamster kidney (BHK) cells. SFV also infects 
experimental animals including mice, rats, rabbits and guinea pigs (Bradish et al., 
1971).  Following intraperitoneal (IP) inoculation into adult mice, SFV replicates in 
the muscles, including skeletal, smooth, and cardiac muscle (Amor et al., 1996; 
Fazakerley, 2002). A high titre transient plasma viraemia is produced within 24 
hours. In neonatal mice, the A7(74) and L10 strains of SFV are virulent. However, in 
3- to 4- week-old mice only L10 strain is virulent. The distribution of viral RNA in 
the brain shows the virus first apparent as small foci of infected cells around cerebral 
capillaries (Fazakerley et al., 1993). Once in the CNS, the SFV infects neurons and 
oligodendrocytes but not astrocytes.  In both neonatal and 3- to 4- week-old mice 
infected with L10 or neonatal mice infected with A7(74), the infection spreads 
rapidly from the original foci to infect large areas throughout the brain resulting in 
pycnosis and death (Oliver & Fazakerley, 1998). In contrast, 3- to 4- week-old mice 
infected with A7(74) virus showed little spread in the brain from the original 
perivascular foci. The same pattern of A7(74) infection is observed in 3- to 4- week-
old nu/nu mice (mice that make immunoglobulin (Ig) M antibodies but cannot class-
switch to produce IgG antibodies and have no T cells) and mice with severe 
immunodeficiency, indicating that failure to spread is an age-related virulence 
characteristic of the avirulent SFV strains (Fazakerley et al., 1993).  This age related 
virulence of avirulent SFV strains is related to the maturation of the CNS. Upon 
completion of the CNS maturation, there is a decrease in susceptibility to virus 
infections. The decrease in susceptibility may be linked to shutdown of metabolic 
processes required by the virus, e.g. production and transport of smooth membrane 
vesicles (Oliver et al., 1997) or to up-regulation of inhibitory processes, e.g. anti-
apoptotic genes (Scallan et al., 1997).  It is believed that virulent strains induce death 
because of their ability to replicate productively and destroy a large number of 
mature neurons before intervention of immune responses. 
Apart from causing CNS disease, another interesting property of some SFV strains, 
e.g. A7, is their ability to cross the mouse placenta which can either lead to abortions 
or have a teratogenetic effect in developing foetuses (skeletal, skin, and neural tube 
defects)(Atkins et al., 1982). 
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Alphavirus reverse genetics 
Alphaviruses are positive strand RNA viruses and the genomic RNA can directly be 
translated to produce the proteins required for its own replication and to produce new 
virus particles, the genomic RNA is therefore considered to be infectious.  This RNA 
can be generated by capped in vitro transcription from a cDNA plasmid.  If this 
plasmid contains the full length virus genome, it is generally refereed to as an 
infectious cDNA (icDNA).  The virus genome can be reverse engineered by 
changing the sequence of the icDNA plasmid by standard molecular biology 
techniques.  This can include deletions, insertions and point mutations.  In addition, 
there are replicon systems available which are cDNA plasmids containing the 
sequence for the virus non-structural genes, or replicase; capped in vitro transcription 
of this gives rise to an RNA which within cells produces the virus non-structural 
proteins and replicates this RNA.  This RNA can be packaged into virus replicon 
particles (VRP) by virus structural proteins encoded in trans on a separate RNA 
species.  The icDNA clones of several alphaviruses, including SFV, SINV, VEEV 
and CHIKV have been developed (Caley et al., 1999; Davis et al., 1989; Hahn et al., 
1992; Liljeström & Garoff, 1991; Rice et al., 1987; Vanlandingham, Dana L 
Tsetsarkin et al., 2005; Vähä-Koskela et al., 2003) 
Alphavirus systems have been used by many laboratories to express foreign proteins. 
One strategy to construct a replication-competent alphavirus vector is to insert the 
foreign gene of interest under the control of a duplicated subgenomic promoter.  this 
results in high levels of transcripts for the foreign gene. The duplicated subgenomic 
promoter and foreign gene can be inserted either into the short non-translated region 
between the replicase and the structural ORF, or into the 3’ non-translated region of 
the genome. Figure 1.5 shows examples of the possible ways to insert a second 
subgenomic promoter and a foreign gene. 




Figure 1.5: Schematic representation of alphavirus replication-competent vectors 
(A) Schematic representation of the alphaviral genome. (B) Insertion of a second 26S promoter 
and a foreign gene of interest at the 5’ end of the structural polyprotein. (C) Insertion of a second 
26S promoter and a foreign gene of interest at the 3’ end of the structural polyprotein  
Most studies suggested that expression is stronger if the foreign gene is inserted with 
the subgenomic promoter at the 3’of the structural ORF. Examples of stronger 
expression through insertion at the 3’ end of the structural ORF include expression of 
immunogenic proteins of Japanese encephalitis virus (JEV) under duplicated 
subgenomic vectors in SINV, expression of MA/CA domain of HIV gag protein in a 
VEEV vector, and expression of eGFP in CHIKV vectors (Caley et al., 1999; Pierro 
et al., 2003; Pugachev et al., 1995; Vanlandingham et al., 2005). These authors have 
also shown that the strategy of inserting the second subgenomic promoter and the 
foreign gene at the 5’ of the structural ORF remains useful because it provides 
greater genetic stability compared to vectors carrying an insert at the 3’ of the 
subgenomic ORF.  
Recombination between the duplicated subgenomic promoter sequences is thought to 
be the main mechanism that causes genetic instability in these vector constructs. The 
main factors that influence the genetic instability are the length and the nature of the 
transgene. For example, vector viruses expressing a 3-4 kb long foreign sequence are 
less stable than constructs carrying a 1-2 kb shorter sequence, and natural selection 
favours the virus that eliminates  the inserted sequence and is capable of replicating 
faster (Caley et al., 1999; Chen et al., 1995). Constructs with a duplicated 
subgenomic promoter are often used to express foreign marker genes that do not 
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provide any selective advantage to the virus; examples include influenza 
haemagglutinin, bcl-2, eGFP, luciferase, and antisense RNAs (Fragkoudis et al., 
2008, 2009; Hahn et al., 1992; Johnson et al., 1999; Levine, 1996). These vector 
viruses exhibit high levels of genetic instability because inserted sequences are 
incorporated as separate transcription units which can be eliminated easily to gain 
advantage in replication (Thomas et al., 2003; Vähä-Koskela et al., 2003).  
As an alternative to duplicating the subgenomic promoter for transgene expression in 
alphavirus vectors, the gene of interest can be fused with one of the viral replicase 
sequences (Figure 1.6A). By fusing the transgene with the replicase gene, 
recombinant SINV and SFV expressing eGFP or luciferase in fusion with nsP2 or 
nsP3 have been produced (Atasheva et al., 2007; Fragkoudis et al., 2008; Frolova et 
al., 2006; Tamberg et al., 2007). However, in this approach, the transgene expression 
is driven by the genomic promoter. This limits the expression of the transgene to 
early infection.  Another alternative is to insert the gene of interest followed by the 
2A sequence from foot-and-month disease virus (FMDV) into the structural ORF as 
a cleavable component (Figure 1.6B). This utilises the autocatalytic activity of the 
capsid protein at the 5’ end of the foreign protein and the autoprotease activity of the 
2A peptide to release the transgene (Donnelly et al., 2001; Fragkoudis et al., 2008; 
Thomas et al., 2003). Both of these approaches improve genetic stability when 
compared to duplicated subgenomic constructs. 
 
Figure 1.6: Schematic representation of “fusion” alphavirus replication-competent vectors 
(A) Insertion of a foreign gene fused at the 3’-end of the nsP3 protein (B) Insertion of a foreign 
gene followed by a 2A sequence between the capsid and the p62 sequence. 
All of the above icDNA constructs share a common problem when amplified in 
Escherichia coli cells. It appears that E. coli cells transformed with the SFV icDNA 
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constructs grow poorly. It is believed that in the nsP2 sequence of SFV, there are 
cryptic promoters active in E. coli cells. These promoters drive the expression of 
viral structural proteins and these are toxic for the bacterial cells (Prof. Andres 
Mertis, personal communication). This problem is reduced by using low-copy 
number plasmids for icDNA constructs to limit the toxicity in E.coli cells (Petrakova 
et al., 2005) 
 
Propagation-deficient vectors provide a high level of biosafety and are preferred for 
clinical use (i.e. vaccination and gene therapy) and experiments that require a non-
propagating virus particle for a single round of infection. This is achieved by 
removing the subgenomic sequences to generate a replicon RNA.  If required, a 
foreign gene of interest placed under the control of the subgenomic promoter can be 
inserted. Figure 1.7 shows examples of the propagative-deficient alphavirus vector 
system 
Figure 1.7: Schematic representation of alphavirus propagative-deficient vector 
(A) Schematic representation of the alphaviral genome. (B) In the propagative-deficient 
alphavirus vector the subgenomic sequence is replaced by a foreign gene and placed under the 
control of a subgenomic promoter.  
There are three different strategies to insert the propagative-deficient vector to the 
inside of a cell. The first strategy is to synthesise suicidal viral particles known as 
virus replicon particles (VRPs). VRPs are capable of only one round of replication. 
To synthesise VRPs, the structural genes are provided in trans either as separate 
RNA messages (helper) or in packaging cell lines (Karlsson & Liljeström, 2003; 
Polo et al., 1999). In the early studies, the structural genes were provided as a single 
helper RNA transcript. This allowed recombination between the replicon and the 
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helper RNA to take place easily and led to the production of infectious virus 
(Berglund et al., 1993). Therefore, to overcome this problem a split-helper system 
was developed where structural genes were provided as two separate RNA 
transcripts and a mutation was introduced in the structural genes. In the split-helper 
system, the capsid and glycoproteins are separated into two different RNA transcripts 
and are expressed separately (Fayzulin et al., 2005; Smerdou & Liljeström, 1999). 
The production of VRPs by the split-helper system is shown in Figure 1.8. 
 
Figure 1.8: Schematic representation of production of VRPs by split-helper system. 
The recombinant plasmid is coding for the replicase genes with the foreign gene of interest under 
the control of a subgenomic promoter. The two helper plasmids are coding for the capsid and 
glycoprotein genes. The three plasmids are linearised using Spe I followed by in vitro 
transcription. Three RNA transcripts are used to co-transfect BHK-21 cells. Recombinant VRPs 
are made and released. The released VRPs can be puriflied and used to infect cells to produce 
transient expression of foreign gene (see also Material and Methods). 
The second approach involves converting the replicase genes followed by a foreign 
gene (placed under the control of subgenomic promoter) into DNA and cloning them 
into a DNA plasmid placed under the control of a eukaryotic promoter derived from 
the CMV – IE (cytomegalovirus immediate-early) promoter. This DNA plasmid is 
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then directly transfected or electroporated into cells and this system is known as a 
layered DNA/RNA vector. This method is less time-consuming and more cost-
effective because in vitro transcription is not required (Berglund et al., 1998; 
Dubensky Jr et al., 1996). The third approach involves transfection or electroporation 
of in vitro transcribed RNA encoding the replicase followed by the gene of interest 
(Karlsson & Liljeström, 2003). The disadvantage of the second and third approaches 
is that it is often difficult to achieve high transfection efficiency and electroporation 
is often damaging to cells. Nevertheless, all the approaches have been proven to be 
efficient to express transgenes up to 5 kb at high levels for up to seven days (Morris-
Downes et al., 2001). 
Innate immunity in mammals 
Toll-Like Receptors (TLR) 
Toll-like receptors (TLRs) are a family of type I transmembrane receptor proteins 
responsible for the detection of infections. These receptors are characterised by an 
extracellular leucine-rich repeat (LRR) domain and an intracellular Toll/IL-1R (TIR) 
domain. The first member of this family, Toll, was first identified in Drosophila in 
1988 during a screening of genes responsible for embryonic polarity (Hashimoto et 
al., 1988). Five human Tolls were then discovered by Rock and co-workers and 
termed “Toll-like receptors” (TLR) (Rock et al., 1998). TLRs recognise different 
types of conserved pathogen associated molecular patterns (PAMPs).  Activation of 
TLRs through the detection of specific PAMPs leads to activation of NFκB and 
phosphorylation of interferon regulatory factor (IRF) -3 and -7 (Fitzgerald et al., 
2003). Characterised PAMPs include bacterial cell wall components such as 
lipopolysaccharide (LPS), peptidoglycan (PGN), lipoteichoic acid (LTA), and 
lipoarabinomannan (LAM). Viral-related PAMPs recognised by TLRs include: 
cytosine-phosphate-guanine (CpG) motifs on pathogen DNA by TLR 9, single-
stranded RNA (ssRNA) rich in guanine and uridine by TLRs 7 and 8 and double-
stranded RNA (dsRNA) by TLR 3 (Alexopoulou, 2001; Bauer et al., 2001; Diebold 
et al., 2004; Lund et al., 2004).  To date at least 11 TLRs have been identified in 
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humans and 13 in mice. The localisation of TLR is dependent on both the type of 
TLRs and the cell type. For example, TLR3 localises to the cell surface in human 
lung fibroblast cells and to intracellular vesicles such as phagosomes and endosomes 
in human monocyte-derived dentritic cells (Johnsen et al., 2006; Matsumoto et al., 
2002); TLR 7 and 9 localise to endosomes (Nishiya et al., 2005).  
Toll immune pathways 
In mammals, TLR signalling involves the binding of the receptor to a selection of 
downstream adaptor proteins. These adaptor proteins include myeloid differentiation-
88 (MyD88), TIR domain containing adaptor protein (TIRAP), Toll/IL-1R domain 
containing adaptor inducing IFN-β (TRIF), TRIF-related adaptor molecule (TRAM) 
and sterile α motif (SAM) and Armadillo repeat motif (ARM)-containing protein 
(SARM). Upon binding of ligand to the TLR, MyD88 mediates the association of a 
serine/threonine kinase called interleukin-receptor associated kinase-4 (IRAK-4) to 
the receptor complex. IRAK-4 recruits and phosphorylates IRAK-1 and IRAK-2. 
TNF receptor associated factor-6 (TRAF6) is then activated by IRAK-1, allowing 
translocation and interaction with membrane-bound TGF-β activated kinase (TAK1) 
and TAK-1 binding proteins (TAB) complex. TRAF6 and TAK-1 undergo 
polyubiquitination and TAK1 and TAB-2 undergo phosphorylation allowing the 
complex to translocate from membrane to cytosol, and the degradation of IRAK-1. 
Activated TAK-1 phosphorylates downstream targets such as IκB kinases (IKKs). 
The activated IKK complex phosphorylates and induces degradation of IκB which 
leads to activation of nuclear factor-κB (NF-κB).  Activated NF-κB can freely 
translocate to the nucleus and promotes transcription of proinflammatory cytokines, 
such as TNFα, IL-1, and IL-2.  The MyD88 pathway is utilised by TLR 7, 8 and 9 
(Takeuchi & Akira, 2007). However, TLR 3 associated with the endosomes utilises a 
MyD88-independent pathway with different adaptor proteins, TRIF and TRAM. 
Through interaction with TRIF and TRAM, IKKs, IKKε and TANK-binding kinase-
1 (TBK1) mediate activation of IRF3 to induce IFNβ promoter (Doyle et al., 2002; 
Kawai et al., 2001). Alternatively, TRIF can directly recruit and activate TRAF6, this 
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leads to the formation of the TAK1-TAB2 complex which activates the IKK 
complex which then activates NF-κB. 
The c-Jun N-terminal kinases (JNKs) signal transduction pathways 
The JNKs are an evolutionarily conserved sub-group of mitogen-activated protein 
(MAP) kinases (MAPK). Other sub-groups of MAPKs include extracellular signal-
regulated protein kinases (ERK) and the p38 MAP kinases. In mammals, JNK is 
activated in response to inflammatory cytokines (e.g. interleukin-1, lymphotoxin-β, 
tumor necrosis factor, and transforming growth factor-β), activation of TLRs (TLR-
3, TLR-4 and TLR-9) or exposure to environmental stress.  JNKs are 
phosphorylated/activated by upstream MAPK kinases (MKKs), MKK4 and MKK7. 
MKKs are in turn phosphorylated/activated by upstream MAP kinase kinase kinases 
(MAPKKK). MAPKKKs respond to diverse stimuli, examples include: Ras or Rho 
family GTPase, ubiquitination by IL-1 receptor signalling complex for TAK1, 
phosphorylation by PAK, GCK and HPK. It is well-established that JNK is related to 
apoptotic cell death. It appears to promote ubiquitination of the caspase-8 inhibitor 
cFLIP.  JNK also phosphorylates H2AX, a DNA damage repairing protein which 
may be responsible for DNA fragmentation. The use of JNK knock-out primary 
fibroblast cells shows that JNKs are responsible for the downstream release of pro-
apoptotic protein from mitochodria in stress-induced apoptosis. Another important 
role of MAPKs is regulation of T cell development, activation and differentiation. 
However, the contribution of the JNK signalling pathway to these processes has not 
been resolved (Rincón et al., 2001). 
Retinoic acid-inducible gene-I and melanoma differentiation-associated gene 
5 
Retinoic acid-inducible gene-I (RIG-I), melanoma differentiation-associated gene 5 
(MDA5) and laboratory of genetics and physiology-2 (LGP-2) are protein receptors 
within the RIG-I like receptors (RLRs) family. These proteins are present in the 
cytoplasm and characterised by containing a DExD/H-box RNA helicase domain. In 
addition to the DExD/H-box RNA helicase domain, RIG-I and MDA5 have two N-
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terminal caspase activation and recruitment domains (CARDs). A CARD domain is 
also present on the mitochondrial adaptor protein MAVS, also known as Cardif, IPS-
1 or VISA. In the present of viral RNA ligand, RIG-I interacts with MAVS through 
CARD-CARD interaction. MAVS then activates downstream signalling leading to 
the activation of transcription factors such as IRF-3, IRF-7 and NF-κB (Yoneyama & 
Fujita, 2009). Therefore, RIG-I and MDA5 are key mediators of antiviral immunity 
responsible for detection of infection by RNA viruses and induction of interferons.  
The natural RIG-I ligands include: virus genome containing 5’-PPP groups (Figure 
1.9), such as genomes from flu and rabies viruses (Hornung et al., 2006; Pichlmair et 
al., 2006; Plumet et al., 2007); non-genomic viral transcripts or replication 
intermediates and RNA derived from host cells that is cleaved by RNase L (Malathi 
et al., 2007; Samanta et al., 2006). On the other hand, the natural MDA5 ligands are 
less well defined. MDA5 recognises polyinosine-polycytidylic acid (poly(I:C)) and 
high levels of dsRNA during viral infection but also mixed structures of single and 
double stranded RNA (Kato et al., 2006; Pichlmair et al., 2009). Nevertheless, RIG-I 
and MDA5 have different roles in the recognition of RNA viruses (Kato et al., 2006).  




Figure 1.9: Illustration of dsRNA detection by RIG-I and the downstream signalling 
pathway. 
This is a diagram of the flu virus life cycle and the detection of viral RNA molecules carrying 5’-
PPP groups by a cell. Viral RNA molecules containing 5’-PPP groups are detected by RIG-I. 
Activated RIG-I signals MAVS via the CARD domain. NF-κB and IRF-3 are activated in turn 
and induce transcription of antiviral genes.  RD/CTD (repressive domain/C-terminal domain); 
TM (transmembrane domain). Figure adapted from Rehwinkel, 2010 with permission. 
Protein Kinase R 
Protein kinase R (PKR) is an interferon induced enzyme which is activated by 
double-stranded RNA or PKR-activating protein (PACT). PKR is a 65-KDa protein 
first discovered in mouse L cells by treatment of sepharose bound Poly (I:C). The 
protein was isolated by chromatography on columns of Poly I:C-Sepharose 
(HOVANESSIAN & KERR, 1979).  PKR consists of a dsRNA binding domain 
located at the N-terminal and a kinase domain and PACT binding motif at the C-
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terminal. The protein is constitutively expressed at a low level in cells and expression 
is enhanced when the cell is exposed to IFN-α/β or virus infection. PKR remains 
inactive until it binds with specific activators such as dsRNA, e.g. dsRNA from viral 
replication intermediates.  Activated PKR becomes auto-phosphorylated and in turn 
phosphorylates the eukaryotic transcription initiation factor 2α (eIF2α) which 
modulates translation in cells (Li et al., 2006). Phosphorylation of eIF2 impedes 
recycling of eIF2 to its active guanosine triphosphate (GTP) bound form, which leads 





 is required for loading the initiator methionine onto the 48S 
preinitiation complex to begin translation (Wek et al., 2006).  
In mammals SFV infection highly activates PKR, leading to almost complete 
phosphorylation of eIF2α and subsequent translational shut down (Barry et al., 2009; 
Ventoso et al., 2006). This shut-off affects host protein synthesis and the production 
of viral non-structural proteins but not structural protein (McInerney et al., 2005). 
Structural protein escapes translational shut-down and is translated efficiently in the 
presence of eIF2α phosphorylation due to a hairpin loop structure located 
downstream of the AUG initiator codon at the 5’ end of the subgenomic RNA. This 
loop structure stalls the ribosomes on the correct site to initiate translation on 
subgenomic mRNA (26s), bypassing the requirement for eIF2α (Ventoso et al., 
2006).  PKR also activates the transcription factor NF-κB by phosphorylation of its 
inhibitor, IκB, for targeted polyubiquitination and subsequent degradation by 
proteosomes (Kumar et al., 1994). This allows NF-κB to bind on promoters of pro-
inflammatory genes such as IFN and promote transcription. In some viral infections, 
PKR has been shown to be an essential defence mechanism. For instance, mice 
lacking PKR are predisposed to lethal intranasal infection by the usually innocuous 
vesicular stomatitis virus, and also display increased susceptibility to influenza virus 
infection (Balachandran et al., 2000). Also, in Herpes simplex virus 1-infected cells, 
NF-κB is activated in wild-type murine embryonic fibroblast cells (MEFs) but not in 
PKR-null cells which strongly supports the idea that PKR plays an important role in 
the innate immune response (Taddeo et al., 2003). In MEFs, PKR delayed virus 
protein synthesis, production of infectious virus and caspase-3-activated cell death 
and reduced the yield of infectious virus by 90 %. Furthermore, PKR contributes to a 
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large proportion of the IFN-β response, the levels of IFN-β transcripts in PKR
−/−
 
MEFs at 8 h were 80 % lower than those in wt MEFs and levels of functional IFN at 
24 h were 95 % lower (Barry et al., 2009). 
Endoribonuclease (RNase L) 
RNase L is an effector enzyme in the 2-5A enzymatic pathway, and the pathway is 
under interferon regulation. It is constitutively expressed in most mammalian cell 
types and it remains inactive under normal circumstances. The pathway is activated 
by IFN, inducing transcription of several 2-5A synthetase genes. These synthetase 
proteins will be activated when they bind with dsRNAs. Activated 2-5A synthetase 
converts ATP into 5’-triphosphorylated oligoadenylates; these contain 2’-5’ 
phosphodiester bonds, unlike 3’-5’ linkages in RNA and DNA.  2-5A acts as a 
specific activator of RNase L. Upon binding, RNase L is activated to cleave single-
stranded RNAs at UpN (mainly UpU and UpA) sequences in single stranded regions 
of RNA (both cellular and virus).  The role played by RNase L in IFN-induced 
antiviral activity has been demonstrated by i) transfection of 2-5A or stabilised 2-5A 
analogues to cells to inhibit the pathway (Watling et al., 1985)  which restores 
encephalomyocarditis virus (EMCV) RNA synthesis and virus yield, ii) constitutive 
expression of 2-5A synthetase and RNase L, which confers resistance to picornavirus 
infection (Chebath et al., 1987; Ghosh et al., 2000) , iii) in vitro study in mice which 
shows RNase L is activated in WNV infected cells and responsible for antiviral 
response to flaviviruses (Scherbik et al., 2006) iv) in vivo studies on RNASEL
-/- 
mice 
which show increase in susceptibility to infection with EMCV, Coxsackievirus B4, 
WNV and Herpes simplex virus 1 (Samuel et al., 2006; Zheng et al., 2001; Zhou et 
al., 1997).  
RNA interference (RNAi) 
To date there is no evidence of that RNAi function as an antiviral defence in 
mammals. There is no evidence that long double stranded RNA are being processed 
into 21–23 nt in human cells. However, introduction of small interfering RNA 
(siRNA) can trigger RNAi in human Hela cells (Hall & Alexander, 2003).  




Apoptosis is a vital process in development, in the regulation of cell numbers in the 
mature organism and in the elimination of damaged cells. It also functions as an early 
defence against virus infection at least in mammals and possibly also in 
invertebrates.  The term apoptosis was used to describe a dying cell displaying 
unique morphology including cell shrinkage, nuclear condensation and cytoplasmic 
blebbing.  In mammals, apoptosis can be triggered by at least two different paths, the 
intrinsic and extrinsic pathways. The intrinsic pathway involves permeabilisation of 
the mitochondrial outer membrane and subsequent release of mitochondrial contents 
(such as: cytochrome c, complex of apoptotic protease activating factor (Apaf) -1 
molecules, pro-caspase-9 and ATP).  Upon the release of mitochondrial contents, the 
apoptosome forms and caspase-9 is activated. Caspase-9 cleaves and activates the 
effector caspases-3 and -7.  The extrinsic pathway is cell surface receptor-mediated. 
The receptors involved in initiating this pathway are predominantly from the tumour 
necrosis factor (TNF) receptor family. Receptors of this family have an intracellular 
death domain (DD).  Ligands induce oligomerisation of the receptors and 
conformational change which allows the binding and activation of the adaptor 
protein Fas-associated DD protein (FADD). The receptors and FADD proteins form 
a death-inducing signalling complex (DISC). Multiple caspase-8 molecules can bind 
to a DISC complex allowing the proteolytic activation of neighbouring caspase-8. 
Activated caspase-8 can directly activate caspase-3.  Notably, both intrinsic and 
extrinsic pathways lead to the activation of caspase-3 and -7. Upon activation, 
caspase-3 cleaves a variety of downstream proteins, including inhibitor of caspase-
activated deoxyribonuclease (ICAD), which leads to degradation of chromosomal 
DNA, a DNA repairing protein Poly (ADP-ribose) polymerase and cytoskeleton 
proteins. 
For some viruses apoptosis may aid propagation, but in most virus infections, 
apoptosis is a cellular altruistic response which terminates the infected cell 
prematurely to prevent the virus from replicating and being released to infect 
surrounding cells.  Numerous viruses have evolved pro- and anti-apoptotic genes to 
mediate their propagation and replication.  There are multiple interactions between 
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viruses and host cells which lead to the apoptotic response of the host cell.  For 
example, attachment and entry can trigger caspase-8 via the Fas signalling pathway 
(Liu & Zhang, 2007). Presence of dsRNA in the cytoplasm also triggers an apoptotic 
response. During replication, RNA viruses produce dsRNA replication intermediates. 
These are detected by mechanisms including TLR, PKR, RIG-I and MDA5.  On the 
translational level, viral protein synthesis at the endoplasmic reticulum (ER) can also 
trigger an apoptotic response by activation of the unfolded protein stress response. 
This attempts to restore balance by increasing protein folding capacity and inhibiting 
translation but if this fails it induces cell death (Barry et al., 2010). 
Interferon (IFN) system 
Interferon was first discovered during an experiment in which a transferable anti-
viral state was produced by fluid from a chick chorio-allantoic membrane infected 
with heat-inactivated influenza virus (Isaacs & Lindenmann, 1957) . IFNs are a 
multi-gene family of inducible protein cytokines. Their best characterised role is the 
ability to inhibit replication of viruses through induction of an antiviral state.  The 
IFN proteins consist of two families, the type I viral induced IFN family including 
IFN-α and IFN-β and the type II immune induced family (induced by mitogenic or 
antigenic stimuli of leukocytes) IFN-γ.  Most virus-infected mammalian cell types 
are capable of producing IFN-α/β. In contrast, IFN-γ is only produced by cells of the 
immune system including natural killer (NK) cells, CD4 Th1 cells, and CD8 
cytotoxic suppressor cells (Samuel, 2001) .   
In human there are 13 IFN-α genes, 1 IFN-β gene, and 1 IFN-γ gene. IFN-α genes 
can be divided into two groups: an immediate-early response gene (IFN-α4) which is 
induced rapidly and without the need for ongoing protein synthesis; and a set of IFN-
α genes consisting of IFN-α2, IFN-α5, IFN-α6, and IFN-α8, that display delayed 
induction and are induced more slowly and require cellular protein synthesis (Marié 
et al., 1998) .  The alpha4 and beta IFNs initially stimulate the JAK-STAT pathway 
through a common cell surface receptor consisting of two interferon-alpha/beta 
receptor (IFNAR) subunits, IFNAR-1 and IFNAR-2. This results in activation of 
transcription factor interferon-stimulated gene factor 3 (ISGF3). IFN-stimulated 
Chapter 1  Introduction 
39 
 
genes are induced by ISGF3 and activated IFN regulatory factor 7 (IRF7) is 
produced. IRF7 is activated (phosphorylated) in response to detection of virus and in 
turn induces the delayed IFNα gene set. IFNs are essential to protect against many 
viruses. IFN-β
-/-
 mice and IFNAR
-/-
 mice are highly susceptible to many viruses 
(Deonarain et al., 2000).   
Janus kinases (JAK) & signal transducers and activators of transcription (STAT) 
The Janus kinases (JAK) and signal transducers and activators of transcription 
(STAT) are key components of the JAK/STAT signalling pathway. The pathway 
begins with activation of the IFN receptor by IFN-mediated heterodimerisation of the 
cell surface receptor subunits, IFNAR-1 and IFNAR-2 with IFN-α/β and IFNGR-1 
and IFNGR-2 with IFN-γ.  The intracellular domains of the IFN receptor subunits are 
already in association with JAK. There are four members of the JAK family, Jak-1, 
Jak-2, Jak-3 and Tyk-2.  Activation of the interferon receptor (heterodimerisation) 
brings two JAK tyrosine kinases enzymes together, allowing transphosphorylation of 
tyrosine residues in juxtaposition. Transphosphorylation of JAKs allows cytosolic 
STAT protein to dock onto the receptor complex via their SH domain.  The STAT 
family of proteins are latent cytoplasmic transcription factors that become tyrosine 
phosphorylated by the JAK kinase after recruitment. There are seven known 
members of the STAT protein family, Stat-1, Stat-2, Stat-3, Stat-4, Stat-5a, Stat-5b, 
and Stat-6.  Activated STATs form either heter- or homo-dimers prior to nuclear 
translocation (Figure 1.10). Different members of the JAK and STAT families have 
different functions in cytokine signalling. The Jak-1, Jak-2 and Tyk-2 kinases and the 
Stat-1 and Stat-2 transcription factors are the main players in IFN-dependent 
signalling for induction of anti-viral responses. In mammals, there are four JAK and 
seven STAT genes which are activated in different combinations by more than 30 
cytokines and growth factors (Darnell Jr., 1997). 
Once localised in the nucleus, STATs bind to specific DNA sequences 
(TTCNNNGAA) and induce transcription of specific genes (Agaisse & Perrimon, 
2004). Activation of STAT proteins can lead to macrophage activation, increase in 
expression of MHC proteins, cytokine and interferon synthesis, and stimulation of 
the production of granulocytes and macrophages. 




Figure 1.10: A schematic representation of IFN signaling by the JAK-STAT pathway. 
The signalling cascade begins with binding of the IFN-α/β or IFN-γ to their respective receptor 
subunits. IFN binding leads to receptor dimerisation and transphosphorylation of pairs of Jak. 
Stat are in turn phosphorylated.  IFN-α/β activated pathway leads to the phosphorylation and 
dimerisation of the Stat-1 (p91) and Stat-2 (p113) proteins and subsequent translocation, along 
with IRF-9 (p48), to the nucleus. This protein complex is known as IFN-stimulated gene factor 3 
(ISGF-3), which activates the transcription of IFN-α/β inducible genes through the ISRE.  IFN-γ 
activates and dimerises 2 Stat-1 proteins through Jak-1 and Jak-2 kinases. The Stat-1 dimer 
complex, known as GAF for gamma activation factor, activates the transcription of IFN-γ 
inducible genes through the GAS enhancer element. Figure adapted from Samuel, 2001 with 
permission. 
Innate immunity in insects 
Like mammals, insects are also vulnerable to invading pathogens but unlike 
mammals they do not have an IFN system or any adaptive immunity. However, 
arboviral infection of arthropod cell cultures often leads to a non-lethal persistent 
infection. The ability to efficiently control arboviral infection is solely achieved by 
the innate immune system. Upon detection of Gram-positive bacterial or fungal 
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infection, the proteolytic signal cascade pathway Toll is activated whilst the 
detection of Gram-negative bacterial infection activates the immunodeficiency 
(IMD) pathway. Although, these two pathways are homologues of the nuclear factor-
κB (NF-κB) signalling pathways in mammals, they do not appear to share any 
intermediate components and they mediate differential expression of antimicrobial 
peptide (AMP) -encoding genes via distinct NF-κB-like transcription factors. 
Activation of these defence pathways leads to transcriptional induction of AMPs 
including attacin, ceropin, defensin, diptericin, drosocin, drosomycin, and 
metchnikowin. These are made in the fat body, a functional equivalent of 
mammalian liver, and secreted in the haemolymph to control and eliminate invading 
pathogens (Hoffmann et al.., 2002). Other evolutionary conserved signalling 
pathways include Janus kinase (JAK)/signal transducer and activator of transcription 
(STAT), c-Jun N-terminal kinase (JNK) and RNAi pathways. 
Toll pathway 
In Drosophila there are three NF-κB homologues, Doral, Dif and Relish. Toll does 
not act as a pathogen recognition receptor (PRR). Upon Gram positive bacterial or 
fungal infection, the toll pathway is triggered by PAMPs such as peptidoglycan 
binding with peptidoglycan recognition proteins (PGRPs) leading to an 
uncharacterised serine protease cascade and the processing of Spätzle.  Cleaved 
Spätzle becomes a dimeric cytokine that binds to extracytoplasmic regions of Toll 
and cross links two Toll ectodomains. Activated dimeric Toll recruits adaptor 
proteins dMyD88 (myeloid differentiation primary-response gene 88), a functional 
homologue of mammalian MyD88, Tube and Pelle via its intracytoplasmic TIR 
domain. MyD88 recruits and activates Tube and in turn, Tube recruits and activates 
protein kinase Pelle, a homologue of mammalian serine/threonine kinase a 
homologue of IL-1R-associated kinase (IRAK-1). All three adaptor proteins contain 
death domain (DD). Pelle phosphorylates the I-κB like protein Cactus for 
degradation, possibly through polyubiquitylation, allowing nuclear translocation of 
the NF-κB like transcription factors DIF (dorsal-related immune factor) and Dorsal 
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to promote transcription of antimicrobial peptide genes (Rämet et al., 2002; Weber et 
al., 2003). Figure 1.11 shows the Toll pathway and its components schematically.  
  





Figure 1.11: A schematic representation of Toll pathway in Drosophila. 
The antifungal and anti-Gram positive bacteria Toll pathway. Toll pathway is initiated when the 
Spatzle protein binds to its ligand. Cleaved Spatzle binds and activates Toll receptor, lead to the 
formation of Toll-induced signalling complex (TISC) consisting of dMyD88, Pelle, Tube, and 
possibly dTRAF2. Pelle phosphorylates Cactus, an IκB homologue, for degradation. This allows 
DIF and Dorsal (NF-κB homologues in flies) in the cytoplasm to translocate into the nucleus and 
induce transcription of antifungal factors such as Drosomycin. Figure adapted from Ferrandon et 
al., 2007 with permission. 
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Immune deficiency (IMD)/ JUN N-terminal kinases (JNKs) signal transduction 
pathways 
In Drosophila, the IMD pathway responds to interaction of peptidoglycans in Gram-
negative bacteria with peptidoglycan recognition proteins (PGRP), PGRP-LC and 
PGRP-LE (Choe et al., 2002; Ferrandon et al., 2007; Gottar et al., 2002; Kaneko et 
al., 2006; Rämet et al., 2002). PGRP-LC is a transmembrane receptor of the IMD 
pathway, whereas PGRP-LE is a secreted receptor in the haemolymph. Both PGRPs 
contain a receptor interacting protein (RIP) and a homotypic interaction motif 
(RHIM) and are presumed to be responsible for initiating signal transduction cascade 
of the IMD pathway. However, it is unclear whether there are unidentified adaptors 
that mediate the interaction between PGRP and IMD (Kaneko et al., 2006).  IMD is a 
death domain protein which is homologous to the mammalian receptor interacting 
protein 1 (RIP1) from the tumour necrosis factor (TNF) pathway which is essential 
for NF-κB and mitogen activated protein kinase (MAPK) activation (Georgel et al., 
2001). Activation of IMD also ultimately targets the NF-κB-like transcription factor 
Relish for activation (Hedengren et al., 1999). Unlike other NFκB-like transcription 
factors, Relish is bipartite, consisting of an N-terminal Rel/NF-KappaB homology 
domain and a C-terminal IκB -like domain with Ankyrin repeats. Upon bacterial 
infection, IMD initiates two different processes signalling the endoproteolytic 
cleavage of Relish.  
The first process is to phosphorylate Relish. IMD activates the downstream 
MAPKKK, transforming growth factor-β (TGFβ)-activated kinase 1 (TAK1). TAK1 
then forms a complex with regulatory subunit TAK-binding protein 2 (TAB2). 
TAK1 complex (TAK1/TAB2), also known as Drosophila TAK1 (dTAK1), 
mediates the activation of the IKK signalling complex formed by the catalytic 
subunit IRD5 (immune-response deficient 5; the fly homologue of mammalian 
IKKβ) and a regulatory subunit Kenny (the fly homologue of mammalian IKKγ). 
This phosphorylation process is thought to target Relish for subsequent cleavage but 
direct evidence of this process is still lacking.  This process shares striking 
similarities with mammalian activation of TAK1 and IKK, as they both require K63-
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linked polyubiquitin conjugation (Chen, 2005; Hasdemir et al., 2009; Zhou et al., 
2005). 
The second process is the cleavage of Relish. This involves 3 genes: imd, Fadd 
(FAS-associated death domain), and Dredd (death-related ced-3/Nedd2-like protein). 
IMD recruits the DD-containing adaptor FADD which interacts with the caspase-8 
homologue DREDD. This process is absolutely required for DREDD to interact with 
Relish to direct endoproteolytic cleavage (Leulier et al., 2000; Leulier et al., 2002; 
Naitza et al., 2002). Endoproteolytic cleavage separates N and C terminal domains. 
C-terminal Ankyrin domain remains in the cytoplasm and N-terminal Rel-homology 
domains translocate to the nucleus to promote transcription of antimicrobial peptide 
genes include Cecropin, Diptericin, Attacin, Defensin and Metchnikowin (Stöven et 
al., 2000). The FADD-DREDD complex is also required upstream of the dTAK1 
complex in the first process to activate the IKK complex (Figure 1.12).  




Figure 1.12: A schematic representation of the IMD pathway in Drosophila. 
The anti-Gram negative bacteria IMD pathway. This cascade signals through the receptor PGRP. 
Relish is activated by endoproteolytic cleavage in response to bacterial infection, leading to the 
production of N-terminal Rel-homology domains that translocate to the nucleus. Figure adapted 
from Ferrandon et al., 2007 with permission. 
 
Besides Relish activation, the IMD pathway splits into a second branch which also 
activates the JUN N-terminal kinase (JNK) pathway. The branch point begins 
downstream from the TAK1/TAB2 complex, which may signal a TNF-like signalling 
cascade controlled by Eiger and Wengen (Geuking et al., 2005).  Genome-wide 
expression profiling has revealed that JNK and JAK/STAT pathways contribute to 
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the temporal expression of microbial challenge-induced genes (Boutros et al., 2002). 
Medeiros and co-workers showed that the JNK pathway was triggered in 
Frankliniella occidentalis by infection with Tomato spotted wilt virus (TSWV). A 4 
fold increase in transcriptional level of JNK cascade receptor signalling protein was 
observed (Medeiros et al., 2004). 
Janus kinases (JAK) & signal transducers and activators of transcription 
(STAT) 
In insects, no interferon or interferon homologue has been identified.  However, 
STAT exists in insects and it is activated in response to bacterial infection in the 
mosquito Anopheles gambiae (Barillas-Mury et al., 1999).  Activation of the 
Drosophila JAK-STAT pathway is initiated by binding of ligand Upd to a 
homodimer subunit of the transmembrane cell surface receptor Domeless (Dome), a 
homologue of the vertebrate type I cytokine receptors (Brown et al., 2001). Upd is a 
protein encoded by unpaired (upd) to regulate cell proliferation in Drosophila 
growth and development (Arbouzova & Zeidler, 2006).  The intracellular domains of 
the Dome receptor subunits are already in association with the homologue of JAK 
tyrosine kinase, Hop. Activation of Dome receptor (homodimerisation) brings two 
Hop together, allowing transphosphorylation. The activated Hop will in turn 
phosphorylate Dome resulting in the formation of docking sites for cytoplasmic 
STATs. This activated Dome/Hop complex recruits and mediates 
dimerisation/activation of STATs. Activated STAT dimers translocate into the 
nucleus and induce transcription of target genes.  Infection of Drosophila with 
Drosophila C virus (DCV) did not trigger the induction of antimicrobial peptides but 
triggered transcription of a set of genes which contain consensus binding sites for the 
transcription factor STAT (Dostert et al., 2005).  In another study, Souza-Neto and 
co-workers have shown that the JAK-STAT pathway in Ae. aegypti is responsible for 
controlling dengue virus infection. RNAi-mediated silencing of Hop and Dome 
increased the mosquito’s susceptibility to dengue virus infection, whereas silencing 
of protein inhibitor of the activated STAT (PIAS), the negative regulator of the JAK-
STAT pathway, increased the resistance to virus infection. This suggested the JAK-
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STAT pathway is part of Ae. aegypti’s antiviral defence independent from other 
pathways (Souza-Neto et al., 2009). 
Apoptosis 
Apoptosis also takes place in insect cells. An example of apoptosis in insect cells as a 
response to infection is observed in baculovirus infection of Spodoptera frugiperda 
cells (SF-21) (Prikhod’ko & Miller, 1996). Baculoviruses have evolved mechanisms 
to regulate apoptosis during infection by expressing proteins that inhibit caspase 
activation, for example, caspase inhibitor p35 and the inhibitor of apoptosis (IAP) 
proteins.  Infection of SF-21 cells with a mutant strain of Autographica californica 
multicapsid nucleopolyhedrovirus (AcMNPV) containing mutations in the p35 gene 
triggers early apoptosis and results in 100-fold decrease in virus production and the 
loss of occluded virus.  Infectivity is reduced compared to wild type virus when p35-
mutant viruses infect S. frugiperda larvae. Apoptosis has been observed in the 
mosquito midgut epithelia after WNV infection (Vaidyanathan & Scott, 2006). 
RNA interference (RNAi) in insects 
RNAi is an evolutionarily conserved cellular process which was first discovered in 
plants and termed co-suppression (Napoli et al., 1990) and is also known as post-
transcriptional gene silencing (PTGS). This discovery was first made when an 
antisense chalcone synthase gene was introduced into transgenic plants resulting in 
suppression of both introduced gene and the homologous endogenous gene of flower 
pigmentation (van der Krol et al., 1988). Since then, the phenomenon has been 
observed in other plant species and in fungi (Neurospora crassa). The gene 
responsible for post-transcriptional transgene-induced gene silencing was identified 
and silencing was termed as quelling in fungi (Cogoni & Macino, 1997). PTGS can 
be triggered by introduction of transgenes or plant virus, and the silencing effect is 
transmitted from cell to cell, and spreads throughout the entire plant.  Fire and co-
workers decided to utilise and investigate a technique called antisense inhibition in 
Caenorhabditis elegans, this later became known as RNAi. Antisense inhibition was 
first manipulated by by reinserting a clone of the thymidine kinase (TK) gene in 
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reverse orientation and expressing it in mouse L cells resulting in transient reduction 
of the TK gene (Izant & Weintraub, 1984). Fire and co-workers discovered that 
production of antisense RNA through a DNA vector disrupts target gene expression 
(Fire et al., 1991). This group later observed that injection of double stranded RNA 
molecules into a cell produced a target gene silencing effect far more potent than 
injecting sense or antisense RNA alone. This suggested a catalytic or amplification 
component in the interfering process (Fire et al., 1998). Then Hamilton and 
Baulcombe made the important discovery of 25nt RNA species in plants undergoing 
co-suppression. These small RNAs were complementary to both the sense and 
antisense strands of the gene being silenced (Hamilton & Baulcombe, 1999). Then 
Zamore and co-workers demonstrated that dsRNAs are processed to RNA segments 
of 21-23 nucleotides in Drosophila embryo lysates (Zamore et al., 2000).  
RNAi is triggered by the presence of (exogenous or endogenous) long double-
stranded RNA (dsRNA) in the cell.  Long dsRNA is processed by the enzyme Dicer, 
into 21 to 26-nt siRNAs with 2-nucleotide overhangs at the 3’-ends. These siRNAs 
are then assembled into a RNA-induced silencing complex (RISC). During assembly, 
one strand (passage strand) of the siRNA duplex is removed and the other (guiding 
strand) is assembled into the RISC to direct target degradation.  This results in the 
degradation of any RNA with sequence homology to the siRNA (Bernstein et al, 
2001). 
Dicer 
Dicer is an enzyme of the RNase III endonuclease family. There are 3 classes of 
proteins within this family but all contain one or two RNase III domains in tandem, 
and are conserved in bacteria, bacteriophages, and fungi. Class 1 RNase III enzymes 
were discovered in bacteria. They consist of a single N-terminal RNase III domain 
and a single C-terminal dsRNA binding domain (dsRBD).  Class 2 RNase III 
enzymes consist of two RNase III domains and one dsRBD at the C-terminal with an 
uncharacterised structural motif at the N-terminal. An example of a class 2 enzyme is 
the human Drosha protein responsible for processing pri-miRNA into pri-miRNA 
hairpin.  Class 3 enzymes have multiple domains including two ribonuclease 
domains, one or two dsRBD at the C-terminus, an N-terminal DExD/H-box helicase 
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domain, a small domain with unknown function (DUF283), and a PAZ domain. An 
example of class 3 RNAse III endonuclease is the Giardia intestinalis Dicer (Gi-
Dicer). X-ray crystallography shows the protein contains two endonucleases, PAZ, 
and platform domains (Macrae et al., 2006).  A single RNase III domain has seven α-
helices and dimerisation of two RNase III domains provides a valley-shaped dsRNA-
binding surface which is the active site for cleavage. In additional, a divalent metal 
ion Mg
2+
 is required for the catalytic cleavage reaction (Nowotny & Yang, 2009). 
The hallmark of RNase III cleavage is a product with a 5’-phosphate and a 2nt 3’-OH 
overhang. Both Drosha and Dicer can process imperfectly base paired dsRNA, 
furthermore Dicer is reported to cleave substrates with bulges or bubbles 6-10 bps 
away from the endonuclease active site (MacRae et al., 2007).   
Plant and insect genomes encode multiple Dicers or Dicer-like proteins. Different 
Dicer-like proteins function either independently or redundantly within the RNA 
silencing pathway.  In Drosophila, miRNA are generated by Dicer-1 (Dcr-1), 
whereas siRNAs and viRNAs are generated by Dicer-2 (Dcr-2).  In Arabidopsis 
thaliana, there are four Dicer-like proteins (DCL), DCL1-4. Each has a different 
role. DCL1 is responsible for miRNA processing, whereas DCL2, DCL3 and DCL4 
process long dsRNA into 22, 24 and 21 base pair products, respectively.  However, 
the situation is different in helminths and vertebrates, in which there is only one 
Dicer encoded in the genome.  
RNA-induced silencing complex (RISC) 
Once dsRNA is processed, siRNA is transferred into the RISC complex. In 
Drosophila, Dcr dimerises with R2D2 to present siRNA into AGO2-RISC. The 
RISC complex is the effector of silencing in the RNAi pathway. The exact molecular 
composition of the RISC is not well defined due to its wide range of binding 
partners. However, at the core of the RISC complex is a member of the Argonaute 
protein family. The eukaryotic Argonaute family is classified into three major 
phylogenetic classes based on amino acid sequence homology.  The three classes 
include Argonaute (Ago), Drosophila protein P-element induced wimpy testis (PIWI) 
and nematode-specific worm Argonaute (WAGOs).  Protein structural analysis 
carried out mostly on prokaryotic Argonautes has revealed a bilobed structure, with 
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each lobe responsible for binding opposite ends of the guiding strand.  The N-
terminal contains a PAZ domain, which binds to the 3’ end of the guiding strand.  
The C-terminal contains a middle domain which binds to the 5’-phosphate of the 
guiding strand and a RNase H-like PIWI domain which hydrolyses target RNA.  
Upon transfer of siRNA into RISC, the 5’-phosphate and the first base are held in a 
pocket between the middle and PIWI domains. Therefore the first base of the guiding 
strand does not contribute to target recognition. The rest of the guiding strand stays 
in contact with the Argonaute protein with its phosphodiester backbone. The 3’ two 
nucleotides are clamped into a hydrophobic cleft in the PAZ domain. Bases 2-6 of 
the guiding strand, named the “seed region”, are fully exposed and face out from 
Argonaute and act as an initial probe for RNA targets. Once the guiding strand is in 
place, Argonaute engages target RNA for degradation (Kim, 2008; Mi et al., 2008; 
Nowotny & Yang, 2009). 
It is now understood that RNAi is an evolutionarily conserved mechanism that 
provides a sequence-specific immunity against viruses in plants and insects 
(Baulcombe, 2004; Lecellier & Voinnet, 2004), regulates expression of cellular 
genes by sequence-specific degradation of RNA transcripts and maintains the 
genome by suppressing mobilisation of transposable elements (Ketting et al., 1999). 
The primary function of RNAi is to destroy viral RNA transcripts in a sequence-
specific manner (Jorgensen et al., 1998). As a defence mechanism, RNAi is 
especially effective against virus present in a cell as dsRNA because RNA can form 
double stranded structures throughout the course of viral replication.  
In insects, RNAi is capable of post-transcriptional gene silencing, destroying foreign 
dsRNA and mounting a sequence specific antiviral response. In Drosophila 
melanogaster, Dicer is responsible for cleaving dsRNA into 21-23 bp siRNA 
(Zamore et al., 2000) and RNAi is an essential part of the antiviral response against 
Drosophila X Virus (DXV) infection. RNAi pathway mutants were found to be 
highly susceptible to DXV infection (Zambon et al., 2006). The RNAi pathway was 
shown to exist in Ae. albopictus C6/36 cells by using dsRNA to silence transgene 
expression from plasmids, SFV replicons and DENV replication. (Adelman et al., 
2002; Caplen et al., 2002). RNAi was shown to interfere with DENV-2 replication in 
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C6/36 cells previously infected with genetically modified SINV that contained a 290 
base region of DENV-2 prM in either sense or antisense orientation (Sanchez-vargas 
et al., 2004). In Anopheles gambiae, virus spread was significantly inhibited when 
ONNV was coinjected with dsRNA of ONNV nsP3 sequence (Keene et al., 2004). 
These authors demonstrated that the silencing An.gambiae Arganaute2 (AgAgo2) 
made mosquitoes more permissive to virus infection. Since then attempts have been 
made to produce transgenic mosquitoes expressing dsRNA in midgut or salivary 
gland tissues to block DENV infection in the mosquito vector (Travanty et al., 2004).  
Effect of alphaviruses on the innate immune response 
The interaction between replicating virus and host innate immune response is a 
critical factor in viral pathogenesis. Alphaviruses do not encode any protein that 
functions solely as an inhibitor of the innate immune response. However, replication 
of alphaviruses strongly down-regulates transcription and translation of cellular 
mRNAs which in turn affects activation of viral stress-inducible genes and 
suppresses the development of an antiviral state. Sarver & Strollar have 
demonstrated that host RNA synthesis is inhibited 1.5 to 1.7 fold in SINV infected 
Ae. albopictus cells by measuring 
3
H-uridine incorporation into cellular RNA (Sarver 
& Stollar, 1977). This host gene expression reduction was also observed in SFV 
infected Ae. albopictus cells and mouse NIH 3T3 cells (Fragkoudis et al., 2008). The 
expression of EEEV and VEEV capsid protein inhibits general cellular gene 
expression (Aguilar et al., 2007; Garmashova et al., 2007).  As mentioned above, 
SFV infection highly activates PKR, leading to almost complete phosphorylation of 
eIF2α and subsequent translational shut down (Barry et al., 2009; Ventoso et al., 
2006). This global shut-off effect affects host protein synthesis and is likely to play a 
part in dampening the activation of viral stress-inducible genes (McInerney et al., 
2005). 
In contrast to non-specific suppression, the multi-functional nsP2 plays a role in 
suppression of the type I interferon response (Breakwell et al., 2007). The effect of 
nsP2 on interferon production is demonstrated by infection with SINV with a 
mutation in the nsP2, which induces significantly higher levels of IFN-α/β secretion 
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both in vivo and in vitro (Frolova et al., 2002). In addition, SINV has also been 
shown to inhibit cellular transcription (Gorchakov & Frolova, 2005). The higher 
level of IFN-α/β could be due to the inability of this mutated virus to inhibit host 
gene expression, leading to activation of viral stress-inducible genes, which may be 
involved in development of an antiviral state. The same phenomenon has also been 
observed in cells infected with SFV (Gerald Barry, personal communication).  
Recently, the nsP2 of CHIKV has been shown to inhibit type I/II interferon-
stimulated JAK-STAT signalling by blocking STAT1 phosphorylation and nuclear 
translocation in mammalian cells (Fros et al., 2010). Individual expression of 
CHIKV nsPs showed that nsP2 is a powerful inhibitor of IFN-induced JAK-STAT 
signalling.  
In Ae. albopictus mosquito cells, SINV infection resulted in an increase in 
translocation of Relish into the nucleus. This strongly implies that SINV activates 
Relish-mediated transcription (Avadhanula et al., 2009).  In Ae. aegypti mosquitoes, 
SINV infection leads to changes in the transcription levels of 135 genes. Sanders and 
co-workers have shown that during early infection (PID 1) there was an almost 2-
fold increase in transcription level of Dorsal-related immunity factor (Dif). This 
suggests that the Toll innate immunity pathway responds to alphavirus infection. 
However, this transcript returned to the background level by (PID 4). At the same 
time (PID 4), transcription of three ubiquitin-ligase pathway components was down-
regulated. This ubiguitin-ligase pathway is a known regulator of NF-κB-like 
proteins. The Toll pathway requires ubiquitin ligase-mediated degradation of Cactus 
to activate Dif. Therefore, decrease in ubiquitin ligase levels may inhibit activation 
of the Toll pathway. This suggests that alphavirus infection can lead to modulation of 
NF-κB mediated innate immune pathways, whether this modulation is a direct effect 
of interaction between viral proteins and innate immune components has not yet been 
proven. On PID 8, there was a 4-fold increase in transcriptional level of a JNK 
cascade receptorsignalling protein, suggesting induction of the JNK cascade in 
response to SINV infection. More importantly, this study also showed that the 
transcription levels of a large number of genes with unidentified function changed 
upon SINV infection (Sanders et al., 2005). These unidentified genes may represent 
unidentified innate immune pathways in insects that are responsible for controlling 
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alpha virus infection. Sanders and co-workers have provided evidence that indicates 
that SINV may respond to innate immune defences by inhibiting Toll pathway 
activation  In Drosophila S2 cells, SINV infection leads to up-regulation of 210 
genes and down-regulation of 68 genes at PID 5. These genes encode for cytoskeletal 
and membrane trafficking components, immune-related components, transcription 
factors, cell cycle and cell division factors. Four of the immune-related genes are, 
again, involved in ubiquitination. The transcription level of Relish was also increased 
1.5-2 folds (Mudiganti et al., 2010). Avadhanula and co-workers have shown that 
Relish has a role in controlling SINV in Drosophila, as a relish
-/-
 mutant showed 
higher viral load and enhanced replication compared with the wild type (Avadhanula 
et al., 2009). Mudiganti and co-workers also showed that Thiol-ester containing 
protein II (TEP II) was up-regulated in S2 cells at PID5. TEP II is a member of the 
TEP family which plays an important role in immune responses as a component of 
the complement system in vertebrates, and is induced upon bacterial challenge in 
Drosophila (Meister & Lagueux, 2003). It has been suggested that expression of 
TEPs is under the direct regulation of the JAK-STAT pathway (Mathey-Prevot & 
Perrimon, 1998).  In An. gambiae mosquitoes, Sim and co-workers have shown that 
ONNV infection leads to changes in the level of transcription of 18 genes on PID14. 
Seven of these genes have been proven to be infection-induced and are involved in 
modulation of translation/replication factors and intracellular transport pathways. 
However, none of these seven genes are related to the innate immune signalling 
pathways. These genes included: EF-1α which is involved in host translational 
elongation and has been shown to bind with the positive strand of RNA viruses 
(BLACKWELL & BRINTON, 1997; Joshi et al., 1986); RpL35 encoding for 
ribosomal protein which may interact with the capsid protein of SFV (Ranki & 
Ulmanen, 1979); HSP70 encoding for heat shock molecular chaperone which may be 
involved in ONNV entry and protecting the vector vells from ONNV-induced 
molecular damage; DAN4 and agglutinin encoding for host membrane proteins .  
The findings of these authors have shown that different member of the alphavirus 
family can induce change in levels of gene transcription in Ae. aegypti and An. 
gambiae mosquitoes, and induce innate immune pathways such as Toll, JAK-STAT 
and IMD. However, viruses within the same family do not induce changes in level of 
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transcription of the same set of infection-inducible genes.  To date, there is no 
evidence that alphaviruses suppress immune signalling in mosquitoes. However, 
mosquito immune signalling is prone to interference by other viruses such as 
Japanese Encephalitis Virus (JEV). The NS5 protein of JEV has been shown to 
prevent STAT1 and TYK-2 phosphorylation in vertebrates and has been implicated 
in blocking phosphorylation of STAT in Ae. albopictus C6/36 cells (Lin et al., 2004, 
2006).  
  




Infection of mosquito cells with SFV activates anti-viral defences which reduce virus 
replication to levels below that required to trigger cell death resulting in a persistent 
infection. 
Aims and objectives 
AIM 
To characterise mosquito cell defence mechanisms against SFV infection. 
OBJECTIVES 
 Determine whether SFV infection of mosquito cell lines can be established.  
 Characterise SFV infection of mosquito cell lines.  
 Determine whether SFV triggers anti-viral defence mechanisms in mosquito 
cells. 
 Determine whether defence mechanisms include signalling from infected to 
uninfected cells. 
 Determine whether activation of known defence systems triggered by bacteria 
affects SFV infection. 
 Determine whether STAT gene expression affects virus replication. 
 Characterise viRNA biogenesis from SFV genome in mosquito cells. 
 Determine the efficiency of RNAi silencing in SFV infected mosquito cells. .
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Chapter 2: Materials and Methods 
Bacterial protocols 
Bacterial culture 
Escherichia coli (E. coli) strains were grown in Luria-Bertani (LB) medium or on LB 
plates with 1.5% agar. (Please see Appendix 1 for composition of LB.)  Media and 
agar were sterilised and melted during autoclaving.  For selection purposes, 
appropriate antibiotics were added to the medium prior to use; 100μg/ml ampicillin 
or 50μg/ml kanamycin (depending on strength of antibiotic resistance conferred by 
plasmids).  To prepare agar plates, LB agar was poured into Petri dishes (10 cm).  A 
suspension of bacteria was spread out on the surface of the agar with a glass 
spreader.  Plates were inverted and incubated at 37
o
C overnight (16 hr).  Single 
colonies retrieved from agar plates were picked to inoculate liquid medium.  Liquid 
cultures were incubated overnight (16 hr) at 37
o
C with constant shaking (225 rpm).  
All procedures were carried out under aseptic conditions.  
Transformation of XL 10-Gold® Ultracompetent cells 
The infectious SFV cDNA plasmid clone is a relatively large plasmid construct. The 
transformation of this large construct in regular competent cells i.e. DH5α cells does 
not often produce viable bacterial colonies. Therefore XL 10-Gold ultracompetent 
cells were used for efficient transformation of large DNA constructs (Please see 
Appendix 1 for source of competent cells). A vial of ultracompetent cells was thawed 
on ice and 100 l were aliquotted into 1.5 ml sterile pre-chilled eppendorf tubes.  
One μl of β-mercaptoethanol was added to the cells and incubated for 10 minutes on 
ice, and gently mixed every 2 minutes for the duration.  Approximately 200ng of 
plasmid was added to the cells and the mixture was incubated on ice for 30 minutes. 
Cells were then heat-shocked at 42
 o
C for approximately 30 sec followed by 2 
minutes of incubation on ice. The time of heat shock is crucial as it affects the uptake 
of DNA.  Nine hundred μl of pre-warmed SOC medium (Sigma-Aldrich) was added 
and the mixture was incubated at 37
o
C in an orbital shaker (225 rpm) for 1 hour.  
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During incubation, LB agar plates supplemented with corresponding antibiotics, 50 
to 100 μg/ml of ampicillin or kanamycin were placed in an incubator at 37
 o
C with 
the lid slightly tilted to warm and air dry the surface of the agar. Ten, 50 or 100 μl of 
transformed cells were pipetted on agar plates and evenly distributed across the 
surface with a sterile glass spreader beside a Bunsen burner. Transformation of pUC 
19 plasmid was carried out as a positive control. The agar plates were then inverted 
and incubated overnight (16 hr) at 37
o
C. The plates were examined for colony 
growth.  
Only uptake of plasmid would confer antibiotic resistance and allow formation of 
colonies. A single colony was used to prepare a small bacterial amplification (up to 
10 ml) as later described in “miniprep”, or to create a large plasmid stock as later 
described in “maxiprep”. 
Preparation of frozen stocks of transformed bacteria 
A single colony was isolated from an LB agar plate and used to inoculate 5ml of LB 
medium containing appropriate antibiotic. The culture was grown overnight (16 hr) 
in an orbital shaker (225rpm) at 37
o
C. The cultured bacteria were pelleted by 
centrifugation (6 minutes at 1500 x g) and the pellet was resuspended in 1 ml of 
sterile 50% glycerol in H2O. The sample was transferred to a sterile eppendorf tube 
and snap frozen using dry ice. The tube was stored at -80
o
C. 
Eukaryotic tissue culture 
Baby hamster kidney (BHK-21) cells 
BHK-21 cells were used to produce and titrate viruses.  BHK-21 cells were 
cultured in T175 flasks (Nuclon, UK) with Glasgow’s minimum essential medium 
(GMEM) (Gibco, UK) until a confluent monolayer was formed. The medium 
contains an energy source (D-glucose), amino acids, inorganic salts and all 
vitamins required for cell growth.  Additionally, the medium was supplemented 
with 10% (volume/volume (v/v)) new born calf serum (NBCS) (Invitrogen), 10% 
Chapter 2  Materials and Methods 
61 
 
(v/v) tryptose phosphate broth (TPB), and L-glutamine (2 mM) (10% GMEM+). 
As required, antibiotics were added to the medium (penicillin/streptomycin – 100 
units/ml and 100 μg/ml, respectively) to protect cells from contamination by Gram 
positive and Gram negative bacteria.  BHK-21 cells grow at optimum pH of 7.2 to 
7.4, therefore the pH indicator phenol red is incorporated into the medium to 
monitor pH during cell growth.  The medium turns yellow when the pH is acidic 
and pink when it is basic.   
Harvesting, counting and passaging BHK-21 cells 
Adherent cells were passaged to new flasks when 80-90% confluence was reached. 
To passage the cells, old medium was removed from the flask and the cell monolayer 
was rinsed with 5 ml of 0.02% versene (EDTA) to chelate any Ca
2+
 ions. After the 
versene was removed, 5 ml of Trypsin-ethylene diamine tetraacetic acid (EDTA) 
(0.05% Trypsin, 0.53 mM EDTA, Invitrogen) was added to the cell monolayer and 
incubated at 37
o
C until the cells had detached. The trypsin-cell mixture was diluted 
in twice the volume of complete medium (10% GMEM+) to inactivate the trypsin. 
The cells were then pelleted at the bottom of a universal tube by centrifugation (378 
x g) for 5 minutes. The pellet was resuspended in 10 ml of medium, 10 μl of this was 
diluted with 90l of trypan blue (1 in 10) and a haemocytometer was used to count 
the cells. To prepare the next passage of cells, fresh T175 flasks were then seeded 
with 5x10
6 
cells in 30 ml of medium (10% GMEM+) and incubated at 37
o
C in an 
atmosphere of 5% CO2 in air. Cells were used between passages 4 and 40 at which 
point their growth became obviously slowed.  All tissue culture procedures were 
carried out in a class II microbiological safety cabinet under aseptic conditions. 
Culture of mosquito cell lines 
The Aedes albopictus-derived cell lines C6/36, C7.10 and U4.4 (Condreay & 
Brown, 1986) and Aedes aegypti-derived cell line Aag2 (Peleg, 1968) were grown 
in L-15 (Leibovitz) Medium (Sigma-Aldrich) with 10% v/v foetal calf serum 
(FCS), 10% v/v TPB, and 2mM L-glutamine (Merck) (10% L-15) in T175 flasks 
(Nunclon, UK) at 28
o
C (without addition of extra CO2).  
Chapter 2  Materials and Methods 
62 
 
Harvesting, counting and passaging mosquito cells 
Cells were passaged when 80-90% confluence was reached. To passage the cells, 
old medium was removed from the flask and 5 ml of fresh incomplete medium (L-
15) was added to gently wash the cell monolayer. The medium was then removed, 
10 ml of fresh complete medium (10% L-15) was then added and the cells were 
gently dislodged with a cell scraper (Falcon).  The suspension was then transferred 
into a universal tube.  Ten l of the resuspended solution was taken and diluted 
into 90l of trypan blue, then 10 μl of this was diluted with 90l of trypan blue 
(final dilution 1 in 100) and a haemocytometer was used to count the cells. To 
prepare the next passage of cells, fresh T175 flasks were then seeded with 5x10
6 
cells in 30 ml of medium (10% L-15) and incubated at 28
o
C without addition of 
extra CO2. All tissue culture procedures were carried out in a class II 
microbiological safety cabinet under sterile conditions.  
Freezing and thawing cells 
Cells were prepared for cryogenic storage when they were healthy, in the middle of a 
growth phase and below 80% confluency. To prepare cells for freezing, cells were 
trypsinised or mechanically agitated, pelleted and resuspended in 10 ml of complete 
media and then counted using a haemocytometer. Once cells were counted, the cell 
suspension was pelleted by centrifugation (500 x g) for 5 minutes and then 
resuspended in freezing medium (10% dimethyl sulfoxide (DMSO) and 90% FCS) to 
the optimal freezing concentration of 5x10
6 
cells per ml. One ml aliquots of this 
suspension were then put into 1.5 ml cryovials (Nunc), the tubes were placed in a 
freezing container (Mr. Frosty, Sigma) filled with 200 ml of isopropanol. The 
container was transferred to -80
o
C and stored overnight. The isopropanol insulation 
allows the cells to cool at approximately 1
o
C per minute which permits water to 
escape from cells to avoid freezing damage (avoid formation of ice crystals which 
fragments and damages cells). Frozen cells were transferred to a liquid nitrogen 
storage container at -130
o
C. 
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To thaw cells, the cryovial was transferred from liquid nitrogen to dry ice. The 
frozen cells were then rapidly thawed by placing the cryovial in a 37
o
C water bath. 
Once defrosted the freezing medium containing the cells was transferred into a 
universal tube with 10 ml of pre-warmed complete growth medium. The cell 
suspension was centrifuged at 478 x g for 5 minutes, the supernatant was removed 
and the cell pellet was resuspended in 1 ml of growth medium and the whole 
suspension was transferred into a 25 cm
2
 flask with 10 ml of pre-warmed medium. 
For BHK-21 cells, the flask was then placed in the incubator at 37
o
C in an 
atmosphere of 5% CO2 in air. For insect cells, the flask was then placed in the 
incubator at 28
o
C without addition of CO2. The cells were allowed to grow normally. 
A high level of cell death is expected from the freeze/defrosting process, and a 25 
cm
2
 flask is appropriate for keeping the surviving cells in close enough contact for 
proliferation. The procedures described were carried out in a class II microbiological 
safety cabinet under aseptic conditions. 
Mosquito rearing and feeding 
Rearing of mosquitoes 
Adult Ae. aegypti mosquitoes were kindly provided by Professor Rick Maizels, 
Institute for Infection and Immunity, School of Biological Sciences, University of 
Edinburgh.  Live mosquitoes were kept in a stockinette sleeve openable cage (mesh 
panels on all sides) and reared at 28
o
C, 70% relative humidity, with a 10 hours light 
14 hours dark photoperiod (Figure 2.1). To maintain the mosquitoes, a sugar meal 
was given to the mosquitoes by placing cotton wool soaked with 10% fructose sugar 
solution on the top of the mosquito cage.  




Figure 2.1: Mosquito cage 
Live mosquitoes were reared in stockinette sleeve openable cage with mesh panels on all sides. 
Mosquito feeding container 
The mosquitoes were caged in waxed paper cartons (ice-cream carton) during 
feeding. The feeding cartons were modified to allow a one way entry point and a 
semi-accessible area for feeding.  The entry point was created by cutting a small 
square hole (approx. 2 cm) in the side of the carton which was taped over with two 
layers of elastic latex (cut from latex gloves). A small hole was cut on each of the 
latex layers (approx. 2 mm). The lid of the carton was replaced with nylon mesh and 
sealed with multiple elastic bands. (Figure 2.2) 
  
Figure 2.2: Mosquito feeding container. 




To infect mosquitoes, defibrinated blood was mixed with virus or virus like particles 
and 10 μl droplets of this infectious mixture were placed on top of the nylon mesh. 
During feeding, the feeding containers were kept in a 28
o
C incubator. This method 
had been used by Cirimotich and co-worker (Cirimotich et al., 2009). Approximately 
one hour was allowed for feeding to take place and fed mosquitoes were selected to 
keep alive for further experimention. To select fed mosquitoes, the feeding container 
was wrapped in a plastic bag and placed on ice in the middle of a large ice bucket for 
10 minutes. Following that, the mosquitoes were checked to confirm that they were 
anaesthetized and unfed mosquitoes were taken out and submerged in ethanol. Once 




Nucleic acid techniques 
Plasmid DNA extraction 
Miniprep 
DNA plasmids were purified on a small scale using a Qiagen Miniprep kit. The 
procedure was carried out according to the manufacturer’s instructions. In brief, a 
small plasmid amplification in up to 10 ml of LB media was prepared in a universal 
container. To harvest the bacteria, the bacteria were pelleted and resuspended in 250 
μl of buffer P1 and transferred into a 1.5 ml eppendorf tube. The cells were then 
lysed by addition of 250 μl of lysis buffer P2. This alkaline lysis buffer solubilises 
the bacterial membrane and denatures the DNA and protein. The mixture was gently 
mixed by inverting the tube 4 - 6 times. To neutralise the reaction and precipitate all 
protein and lipid, 350 μl of buffer N3 was added to the lysate and mixed by inverting 
4 - 6 times and then centrifuged at approximately 17,900 x g for 10 minutes. After 
centrifugation, a white pellet at the bottom was observed, and DNA was left in the 
supernatant. The supernatant was then transferred into a Qiaprep mini column and 
centrifuged at 17,900 x g for 1 minute. The flow-through was discarded and the filter 
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was washed with 750 μl of PE buffer and centrifuged at 17,900 x g for 1 minute. The 
flow-through was again discarded and the filter was centrifuged dry at 17,900 x g for 
further 2 minutes. The plasmid DNA was then eluted by adding 30 μl of RNase and 
DNase free water directly onto the centre of the filter and allowing to sit for 1 
minute. The DNA plasmids were collected by placing filter column in an eppendorf 




To generate large amounts of plasmid DNA, a Qiagen EndoFree Plasmid Maxi Kit 
was used. To prepare large amount of plasmids, a single E. coli colony (containing 
the plasmid of interest) was picked from an LB agar plate and inoculated into 2 ml 
LB medium starter culture containing an appropriate antibiotic e.g. 50 μg/ml 
ampicillin. The starter culture was incubated on an orbital shaker (225 rpm) at 37
o
C 
for 6 to 8 hours. Then 500 μl of the starter culture was transferred to 250 ml of LB 
medium containing the appropriate antibiotic and again incubated overnight (16 hr) 
at 37
o
C in an orbital shaker (225 rpm).  To harvest the bacteria, the bacteria were 
pelleted by centrifugation (6000 x g) at 4
o
C for 15 minutes. The bacterial pellet was 
resuspended in 10 ml of buffer P1 and transferred into a 50 ml sterile centrifuge tube 
(Falcon), followed by addition of 10 ml of lysis buffer P2. The mixture was gently 
mixed by inverting the capped tube 4 to 6 times and allowed to sit at room 
temperature for 5 minutes to break down cell walls and release the DNA. To 
neutralise the reaction, 10 ml of pre-chilled buffer P3 was added to the lysate and 
mixed. The lysate was then poured into the barrel of the QIAfilter Cartridge and 
pushed through the filter into a new 50 ml centriguge tube. Following that, 2.5 ml of 
Buffer ER was then added to the filtered lysate, mixed by gently inverting the tube 
10 times and incubated on ice for 30 minutes. Meanwhile, a QIAGEN-tip 500 was 
equilibrated by allowing 10 ml of Buffer QBT to flow through it. After 30 minutes, 
the filtered lysate was passed through the equilibrated QIAGEN-tip. Supernatant 
(flow-through) was discarded and the QIAGEN-tip was washed twice by passing 
through 30 ml of Buffer QC. Plasmid DNA was eluted from the filter with 15 ml of 
Buffer QN. To precipitate the DNA, 10.5 ml of isopropanol at room temperature was 
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added to the eluted DNA and the mixture was then centrifuged at 15,000 x g at 4
o
C 
for 30 minutes. The supernatant was discarded and the DNA pellet was washed with 
5 ml of 70% ethanol and further centrifuged at 15,000 x g for 10 minutes to remove 
all traces of isopropanol. The supernatant was removed carefully by inverting the 
tube, and the remaining ethanol was allowed to evaporate at room temperature for no 
more than 5 minutes. The pellet was redissolved in 300 μl of endotoxin-free buffer 
TE. Samples were stored in 1.5 ml eppendorf tubes at -80
o
C. 
Restriction enzyme digestion 
To perform a restriction digestion, up to 1 μg of plasmid DNA was digested with 1 
unit (U) of restriction endonuclease. The enzyme unit (U) is a unit for the amount of 
a particular enzyme that catalyses the cleavage of 1 μg of DNA at the appropriate 
temperature per hour. The restriction digestion reaction had a final volume of 20 μl, 
and contained 2 μl of 10X restriction enzyme buffer, 2 μl of 10X acetylated bovine 
serum albumin (BSA), 1 μl of enzyme (1 unit/μl), plasmid DNA, and DNase-free 
H2O made up to a final volume of 20 μl. The reactions were incubated at the 
enzyme’s optimum temperature for 2 to 4 hours. The restriction product(s) was 
analysed using agarose gel electrophoresis or purified for further manipulation. 
The products of a plasmid DNA restriction digestion could result in multiple bands 
on an agarose gel if the DNA plasmid was not completely digested by the enzyme. 
The three resulting products are uncut supercoiled plasmid (migrates furthest), 
linearised plasmid, and nicked plasmid (migrates slowly). 
Purification of restriction digestion products 
After restriction digestion, DNA fragments were purified. Jetquick (Genomed), a 
DNA purification kit, was used. The volume of digestion product was brought up to 
100 μl with DNase-free H2O. Then 400 μl of H1 solution was added. The mixture 
was transferred into the binding column and centrifuged for 1 minute at 12,000 g. 
The flow-through was discarded, and the column was washed twice with 500 μl of 
H2 solution each time. To elute the DNA fragments, 30 μl of DNase-free H2O pre-





C was added directly onto the binding matrix. The column was held 
for 1 minute before it was centrifuged for 1 minute in a sterile eppendorf tube. The 
eluted DNA was stored at -20
o
C.  
In vitro transcription of capped infectious complementary DNA( icDNA) 
Approximately 1.66 g of Spe I linearised icDNA was used in the transcription 
reaction. The RNA was synthesised at 37
o
C for 1 hour, using the cap analogue 
m
7
G(5’)ppp(5’)G to produce capped transcripts. The composition of the reaction is 
listed in following table. The further details of each reagent are tabulated in 
Appendix 1. 
Reagents Volume 
Spe I cut plasmid (1.66μg) xx.x l 
10x SP6 buffer (GE Healthcare) 5.0 l 
10 mM m
7
G(5’)ppp(5’)G (cap) (GE Healthcare) 5.0 l 
50 mM DL Dithiothreitol (Sigma) 5.0 l 
rNTP mix (10 mM ATP, CTP, UTP, 5 mM GTP) (Promega) 5.0 l 
Recombinant RNasin Ribonuclease Inhibitor (60 U/1.5 ul) (Promega) 1.5 l 
SP6 RNA polymerase (50 U/μl) (GE Healthcare) 1.5 l 
Nuclease-free H2O to Total volume 50.0 l 
Table 2.1 Reagents and quantity for in-vitro transcription. 
Synthesised RNA was verified by using agarose gel electrophoresis. In vitro 
transcripts were generally used immediately, but were sometimes stored at -80
o
C. 
Agarose gel electrophoresis 
 DNA and RNA were separated on gels containing 1% or 1.25% agarose in TBE 
buffer (fragment size dependent). To prepare a 1% agarose gel, 1 g of electrophoresis 
grade agarose powder was added to 100 ml of tris-borate (TBE) buffer in a conical 
flask and boiled in a microwave for 1 minute at full power to dissolve the agarose. 
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The gel mix was allowed to cool down before adding ethidium bromide (0.5 μg/ml). 
Once mixed, the gel was transferred into a plastic frame and a comb was placed into 
the gel to produce wells. Bubbles on the gel were removed with pipette tips and the 
gel was allowed to set (15-30 minutes). Once set, the comb was removed and DNA 
samples mixed with 6x loading buffer were loaded into the wells of the gel and run at 
100 V for 45 to 60 minutes.  The nucleic acid bands were visualised under a UV 
transilluminator. Molecular weight markers i.e. 100 bp and 1 kb DNA ladder 
(Promega) were loaded alongside the samples. 
Nucleic acid quantification 
All nucleic acid samples were quantified using a NanoDrop ND-1000 
spectrophotometer. One μl of nucleic acid sample was placed on the lens of the 
NanoDrop ND-1000 spectrophotometer and the quantity was measured. 
Polymerase chain reaction 
PCR was used to amplify a specific region of DNA between 2 primers for diagnostic 
purposes. For different samples, different primers and reaction cycles were used as 
listed below. The PCR reaction mix had a final volume of 20 μl, and contained 2 μl 
of 10X PCR buffer (15mM MgCl2 included), 0.4 μl dNTPs (10 mM) (Promega), 0.5 
μl of each primer, forward and reverse (50 pM) (Invitrogen), 0.3 μl of Taq 
polymerase (Promega), DNA sample and DNase/RNase-free water to a final volume 
of 20 μl. The reactions were incubated in a thermal cycler (Veriti®, Applied 
Biosystems) using the following settings: an initial denaturation stage of 5 minutes at 
95
o
C followed by an amplification stage which consisted of 27 cycles of three steps; 
denaturation at 94
o
C for 30 seconds, annealing at 55
o
C for 30 seconds and extension 
at 72
o
C (duration depends on length of application region); then a final extension 
stage at 72
o
C for 15 minutes. A negative (no template) and a positive (β-actin) 
control were used as control to test for possible contamination and to confirm that the 
reaction itself was functional. The PCR products were examined by agarose gel 
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Negative control β-actin primers  
Forward (Start 225 nt): 5’- CGTTGACATCCGTAAAGACC -3’ 
Reverse (End 465 nt): 5’- CTGGAAGGTGGACAGTGAG -3’ 
Annealing temperature: 60
 o
C. Product size: 241. 
SFV nsP3, C-terminal region primers 
Forward (Start 4974 nt): 5’- ATACCATGTAGATGGGGTGCAGAAGGT -3’ 
Reverse (End 5523 nt): 5’- TGCGGTCCAGGAGGAGAAAATGTACC -3’ 
Annealing temperature: 62
 o
C. Product size: 589 nt 
SFV capsid primers 
Forward (Start 7855 nt): 5’- ACGTGAAAGGAGTCATCGAC -3’ 
Reverse (End 8682 nt): 5’- GGTGGCTACCTTCAAAGATG -3’ 
Annealing temperature: 62
 o
C. Product size: 827 nt 
Reverse transcription PCR 
Reverse transcription RCR (RT-PCR) was used to create cDNA copies of an RNA 
template using an oligo dT primer. For each reaction, 1 μl of deoxyribonucleotide 
triphosphate solution (dNTPs, 10 mM) (Promega), 1 μl oligo dT (500 μg/ml) 
(Promega), dH2O and 5 μg RNA made up to a total volume of 10.5 μl were mixed 
and placed at 65
o
C for 5 minutes and followed by 5 minutes on ice. Meanwhile, 4 μl 
of 5x first strand buffer, 2 μl dithiothreitol (DTT, 0.1 M) (Sigma) and 0.5 μl RNasin 
(Promega) were mixed together and kept on ice. The two mixtures were combined 
and incubated at 42
o
C for 2 minutes, followed by addition of 1 μl of Superscript II 
(Invitrogen).  The reaction mix was incubated at 42
o
C for 1 hour. The reaction 
outcomes were examined by agarose gel electrophoresis. 
Total RNA extraction 
Total RNA was isolated from U4.4 or Aag2 cells by using Trizol (Invitrogen), a 
phenol-based reagent. Approximately 5x10
5
 U4.4 or Aag2 cells were grown in 6-
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well plates overnight (16 hr) at 28
 o
C. The cells were then infected with SFV 
(MOI=10). Total RNA was extracted at 24 h postinfection (p.i.). To extract total 
RNA, medium was removed from the well, and 1 ml of Trizol was added into each 
well (1 ml per 10 cm
2
) followed by passing the cell lysate several times through a 
pipette. The lysate was transferred to a 1.5 ml RNase free tube and incubated at room 
temperature for 5 minutes to allow complete dissociation of nucleoprotein 
complexes. Then 200 μl of chloroform was added to the lysate (0.2 ml chloroform 
per 1 ml of Trizol used) and shaken vigorously for 15 seconds followed by 
incubation at room temperature for 2 to 3 minutes. To remove extracellular 
membranes, polysaccharides, fat, and high molecular weight DNA, the cell lysate 
was centrifuged at approximately 12,000 x g for 15 minutes at 2-8
o
C.  To precipitate 
RNA, the top aqueous phase (containing RNA) was transferred to a sterile 1.5 ml 
RNase free tube by a pipette followed by the addition of 500 μl of molecular grade 
isopropyl alcohol (Invitrogen) (0.5 ml isopropyl alcohol per 1 ml of initial Trizol 
used). The mixture was incubated at room temperature for 10 minutes and 
centrifuged at approximately 12,000 x g for 10 minutes at 2-8
 o
C. The supernatant 
was removed and the RNA pellet was left untouched at the bottom of the tube. The 
RNA pellet was then washed by addition of 1 ml of 75% molecular grade ethanol 
(7.5ml ethanol (Invitrogen) and 2.5 ml RNase-free water (Invitrogen)) and mixed by 
gentle vortexing, followed by 5 minutes of centrifugation at approximately 7,500 x g 
at 2-8
 o
C.  The supernatant was then discarded and the pellet was air dried for 5-10 
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Virus and Virus Replicon Particles (VRPs) 
The viruses used for experiments in this study are detailed in Table 2.2. 
Virus  Backbone Description 
SFV4 n/a Virus derived from the molecular clone of the 
prototype strain of SFV. (GenBank accession 
number X04129) corrected by the recent 
resequencing of SFV4 (GenBank accession 
number AJ251359) 
A7(74) n/a Naturally occurring strain of SFV without 
modification. 
SFV-steGFP SFV4 Maker gene eGFP inserted in the structural ORF 
between the capsid and p62(E2/E3) coding region. 
SFV4-stRluc SFV4 Marker gene Renilla luciferase inserted in the 
structural ORF between the capsid and 
p62(E2/E3) coding region. 
SFV4(3H)-Rluc SFV4 Marker gene Renilla luciferase inserted between 
nsP3 and nsP4. Designed for early expression 
from non-structural polyprotein. 
Table 2.2 List of viruses used in the project. 
All the recombinant viruses were made from plasmids kindly provided by Prof 
Andres Merits, University of Tartu, Estonia.  Viruses were transported to Edinburgh 
in the form of infectious plasmid cDNA (icDNA). These cDNA plasmids, capable of 
giving rise to complete infectious virus, are designated icDNA plasmids. These 
plasmids were amplified by transforming chemically competent E. coli, growing up 
the E. coli cultures and harvesting the plasmids.  To produce virus, the icDNA 
plasmids were linearised using Spe I and used as templates for in vitro transcription 
to produce capped viral RNA. Viral RNAs were then electroporated into baby 
hamster kidney (BHK-21) cells. Virus was harvested in the supernatant at 24 and 48 
hours after electroporation. All viruses were stored at -80
o
C. 
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The VRPs used for experiments in this study are detailed in Table 2.3. 
Virus Strain System Modification 




Split-helper system An IRES element was inserted at 5’ end of 
nsp1 coding region. Subgenomic region was 
deleted. Marker gene zsGreen was fused at 
the end of nsp3. 
SFV1(3F)-ZsGreen Split-helper system Subgenomic region was deleted. Marker 
gene zsGreen was fused at the end of  nsp3. 
Table 2.3 List of VRPs used in this project. 
 
Figure 2.3: A Schematic representation of the SFV1 VRP and split-helper system 
(A) SFV1 VRP is based on SFV4 construct with viral subgenomic region replaced with a 
multiple cloning site (MCS). SFV1 VRP is unable to produce any viral strauctral proteins. 
Foreign gene can be inserted at locations indicated. E.g. ZsGreen sequence can be inserted 
between nsP3 and nsP4, producing SFV1(3F)-ZsGreen; d1eGFP can be inserted at the MSC to 
produce SFV1-d1eGFP (B) The helper 1 construct consists of a 5’ cap, subgenomic promoter, 
capsid and a 3’ poly A tail. (C) The helper 2 construct consists of a 5’ cap, subgenomic promoter, 
enhancer sequence from the capsid protein,  2A sequence, p62(E3+E2), 6K and E1 and a poly A 
tail.  
The “split-helper system” was used to produce non-propagating marker gene 
carrying VRPs (Smerdou & Liljeström, 1999). The cDNA plasmids for making 
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VRPs have viral structural genes removed, and are thus only capable of giving rise to 
the 5’ 2/3 of the viral RNA transcripts (Figure 2.3 A), they are designated pSFV1 
plasmids.  The helper plasmids, one encoding the viral capsid and the other encoding 
the viral envelope genes, were constructed to viral transcripts to produce structural 
proteins in trans for virus packaging (Figure 2.3 B & C). DNA plasmids were kindly 
provided by Prof Andres Merits, University of Tartu, Estonia. To make VRPs, 
pSFV1 plasmids and pSFV-helper plasmids were amplified by transformation and 
growth in chemically competent E. coli cultures. The plasmids were then harvested 
by plasmid extraction (see Transformation and Maxiprep, page 49 and 56). The 
plasmids were then linearised (1.66 μg of each plasmid) using Spe I and in vitro 
transcribed (see in vitro transcription, page 58) to produce RNA.  The three RNA 
transcripts were co-transfected into BHK-21 cells by electroporation. The split helper 
system provides the viral structural proteins in trans for the packaging of SFV1 RNA 
to form infectious particules. The viral structural genes were splitted into two part 
helpers to reduce the chance of recombination which produces propagating virus. of 
Transfected cells were incubated for 48 hours and VRPs were harvested in the 
supernatant. 
Virus or VRP purification 
Forty-eight hours after viral RNA(s) was electroporated into BHK cells, the 
supernatant containing virus or VRPs was collected and clarified three times to 
remove cell debris by centrifugation (27,000 x g) at 4
o
C for 30 minutes, using a JA 
20 rotor in a J2-21 centrifuge (Beckman Instruments). To pellet the virus or VRPs, 
the clarified supernatant was ultracentrifuged through a 20% sucrose cushion.  
Aliquots of 17.5 ml of virus or VRP supernatant were added to four Beckman SW28 
ultracentrifuge tubes followed by addition of 20% (w/v) sucrose (Sigma) in TNE 
buffer pH 7.4 (50 mM Tris HCl pH 7.4, 100 mM NaCl and 0.1 mM EDTA pH 8.0, 
filter-sterilised) underneath the supernatant using a pipette until the tube was filled.  
Virus particles were sedimented through the sucrose cushion at 84,600 x g for 90 
minutes at 4
o
C. Following that, supernatants were decanted from the ultra-centrifuge 
tube. Virus or VRP pellets were re-suspended by adding 100 μl of TNE buffer to the 
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pellet and the tube was left vertically on ice on a rocker for 2 hours. All re-suspended 
virus or VRP was transferred to a sterile eppendorf tube. The centrifuge tube was 
rinsed with 50 μl of TNE buffer to collect any remaining virus/VRP which was 
transferred to the eppendorf tube. The pooled purified virus or VRP was aliquoted 
into eppendorf tubes, 50 l per tube, snap frozen on dry ice and stored at -80
o
C. 
Titration of virus: Plaque assays 
Virus titres were measured by plaque assay.  Six-well plates (Nuclon, UK) were 
seeded with 2 ml of 10% GMEM+ containing 3.5x10
5
 BHK-21 cells per well. Plates 
were left at room temperature (RT) to settle before incubating in 5% CO2 in air at 
37
o
C overnight. Meanwhile, GMEM with 2% NBCS, 0.75% bovine serum albumin 
(BSA) in phosphate buffered saline (PBS) (PBSA) and 4% agarose in PBS (Difco, 
UK) were prepared and sterilised.  In the following day, the BHK-21 cell monolayers 
in the six-well plates were confirmed to have reached 80% before serial dilution of 





.  Plates were labelled with date and sample number.  The 
medium was removed from each well and 400 l of each virus dilution were added 
to duplicate wells (in the order of highest to lowest dilution).  The plates were 
incubated for an hour at RT inside a humid box to avoid dehydration of the 
monolayer and shaken gently every 5 minutes to ensure equal coverage of the 
monolayer.  The 4% agarose was melted in a boiling water bath and then allowed to 
cool to 57
o
C in a separate water bath.  The agarose was mixed with 2% GMEM+ pre-
warmed to 37
o
C (38 ml of medium to 12 ml of agarose to cover 4 plates). 2 ml of the 
agarose/medium mixture was added to each well to cover the monolayer completely.  
Once the agar was set, the plates were incubated for 48 hours (depending on the virus 
strain) at 37
o
C in 5% CO2 in air. After this incubation, the monolayers were fixed by 
adding 3 ml of 4% neutral buffered formaldehyde to each well for at least an hour (in 
a fume cupboard). The fixative was then removed and 0.1% toluidine blue was added 
to each well to stain the monolayer for at least 30 minutes.  Finally, the plates were 
washed with water and after the plates were dried the numbers of plaques were 
counted. 
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Plaque Forming Unit and Limit of Detection 
The plaque forming units (pfu) per ml was calculated with the following formula: 
Average number of plaques x dilution factor 
Amount (ml) of inoculum per well 
The “limit of detection” of each assay is the threshold below which the assay is not 
able to detect infectious virus.  The limit of detection was determined using the 
formula above and assuming the lowest dilution used in each assay caused the 







, and 0.4 ml of each dilution was used to infect 
monolayers of cells in 6 wells plates, 1 plaque observed at 10
-4
 dilution would give a 
titre of 2.5x10
4
 PFU/ml.  The logarithm of that value is 4.4, meaning that the limit of 
detection of that particular assay was 4.4 Log10; virus below 2.5x10
4
 PFU/ml will not 
be detected by this assay.  Normally, plaque assays are performed with the lowest 
dilution at -1. Therefore the limit of detection is 10
1.4
 PFU/ml. 
Microscopic examination of cell cultures 
The confluence or cytopathic effect of cell cultures were checked under a Nikon 
inverted microscope. To check for the presence of eGFP fluorescence a Nikon 
inverted microscope fitted with UV light (with excitation filter 485 and emission 
filter 530) was used. 
Titration of VRPs 
BHK-21 cells were prepared as a suspension of single cells as described above.  Six 
well plates were seeded by placing 22x22 mm cover slips (Chance Propper) into each 
well and then 2 ml of cell suspension, 4x10
5
 cells per well.  The following day, 
medium was removed followed by one wash with sterile PBS (SPBS).  Two wells of 
the plate served as negative controls to which 450 l of 10% GMEM+ was added.  




.  400 l of each dilution were 
added to duplicate wells (in the rder of highest to lowest dilution).  The cells were 
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then left on a shaker for 1 hour for the VRPs to attach.  Two ml of 10% GMEM+ 
was then added to cover each well, and the plate was incubated overnight at 37
o
C in 
5% CO2 in air. The next day, the medium was removed from each well and cells 
were fixed for 20 minutes with 2 ml of 4% paraformaldehyde (Sigma) per well. 
Fixed cells were then washed with SPBS.  For eGFP VRPs, cover slips were 
carefully removed with forceps and mounted onto pre-cleaned microscope slides 
(Surgipath) with fluorescent mounting medium containing DAPI (Vector). For other 
VRPs cover slips were immuno-stained with antibody to nsp3 before being mounted 
on a glass slide. Details of immuno-chemistry are described in the histology section. 
The slides were examined with a standard Zeiss Axioskop2 microscope equipped 
with filters suitable for visualisation of eGFP (green), Alexa Fluor 594 (red) and 
DAPI (UV).  An infectious unit (IU) titration was carried out by counting 15 random 
fields using the X40 objective lens. 
Formula for calculating VRP titre (IU/ml): 
Mean cell count (from 15 random locations) x (constant = 4365.3) x dilution factor 
Volume (ml)of VRPs added 
This constant = total area of a well in a 6 well plate (1133.54 mm
2
) divided by the 
area viewed through the 40X lens the microscope (0.25967 mm
2
) 
Electroporation: delivery of RNA transcripts into BHK-21 cells  
One T175 flask containing confluent BHK-21 cells was trypsinised and the cells 
were counted.  The cell suspension was spun at 378 x g for 5 minutes at room 
temperature.  The cell pellet was resuspended in SPBS to give a density of 5x10
6
 
cells per 400 l.  Then 800 l of cells were placed in a sterile eppendorf tube and 50 
l of RNA transcript was added.  450 l of this mixture was then placed in the 
cuvette of an electroporator (Gene Pulser X cell
TM
 Electroporation System, Bio-Rad 
Laboratories Inc).  The pre-set protocol for the BHK-21 cell line was used, 140 volt 
per square wave pulse with a pulse length of 25 ms. Electroporated cells were then 
placed into a T175 flask containing 25 ml of 10% GMEM+ medium (pre-warmed to 
37 
o
C) which was then incubated at 37
o
C in 5% CO2 in air.  A total of 1x10
7
 cells 
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were electroporated. Electroporation was carried out in a class II microbiological 
safety cabinet under aseptic conditions. 
Nucleic acid transfection using liposomes (Lipofectamine 2000) 
To prepare mosquitoe cells for transfection, 24-well plates were seeded with 1x10
5
 
cells in 500 l of medium per well. Plates were incubated at 28
o
C overnight (16 hr). 
To transfect DNA plasmids or RNA preparations or small RNAs to a well of cells, 
the nucleic acid preparation (amount depends on required final concentration) was 
diluted in 50 ul of Opti-MEM
®
 medium (Invitrogen) and mixed gently in a 
polystyrene tube. Following that, 1 l Lipofectamine 2000
™
 (Invitrogen) was diluted 
in 50 l of Opti-MEM
®
 medium in a separate polystyrene tube. The two different 
mixtures were incubated at room temperature for 5 minutes and then mixed together. 
The mixture was mixed gently and further incubated for 20 minutes at room 
temperature. Meanwhile, the medium in the wells of the 24-well plate was replaced 
with 400 l of antibiotic-free medium. 100 l of the Lipofectamine nucleic acid 
mixture was added to each well. The plate was then incubated at 28
o
C for 5 hours 
before the supernatant mixture was removed and replaced with new 10% L15 
medium.  
One-step growth curve 
A one-step growth curve of a virus assays the accumulation of virus in the 
supernatant over time when virtually all the cells in the population are infected.  Six 
well plates were seeded with BHK-21 cells, as described in the plaque assay section 
and incubated overnight at 37
o
C in 5% CO2 in air. Medium in each well was removed 
and monolayers were washed with SPBS. Virus was diluted in 0.75% PBSA to 
provide an MOI of 10 in 400 μl. Virus/PBSA was added on to the monolayers and 
infection was allowed to take place. The plates were incubated for 1 hour at RT 
inside a humid box to prevent dehydration of the monolayer and shaken gently every 
5 minutes to ensure equal coverage of the monolayer.  After 1 hour, each well was 
washed 3 times with SPBS to remove any unbound virus followed by addition of 2 
ml pre-warmed 10% GMEM+. This point was taken as time-point zero. Aliquots of 
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100 μl of supernatant were collected every 2 hours and replaced with the same 
amount of fresh medium for the following 12 hours. Samples were kept in eppendorf 
tubes at -80
o
C. All samples were titrated by plaque assay. 
Histology 
Immunostaining 
Immunochemistry was used to visualise viral protein to define viral infection in a 
cell. To stain cell cultures on a glass slide, cells were fixed with 10% neutral buffered 
formaldehyde for 45 minutes. The glass slide was then washed in PBS 3 times for 5 
minutes each. To increase cell membrane permeability prior to staining, the glass 
slide was covered in 0.3% Triton-X100 for 20 minutes at room temperature. 
Following membrane permeabilisation, the slide was inserted into a staining rack and 
washed in PBS 3 times for 5 minutes each. The slide was then treated with CAS 
block (Invitrogen) for 30 minutes at room temperature inside a humid chamber. The 
blocking solution was then replaced with primary antibody diluted with CAS block 
solution (Zymed) (Table 2.4). The primary antibody was incubated on the slide for 2 
hours before the slide was washed 3 times in PBS for 15 minutes each. Then a 
secondary biotinylated antibody (diluted in CAS block, Table 2.4) was added onto 
the slide, followed by 1 hour of incubation before the slide was washed with PBS 3 
times for 15 minutes each.  Streptavidin-conjugated Alexa Fluor 594 (excitation 590 
and emission 617 nm) was diluted 1:1400 in H2O and added onto the slide which was 
incubated for 45 minutes at RT.  The slide was then washed in PBS twice (10 
minutes each) before being mounted with fluorescence mounting medium under a 
coverslip sealed with nail varnish. The completed slide was kept at 4
o
C, out of 
sunlight. 
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Name Type Host Isotype Optimum 
Dilution 
Source 
α-nsP3  Primary Rabbit Polyclonal 1:800 Tero Ahola 
Biotinylated α –
Rabbit IgG 
Secondary Goat IgG 1:500 Vector Labs 
SA-Alexa Fluor 
594 
Tertiary - - 1:1400 Invitrogen 
 Table 2.4 List of antibodies used in this project. 
To check for the presence of eGFP fluorescence or fluorophore emission, a Nikon 
inverted microscope fitted with UV light (with excitation filter 485 and emission 
filter 530) was used. 
Video microscopy 
For live cell imaging of mosquito cells, 5 x 10
5
 mosquito cells were seeded in a T20 
flask and incubated overnight at 28 
o
C. All internal surfaces were rinsed with 
medium before filming started to prevent condensation forming inside the top surface 
of the flask during the course of filming. The flask was then placed under a Zeiss 
Axiovert microscope and the microscope was programmed to take 1 frame every 3 
minutes under visible and UV light. The temperature of the room was maintained at 
28 
o
C throughout the course of filming. 
WST-1 Assay  
Cell viability and proliferation rate were measured by WST-1 assays. 96-well plates 
(Nuclon, UK) were seeded with 100 l of 10% L-15 medium containing 5x10
3
 cells 
per well. Following that, the plates were incubated at 28
o
C overnight.  The plates 
were labelled with date and sample number.  The medium was removed from each 
well and 30 l of virus in PBSA was added to give the required MOI.  The plates 
were incubated for an hour at room temperature inside a humid box to avoid 
dehydration of the monolayer and were shaken gently every 5 minutes to ensure 
equal coverage of the monolayer.  The inoculum was then replaced by fresh 10% L-
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15 medium.  The 96-well plate was returned to incubation at 28
o
C. At the required 
time post-infection, 10 μl of the cell proliferation assay reagent WST-1 (Roche) was 
added to each well and the plate was incubated at 28
o
C for 1 hour. The plate was 
then scanned at 420-480 nm in a microtiter plate reader. 
Dual luciferase assays  
The dual luciferase assay is a method of quantifying the level of gene expression 
through the measurement of luminescence produced by the reaction between the 
luminescent substrate and the expressed reporter gene product, firefly and Renilla 
luciferase. To measure luciferase expression, the dual luciferase reporter assay 
system, Dual-Glo Luciferase Assay System (Promega) was used.  In brief, cells were 
grown in a 6-well plate and infected with viruses that express Renilla luciferase or 
transfected with plasmids that express Renilla luciferase.  To release the luciferase 
from the cells, medium was removed 24 hours post-infection and 200 μl of passive 
lysis buffer (1 in 5 dilution) was added directly to the monolayer of cells. For 
experiments carried out in 24-well plates, 50 μl of passive lysis buffer was used per 
well. The plates were then incubated at room temperature in a sealed humid box on a 
shaker for 15 minutes for the cells to lyse. To quantify the amount of luciferase being 
expressed by the cells in each well, 1 μl of the lysate was used for luminescence 
measurements with a Turner Designs model TD-20/20 luminometer.  The following 
steps were used for luminescence measurements:  One μl of the lysate was mixed 
with 70 μl of the firefly luciferase assay reagent II (LARII). The luminescence 
emitted from the mixture was then measured in the luminometer with a 10-s 
equilibration time and a 10-s integration time. After quantifying the firefly 
luminescence, the reaction was quenched, and the Renilla luciferase reaction was 
initiated by addition of 70 μl of Stop & Glo® reagent. The reaction mixture was 
quantified once again with 10-s equilibration time, and a 10-s integration time.  All 
reagents were prepared as described by the manufacturer. The data are represented as 
individual activities of each luciferase and the ratio of firefly to Renilla luciferase 
activity (Fluc/Rluc).  
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Illumina Solexa sequencing 
All of the total RNA samples were subsequently processed at GenePool, University 
of Edinburgh (http://genepool.bio.ed.ac.uk/). Small RNAs below 44 nt were purified 
from a 15% TBE-Urea polyacrylamide gel, and RNA adapters (see below) were 
ligated to the 5’ and 3’ of the small RNAs. These small RNAs which were flanked by 
adapter sequences were then converted to complementary DNA (cDNA) by reverse 
transcription with a reverse transcription primer (see below). These small cDNA 
sequences containing the adaptor sequences were then used as templates for PCR 
using primer 1(see below) to synthesise double-stranded DNA containing an 
additional 23 nt attachment sequence which allows all the PCR products to attach on 
to the inside surface of the flow cell channels. The DNA sequences attached on the 
inside of the flow cell were then bridge amplified into DNA clusters. The flow cell 
was then loaded into the sequencer for automated cycles of extension with the 
sequencing primer (see below) and imaging. Each extension cycle incorporated a 
single fluorescent nucleotide followed by high resolution imaging of the entire flow 
cell. These images contained the physical location of all the clusters and the 
fluorescent emission identified which of the four bases was incorporated at that 




To identify SFV-derived viRNAs, small RNA sequences were compared to the SFV4 
reference genome sequence (GenBank accession number X04129) corrected by the 
recent resequencing of SFV4 (GenBank accession number AJ251359) (compiled by 
Prof A. Merits, personal communication) using SOAP software (with the help of 
Gene- Pool bioinformatics support) (Li, et al., 2008). 
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RNA adapters and PCR Primers 
The RNA adaptors attached on the 5’ and 3’ of small RNA oligonucleotide samples 
were: 
5' RNA Adapter: 
5' GUUCAGAGUUCUACAGUCCGACGAUC 
3' RNA Adapter: 
5' P-UCGUAUGCCGUCUUCUGCUUGUidT 
The small RNA oligonucleotide samples flanked by adaptor sequences were reverse 
transcribed to cDNA with a reverse transcription primer: 
Reverse transcription primer: 
5' CAAGCAGAAGACGGCATACGA 
The small cDNA were amplified by PCR with PCR primers 1 and 2. PCR primer 1 
contains an additional 23 nt attachment sequence which is added to all the PCR 
products and allows them to attach on to the inside surface of the flow cell channels. 
PCR Primer 1 (with attachment sequence): 
5' AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 
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Fluorescence-activated cell sorting (FACS) 
Cell sorting was kindly carried out by Shonna Johnston at Optical Imaging Services 
in the Centre for Inflammation Research, University of Edinburgh. 
RNA secondary structure prediction 
The existence and position of RNA secondary structures in SFV genomic RNA were 
predicted by thermodynamic folding energy calculations that used comparative 
sequence data from the available SFV complete genome sequences (SFV4 as 
described above and GenBank accession numbers EU350586, DQ189086, and 
Z48163). This analysis was performed using the programme UNAFold (Zuker, 
2000). For calculations of folding energies, sequences in the SFV alignment were 
split into sets of 150 base fragments incrementing by 1 base across the genome. 
Folding energies were compared with those of 50 copies of each fragment whose 
sequence order was scrambled using the algorithm NDR, which preserves 
dinucleotide frequencies of the native sequence automated using the programme 
Folding Energy Scan as implemented in the Simmonic2005 v1.8 package (Davis et 
al, 2008). The minimum free energies (MFEs) of each native sequence fragment 
were compared with the mean MFE of the NDR-scrambled controls to produce an 
MFE difference (MFED) as previously described (Simmonds et al., 2004). MFED 
values for each fragment were averaged across the four available SFV complete 
genome sequences. The prediction of specific structures using the available 
comparative sequence data for SFV was done by using the programme StructureDist 
in the Simmonics package. This programme compares minimum energy structures 
from sequence data sets and computes phylogenetically conserved pairings and 
secondary structures. The results were expressed in the form of pairing frequencies, 
which were calculated from the proportion of pairwise comparisons of connect files 
for each sequence with the same pairing predictions, as previously described 
(Simmonds et al., 2004). 
.
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Chapter 3: Infection of mosquito cells with SFV 
Introduction 
The ability of alphaviruses to infect cells of the mosquito Aedes albopictus has 
previously been studied in three cell lines, C6/36, C7-10, and U4.4 which were 
derived from neonate larva Ae. albopictus (Singh, 1967). The cell line C6/36 is one 
of twenty clones isolated from cultured Ae. albopictus cells, a characteristic of this 
clone is the ability to produce high virus yield up to 7 days after dengue and 
Chikungunya virus infections. Sub-clone 36, one of the 43 sub-clones of C6, shows 
mild to extensive cytopathic effect (CPE) several days post-infection with SINV 
(Igarashi, 1978).  C7-10 cells are also a sub-cloned population derived from Singh’s 
cells which display CPE upon alphavirus virus infection (Sarver & Stollar, 1977). 
In this study, there are a number of experiments designed to determine the innate 
immune responses against SFV infection in mosquito cultures. However, all three 
cell lines behave uniquely upon virus infection; some are resistant to infection and 
some are susceptible to infection and display CPE. This project will explore different 
aspects of the mosquito immune system response to alphaviruses using SFV as a 
model virus. The first experiments, described in this chapter were carried out to 
characterise SFV infection in each of the cell lines to determine the ideal cell line for 
subsequent studies.  
Replication of SFV in Aedes albopictus cells  
To determine whether SFV would infect and replicate in U4.4, C7-10 and C6/36 
mosquito cell lines, these cell lines were infected individually with a genetically 
modified marker virus, SFV4-steGFP, a SFV strain with an enhanced green 
fluorescence protein gene inserted in the structural region of the genome followed by 
a foot-and-mouth disease virus (FMDV) 2A sequence to allow for automatic release 
of eGFP protein (Figure 3.1). This virus construct was used for 3 reasons. The 
experiment was designed to determine infection at 12 and 24 hours, therefore a virus 
construct with marker gene expressed in late infection (after 4-6 hours) under the 
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control subgenomic promoter is suitable for this experiment. Secondly, the eGFP 
gene is expressed at a high level under the control of a subgenomic promoter at late 
infection which helps visualisation. Finally, eGFP is self-released as explained in 
chapter 1 which makes this construct ideal for visualisation of infected cell because 
eGFP is not specificically localisised in any part of the infected cell.  
 
Figure 3.1: A Schematic representation of the SFV4-steGFP. 
SFV4-steGFP is based on SFV4 construct with enhanced fluorescence protein gene inserted 
between Capsid and p62 proteins, flanked by three N-terminal amino acids (SAP) of p62 protein 
at the N-terminus and a 2A peptide sequence from FMDV at the C-terminus. 
U4.4, C7-10 and C6/36 cells were seeded in 6 well plates with a cover slip placed at 
the bottom of each well. The plates were incubated overnight at 28
o
C before 
infection with SFV-steGFP (MOI=10).  Cells were fixed with neutral buffered 
formaldehyde at 12 and 24 hours post-infection and examined under a microscope 
with UV light.  All 3 cell types expressed eGFP 12 hours post-infection.  A 
photomicrograph was taken at 24 hours post-infection of U4.4, C7-10 and C6/36 
cells and immunostaining using antibodies against nsp3 was carried out on infected 
C7-10 and C6-36 cells (Figure 3.2). The nsP3 staining is in red. 





Figure 3.2: Infection of Aedes 
albopictus-derived (A) U4.4 (B) C7-
10 and (C) C6/36 cells with SFV4-
steGFP (MOI=10). 
Photomicrograph taken using confocal  
microscope: (A) U4.4 cells showing 
the expression of eGFP at 20x 
magnification; (B) C7-10 cells 
immune-fluorescence stained against 
nsp3 of SFV at 20x magnification; (C) 
C6/36 cells showing the expression of 
eGFP and positive immunostaining  
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During the course of infection, each cell line exhibited different distinctive 
characteristics in cell numbers and morphology. Therefore, SFV4 infection was 
characterised in each cell line by determining virus growth in the first 12 hours post-
infection. Cells were seeded in a 6-well plate and infected with SFV4 (MOI=10) in 
triplicate. 100 μl of supernatant were collected and replaced with the same amount of 
fresh medium every 2 hours for 12 hours. Samples were stored at -80
o
C and titrated 
by plaque assay (Figure 3.3). 
 
Figure 3.3: One step growth curves of SFV4 in different mosquito cell lines.  
SFV4 growth kinetics in U4.4 (▲), C7-10 (■) and C6/36 (●) cells. Each point is the mean of 
triplicate samples. The error bars indicate the standard error of the mean. 
The growth curves show that SFV4 replicates efficiently in all three mosquito cell 
lines and shows a typical virus growth pattern going from stationary to exponential 
and then to a plateau phase.  As shown by the results, virus growth went through an 
exponential phase from 4-8 hours and started to reach a plateau from 8-12 hours. 
C6/36 cells produced virus most rapidly out of the 3 lines, reaching almost 1 log 
higher titre at 12 hours in comparison to the others. Due to the observation of change 
in cell number and morphology, more experiments were designed and carried out in 
an attempt to characterise the viability of cells during the course of infection. 
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The viability of infected mosquito cells 
To determine whether infected cells remained viable, WST-1 cell viability assays 
were carried out.  This assay system uses tetrazolium as a substrate for succinate-
tetrazolium reductase, an enzyme of the mitochondrial respiratory chain. The enzyme 
is only active in viable cells and cleaves the tetrazolium to a soluble formazan dye 
which can be measured at 420-480 nm. The absorbance value is interpreted as the 
metabolic activity of the culture and an indicator of cell viability.  Replicate cell 
cultures were set up in 96-well plates, each well was seeded with 5,000 cells. Cells 
were infected at MOI of 10 with SFV4 for one hour. At each time point, a set of 
triplicate wells were measured and discarded. Uninfected controls were included and 
measured at the same time points. 
  





Figure 3.4: Comparison of the metabolic activity of infected (MOI=10) and uninfected U4.4, 
C7-10 and C6/37 cells. 
(A) U4.4 cells.  (B) C7-10 cells.  (C) C6/36 cells.  The O.D. at 450 nm gives a measure of the 
metabolic activity of the culture.  Each time point is the mean of triplicate samples.  The error 
bars indicate the standard error of the mean. ■ and ● indicate the uninfected and infected cultures 
respectively. 
In U4.4 cells, the metabolic activity of the uninfected cultures increased over the 96 
hours of the study.  There did not appear to be any overgrowth of the culture due to 
the slow-growing nature of this cell type. The metabolic activity of the infected 
cultures was not affected; it remained very similar to the uninfected cultures, as 
shown in figure 3.4. 
In C7-10 and C6/36 cells, the metabolic activity of the uninfected cultures reached a 
maximum at 48 h, decreased from 48 to 72 h and thereafter remained stable from 72 
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to 96 h. The decrease after 48 h was probably due to the accumulation of cells over 
time, contact inhibition and exhaustion of nutrients leading to decreased cell 
metabolism or possible cell death.  The metabolic activity of infected cells remained 
constant throughout the 96 h studied indicating that the culture was viable for up to 
96 h after infection.  WST-1 only measures metabolic activity which is a product of 
several parameters including the number of cells, the cell proliferation rate and the 
cell death rate. The WST value did not change over time in the infected culture. That 
could indicate (i) all cells were static neither proliferating nor dying or (ii) that cells 
were dying and proliferating at the same rate with the metabolic activity of individual 
cells being unaffected by infection.  
The cellular growth of infected mosquito cells 
To directly determine the numbers of C6/36, C7-10 and U4.4 cells in infected and 
mock-infected cultures, a cell counting experiment was set up.  Replicate cultures 
were set up in 24-well plates infected at 10 MOI with SFV4 or mock-infected.  Cells 
were scraped off the plate and diluted with trypan blue at 0, 24, 48, 72 and 96 h post-
infection for counting.  
For all 3 cell types, the number of cells in the mock-infected cultures increased 
steadily over time (Figure 3.5). Infection had no effect on the number of U4.4 cells, 
the number continued to increase slowly as for the mock-infected cells. In contrast, 
the number of cells in infected C6/36 and C7-10 cultures did not change with time. 
Again as with the WST-1 data, these data do not distinguish between the possibility 
for the C6/36 and C7-10 infected cultures that, (i) the culture was static with no cell 
division and no cell death or (ii) cells in the culture were proliferating and dying at 
the same rate. However, the cell counts and the WST-1 data are in agreement that 
SFV4 has no effect on the growth of U4.4 cultures but strongly affects C6/36 and 
C7-10 cultures. 
Trypan blue was used to dilute cells for counting to aid better visualisation of live 
cells as dead cells stain blue due to trypan blue uptake.  The cell diluent in the U4.4 
cell suspension was observed to be clear and blue, whilst noticeable amounts of very 
small cellular debris were observed in the cell diluent from C6-36 and C7-10. This 
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would be consistent with the hypothesis that cells in these cultures were proliferating 
and dying at similar rates.  
 
Figure 3.5: Cell growth after SFV4 infection (MOI=10) as measured by cell count. 
(A) U4.4 cells.  (B) C7-10 cells.  (C) C6/36 cells.  The cell count shows the number of cells 
present in the culture.  Each point is the mean of triplicate samples.  The error bars indicate the 
standard error of the mean. ■ and ● indicate the uninfected and infected cultures respectively. 
There is an apparent difference in the cellular growth pattern between U4.4 , C6/36 
and C7-10 infected cells. However, the virus growth curves are fairly similar from 
cell type to cell type (Figure 3.3). 
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The amount of virus being produced in mosquito U4.4 cell line from 
acute to persistent phase of infection. 
Given the cell viability data it can least be concluded that unlike mammalian cells, 
mosquito U4.4 cells do not undergo apoptosis after SFV4 infection. The next study 
was designed to determine the amount of virus being produced by U4.4 cells during 
acute and persistent phases of infection and also to monitor the time of transition 
between phases.  Cultures of 5x10
5
 U4.4 cells were infected synchronously with 
SFV4 (MOI=10). Aliquots of 100 μl supernatant were collected at 12, 24, 48, 72, 96 
and 120 h post-infection. The remaining supernatant in the cells was completely 
replaced with fresh medium each time after an aliquot of supernatant was collected. 
Supernatant samples were kept in eppendorf tubes at -80
o
C. All samples were titrated 
by plaque assay. As shown in Fig 3.6, high levels of virus production were observed 
from 0 to 24 hours post-infection. Thereafter, virus production dropped to low levels 
as the culture entered the persistent phase of infection.  
 
Figure 3.6: SFV4 production between each time interval up to 120 hours post-infection. 
U4.4 cells were infected synchronously with SFV at MOI of 10. Supernatant was collected for 
titration at 12, 24, 48, 72, 96 and 120 h post-infection. The error bars indicate the standard error 
of the mean. 
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Video microscopy (See attached CD) 
In the previous cell counting experiment, infected C6/36 and C7/10 had shown no 
increase in number of cells over 120 hours post-infection. Therefore, video 
microscopy was used to determine if these cultures maintained cell numbers by 
growing and undergoing apoptosis at the same rate or by cells becoming static post-
infection.  Video microscopy was also carried out on VRP infected U4.4 and C6/36 
cells to observe viral marker gene expression from the acute phase to the persistent 
phase of infection in the absence of new virion production and new infection. A T25 
flask was seeded with 5x10
5
 mosquito cells and incubated overnight at 28 
o
C. Cells 
were then infected with SFV1(3F)-ZsGreen at MOI=1.  SFV1(3F)-ZsGreen is a 
propagating-deficient replicon with the ZsGreen fluorescent protein gene inserted at 
and fused with the C-terminus of nsP3. This suicidal replicon particle was used to 
infect cells at low MOI to show that a small amount of infected cells (with no second 
round of infection) were sufficient to cause arrest in number of cells in C6/36 culture. 
Secondly, ZsGreen fusion protein was used in attempt to produce greater emission 
signal for videomicroscopy, however, due to the nature of this construct, ZsGreen 
signal will be localised at the nucleus.  The flask was then placed under the 
microscope for 16 hours of filming. All internal surfaces of the flask were rinsed 
with medium before filming started to avoid condensation forming on the inside of 
the top surface of the flask during the course of filming. The microscope was 
programmed to take one frame every three minutes under visible and UV light. An 
attempt to film one frame per minute resulted in total cell death due to over-exposure 
to UV light.  A compact disk containing the video clips of video microscopy on U4.4 
and C6/36 cell lines, infected and uninfected, is included at the back of the thesis. 
The videos are each 1 min 4 sec in length, 5 frames per sec, 320 frames in total. 
The U4.4 cell cultures were heterogeneous and contained more than one cell type 
(this cell line was derived from whole mosquito larva.). In figure 3.7 U4.4(A), 4 
frames of the uninfected U4.4 culture at 0 hour, 5 hours 15 min, 10 hours 45 min, 
and 16 hours of video time are shown. This video was filmed under 20 times 
magnification. As observed in the video of the non-infected culture, there were a 
variety of cells with different morphologies. Most of the observed cells were 
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rounded, and relatively stationary. However, approximately a quarter of the cells 
were highly motile and capable of travelling in and out of the microscopic field of 
observation. The morphologies of these motile cells resembled macrophages, and 
these cells could be haemocytes. These motile cells engaged with one cell and then 
actively travelled to another and appeared to engulf very small cell debris. The 
number of cells in the microscopic field increased from 40 to 53 over the period of 
observation thought this is not a good indication of the actual growth rate of the 
culture as different area of the flask had different numbers of settled cells. For the 
SFV infected cultures, videos were started at 6 hours post-infection. Therefore, video 
time label 0 hour is 6 hours post-infection. In SFV1(3F)-ZsGreen infected U4.4 
cultures (figure 3.7 U4.4(B)), infected cultures appeared to behave like uninfected 
cultures, cell migration and cell division were observed. A video under UV light of 
the infected culture was taken and infected cells appeared green (figure 3.7 U4.4(C)). 
This showed that the viral marker gene from the structural region of the virus 
genome is expressed from 6 hours post-infection and the reporter eGFP remained 
visible throughout the entire course of filming. No second round of infection was 
observed. 
The uninfected C6/36 cultures also appeared to contain more than one cell type. The 
first type of cells was rounded and was the predominant type of cell in the culture 
making up 90% of the population. These cells were rounded and appeared to be 
slightly smaller than U4.4 cells. None of the cells were capable of travelling a great 
distance (figure 3.7C6/36(A)). In infected C6/36 cultures, all cells appear to become 
static at video clip time 10 sec, which was 2 hours 30 after filming started and post-
infection time 8 hours 30 minutes. No cell division and no cell death were observed 
throughout this static phase (figure 3.7C6/36(B)). Figure 3.7C6/36(C) shows the 
infected culture under UV light. This showed that infected C6/36 cells are going into 
static phase when infected, ruled out the possibility of cells dying and growing at the 
same rate. 












Figure 3.7: Video microscopy of SFV1(3F)-ZsGreen infected U4.4 and C6/36 cells. 
U4.4 cells (page 87) and C6/36 cells (page 88) were infected with SFV1(3F)-ZsGreen, and light 
and UV video microscopy was performed as described in Chapter 2. Four subsequent frames are 
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displayed separately. (A) Top row, uninfected cells. (B) Middle row, infected cells. (C) Bottom 
row, infected cells under UV light. The total number of frames is 320, recorded during 16 hours, 
20x magnification.  Additional panel (page 89) shows C6/36 cells infected with SFV1(3F)-
ZsGreen at 10 MOI, video microscopy was carried out under visible light. Four subsequent 
frames are displayed separately. (A) Top row, uninfected cells. (B) Middle row, infected cells. 
The total number of frames is 1920, recorded during 96 hours, 20x magnification. (C) Bottom 
row, photomicrographs of infected C6/36 cells taken at 96 hours post-infection (same culture as 
middle row). This showed C6/36 were infected with SFV1(3F)-zsGreen. 
Summary of Findings 
Infection of mosquito cells with SFV 
 Infection of U4.4, C6/36 and C7-10 cells with SFV was established. Infection 
of U4.4 and C6/36 cells with SFV4-steGFP resulted in expression of eGFP. 
Immunostaining of SFV4-steGFP infected C7-10 cells using antibodies 
against nsp3 showed these cells were infected.  
 The growth of SFV4 in the first 12 hours post-infection was characterised in 
all three mosquito cell lines. Growth was exponential from 4 to 8 hours post-
infection. C6/36 cells produced virus most rapidly and reached almost 1 log 
higher titre at 12 hours in comparison to U4.4 or C7-10 cells. 
 Infected U4.4 cells showed no change in the growth of the culture. In 
contrast, C6/36 and C7-10 infected cultures showed no growth.  
 SFV production in U4.4 cells showed virus was being produced most rapidly 
during the acute phase of infection. The amount of virus being produced 
declined after 24 hours. Low level virus production was maintained from 72 
hours onwards.  
Video microscopy 
 U4.4 cell cultures were heterogeneous and contained more than one cell type. 
Most of the cells were rounded, and relatively stationary. However, 
approximately a quarter of the cells were highly motile. These motile cells 
engaged with other cells in the culture and appeared to engulf cell debris. 
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SFV1(3F)-zsGreen VRP infected U4.4 cultures appeared to behave like 
uninfected cultures. Only a single round of infection was observed. A video 
of one of these cultures showed expression of the marker gene for 16 hours. 
 C6/36 cultures were also heterogeneous. Cells were rounded and appeared to 
be slightly smaller than U4.4 cells. None of the cells were extensively motile. 
As shown in a video, infected C6/36 cultures became static. No cell division 
and no cell death were observed throughout this static phase.  
 Video microscopy confirmed that infected C6/36 cells became static after 
infection. No cell division and no cell death resulted in maintenance of the 
cell number at the same level after infection. 
Discussion 
In this series of initial experiments, infection with SFV was established in three Ae. 
albopictus cell lines. U4.4, C7-10 and C6/36 cells were infected with SFV4-steGFP. 
The expression of virus promoter driven eGFP marker gene was observed 24 hours 
post-infection in U4.4 and C6/36 (Figure 3.2A & 3.2C). Immunostaining of SFV4-
steGFP infected C7-10 and C6/36 cells using antibodies against SFV nsP3 showed 
these cells were infected and contained nsP3 in the cytoplasm (Figure 3.2B & 3.2C). 
Figure 3.2C showed eGFP signal overlapping with signal from immunostaining of 
nsP3 in C6/36 cells. In this figure, some cells contained eGFP signal only, some cells 
only contained red signal (staining for nsP3) and a few showed both signals. This 
indicated that infection at 10 MOI did not infect all the C6/36 cells in the culture 
simultaneously because different stages of the virus life cycle were observed. The 
green cells are cells which were initially infected by the virus and are at a late stage 
of viral replication. At the late stage of infection, nsP3 is not being made and only 
viral genes driven by the non-structural promoter are being expressed.  The red cells 
represent cells which were not initially infected but were subsequently infected by 
virus released from initially infected cells. Therefore, the red cells are at an early 
stage of infection, and only non-structural genes are being transcribed and translated.  
The cells showing both red and green are going through the transition from early to 
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late stage of infection where nsPs are not yet fully degraded and structural genes are 
being transcribed and translated. 
The growth of SFV4 in each of the mosquito cell lines was characterised by 12-hour 
one step growth curves which showed that all three cell lines are capable of 
supporting the growth of virus from stationary through exponential to plateau phase. 
The exponential growth phase took place from 4 to 8 hours and started to reach 
plateau from 8 hours post-infection. Cell line C6/36 produced the highest yield of 
SFV4 in comparison to U4.4 and C7-10 which is in agreement with previous 
observations that C6/36 produces highest virus yield amongst other clones and 
viruses tested (Igarashi, 1978). In C7-10 cells, the virus titres at 2 and 4 hours post 
infection were below the limit of detection. These time points are inconclusive and 
time constraints did not allow me to repeat it to resolve this matter. However, based 
on the later time points I would expect the virus to follow a very similar pattern to 
the U4.4 cells.  
Although all three of the mosquito cell lines support virus infection and have been 
shown to maintain infection in low titre through passages, their morphological and 
growth responses are different during the course of infection. Only U4.4 cells 
displayed no change in the growth of the culture after SFV infection, whereas the 
growth of C6/36 and C7-10 cells appeared to be adversely affected. Therefore, WST-
1 assay and cell counting was carried out.  In the U4.4 cells the uninfected and 
infected cultures had similar metabolic activity and numbers of cells over 96 hours. 
At 72 hours post-infection the metabolic activity of both infected and uninfected 
cells did not double from 48 hours post-infection (Figure 3.4A) and generate a 
smooth curve as observed in the results in cellular growth of infected mosquito cells 
(Figure 3.5A). This could be due to the number of cells seeded in that column of the 
96-well plate (the column used for the 72 hour assay) being slightly lower than other 
columns because cells in suspension precipitate over the course of manual pipetting. 
Nevertheless, figure 3.4A shows that the metabolic activity of infected and 
uninfected U4.4 cells closely resembled each other.  The C6/36 and C7-10 cells 
showed no increase in metabolic activity or cell number in infected cultures 96 hours 
post-infection. However, these results did not determine whether infected C6/36 and 
Chapter 3   Infection of mosquito cells with SFV 
103 
 
C7-10 become (i) static with no cell division and no cell death or (ii) were 
proliferating and dying at the same rate. It was later revealed by video microscopy 
that these cells remained static with no cell division and no cell death caused by 
SFV1(3F)-zsGreen infection of C6/36 culture.  The use of suicidal SFV1 particles to 
infect cells at low MOI also showed perhaps an extracellular signal was produced 
from the few infected C6/36 cells to the rest of the uninfected C6/36 in the culture. 
This signal is perhaps also contributed in the anitiviral activity reported by Riedel 
and Brown in 1978. In fact, a pilot experiment was carried out and showed a putative 
signal factor was produced which influenced growth and affected subsequent 
infection by transferring supernatant from SFV1 infected C6.36 cells (MOI=1) to 
uninfected C6/36 culture (results not shown). The results were not further pursued 
because it is beyond the scope of interest and the involvement of extracellular 
signalling, low molecular weight fractionation require different equipments and skill 
set from this laboratory.  Video microscopy also showed that U4.4 cells were 
heterogeneous and contained cells resembling macrophages. These motile cells were 
capable of travelling great distance and engulfing cell debris.  
In conclusion, U4.4 cells displayed a number of characteristics ideal for experiments 
to investigate virus replication. The growth rate of U4.4 cells is much slower than 
C7-10 and C6/36 cells. This allows experiment to be performed at a higher cell 
density without the complication of over-growth and contact inhibition. The growth 
of U4.4 cultures was not affected by infection with SFV, and they showed the acute 
phase of virus production from 12 to 24 hours and transition to low virus production 
during the persistent phase of infection (Figure 3.8, below). This pattern of infection 
was similar to the earlier experiments of Davey & Dalgarno (Davey & Dalgarno, 
1974). These properties of U4.4 cells were also in agreement with infection of U4.4 
cells with Sindbis virus (Mudiganti et al., 2006). This means during the course of 
infection, cell metabolism was not under stress whilst the ability to control SFV 
infection was maintained.  
  





Figure 3.8: SFV4 production in U4.4 cells and characteristics of U4.4 cells infected with 
SFV4. 
U4.4 cells were infected synchronously with SFV at MOI of 10. Supernatants were collected for 
titration at 12, 24, 48, 72, 96 and 120 h post-infection. Virus titre ● is represented in Log10(PFU) 
● indicated on the left Y-axis.  Infected and uninfected U4.4 cell numbers were counted up to 96 
hours, represented in number of cells on the right Y-axis. Each point is the mean of triplicate 
samples.  The error bars indicate the standard error of the mean. 
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Chapter 4: Investigation of the effect of mosquito innate 
immune pathways on virus replication 
Introduction 
Viruses and other intracellular pathogens have to overcome cellular host defences to 
replicate efficiently. In vertebrates, detection of viral molecular patterns, for example 
dsRNA, is an important trigger of antiviral defences. 
Insects have a potent innate immune response that effectively protects them against 
fungi and bacteria (Silverman & Maniatis, 2001). For example, Drosophila produces 
seven types of antimicrobial peptides (AMPs) in response to fungal or bacterial 
infection (Hoffmann & Reichhart, 2002).  Insect innate immune defences have been 
studied mostly in D. melanogaster; in which fungi and Gram-positive bacteria 
activate the Toll pathway (Ferrandon et al., 2004). The activation of Toll pathway 
leads to the production of AMPs such as Drosomycin and Metchnikowin in 
Drosophila. Mutant flies fail to produce these two AMPs are susceptible to infections 
with the filamentous fungus Aspergillus fumigates (Lemaitre et al., 1996).  Gram-
negative bacteria activate the IMD pathway (Royet, 2004) and JNK pathway 
(Silverman & Maniatis, 2001). The activation of IMD pathway induces the 
production of AMPs such as attacin, cecropin, defensin, diptericin, and drosocin. 
Drosophila failed in producing these AMP genes due to a recessive mutation in the 
IMD pathway has been shown to be more susceptible to Gram-negative bacteria 
(Lemaitre et al., 1995). In Anopheles mosquitoes, dsRNA RNAi-mediated 
knockdown of defensin has been shown to be essential for defense against Gram-
positive bacteria (Blandin et al., 2002). Defensin is important as innate antiviral 
immunity in mammals, which can block viral infection by directly interacting with 
the viral envelopes or through interaction with the host cell (Chang et al., 2005; 
Daher et al., 1986; Wang et al., 2004). 
These fundamental immune signalling pathways and the RNAi response (Sanchez-
vargas et al., 2004; Zdobnov et al., 2002) are conserved in Aedes and Anopheles 
mosquitoes. However, little is known about how these pathways respond to virus 
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infections.  Arboviruses establish persistent infections in insect cells, as opposed to 
causing cell death in vertebrate cells. This suggests that the insect’s ability to control 
of viral infections lies within the functions of innate immune defences. 
Although the IMD and Toll pathways are activated upon bacterial and fungal 
stimulation, activation of these pathways ultimately activates the transcription factors 
Relish and Dif, the homologue of NF-κB. Therefore, activation of these innate 
immune pathways may induce transcription of genes that share the same promoter 
element which is involved in the defence against virus infection. In Drosophila, the 
STAT and IMD pathways are involved in responses to drosophila C and Drosophila 
X viruses (Dostert et al., 2005; Zambon et al., 2005). The Toll pathway has been 
shown to be involved in the control of Dengue virus infection in Aag2 cells, with up-
regulation of two Tolls, MyD88, and Rel1. Furthermore, a comparison between the 
transcriptomes of DENV-infected Aag2 cells and Toll pathway-activated Aag2 cells 
(RNAi-mediated silencing of Cactus) revealed a great percentage of overlap genes 
that changed in expression level (Sim & Dimopoulos, 2010). DNA micro-array 
analysis of the gene expression by midgut cells of Ae. aegypti infected with Sindbis 
virus showed that genes involved in Toll and IMD were up-regulated early in 
infection, whereas JNK and RNAi (dicer-2) genes were down-regulated in the 
midgut of infected mosquitoes (Sanders et al., 2005).  The JAK-STAT pathway is 
activated in Ae. Aegypti mosquitoes infected with DENV and the mosquito’s 
susceptibility to DENV infection increases when JAK-STAT pathway is suppressed 
through RNAi depletion of its receptor Dome and the Janus kinase Hop. 
Furthermore, mosquitoes become more resistance to DENV infection when JAK-
STAT is up-regulated prior to infection (Souza-Neto et al., 2009). 
The interplay between mosquito cell signalling pathways and alphaviruses is not 
understood. The principle aim of this series of experiments was to determine whether 
activation of STAT/IMD or Toll pathways had any anti-viral effect on SFV 
replication (represented by viral gene expression). The STAT/IMD or Toll pathways 
were activated in U4.4 cells prior to infection and viral gene expression was 
determined by the level of viral reporter gene expression. Two reporter viruses 
SFV4(3H)-RLuc or SFV4-stRLuc were used to determine the effect of these 
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pathways on the early and late stage of virus replication. The expression of Renilla 
luciferase is driven by the viral non-structural promoter of SFV4(3H)-RLuc and the 
structural promoter of  SFV4-stRLuc. The effect of these pathways on early or late 
virus replication can be interpreted as the changes of Renilla luciferase expression by 
these reporter viruses. 
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Characterisation of SFV4(3H)-RLuc and SFV4-stRLuc marker 
viruses in U4.4 mosquito cells 
New reporter viruses with a Renilla luciferase (RLuc) gene inserted into either the 
non-structural or the structural ORF were available for this study (Figure 4.1).  These 
viruses were constructed by Prof. Andres Merits but had not previously been 
characterised.  To examine the replication ability of these viruses, one-step growth 
curves were determined.  
 
Figure 4.1: A Schematic representation of SFV4, and RLuc expressing SFV4 constructs. 
(A) SFV4. (B) SFV4(3H)-RLuc. This is an SFV4 construct with the RLuc gene inserted between 
nsP3 and nsP4. RLuc is translated as part of the non-structural polyprotein. The native nsP2 
protease recognition site (C-terminus of nsP3) and its duplicate (fused at the C-terminus of RLuc) 
gives rise to mature RLuc through expression of non-structural genes. (C) SFV4-stRLuc. This is 
an SFV4 construct with the RLuc gene inserted between the capsid and p62 genes. RLuc is 
flanked by three N-terminal amino acids (SAP) of the p62 protein at the N-terminus and a 2A 
peptide sequence from FMDV at the C-terminus translated as part of the structural polyprotein.  
One step growth curve analysis was carried out to characterise SFV4(3H)-RLuc and 
SFV4-stRLuc along with the control SFV4 in U4.4 mosquito cells (Figure 4.2). All 
three growth curves started with the stationary phase, then went into exponential 
phase at 6 hours post-infection. At early time points (2 and 4 hours post-infection), 
SFV4(3H)-RLuc had higher average titres than SFV4. However, the error bars on 
those two time points were large and overlapped the average titre of SFV4. This 
indicates that determination of the replication kinetics of SFV4(3H)-RLuc was 
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inconclusive.  Based on the titres of SFV4 and SFV4(3H)-RLuc at 2 and 4 hours 
post-infection, the steep descrease of SFV4-stRLuc titre at 2 and 4 hours post-
infection is unlikely to be the natural replication pattern. I would expect the virus 
titre of SFV4-stRLuc to follow a similar pattern to SFV4 at those time points. 
However, time constraints did not allow me to repeat the experiment to resolve this 
matter. All three viruses reached maximum titre at 12 hours post-infection. At 10 
hours post-infection, the virus tires of both recombinant viruses, SFV4(3H)-RLuc 
and SFV4-stRLuc, were significantly lower than the SFV4 titre (P = 0.0001 and 
0.0003 respectively, by statistical comparison with a nonparametric unpaired t test). 
The titres of SFV4(3H)-RLuc and SFV4-stRLuc were also significantly lower than 
SFV4 at 12 hours post-infection (P = 0.0028 and 0.0038 respectively, by statistical 
comparison with a nonparametric unpaired t test). The lower titre of the recombinant 
marker viruses suggested that insertion of the marker gene had compromised the 
replication of the virus. 
 
Figure 4.2: Growth curves of SFV4, SFV4(3H)-RLuc and SFV4-stRluc in U4.4 cells up to 12 
hours post-infection (MOI=10). 
Virus titres were determined every two hours by plaque assay. Each point is the mean of 
triplicate samples.  The error bars indicate the standard error of the mean.  
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Activation of STAT/IMD pathways in U4.4 cells 
To activate STAT/IMD pathways in U4.4 cells, U4.4 cultures were incubated with 
heat killed bacteria for one hour. The control experiment to determine the activation 
of STAT/IMD pathways was carried out by Rennos Fragkoudis and Yi Chi 
(Fragkoudis et al., 2008).  The Firefly luciferase expression plasmids p6x2DRAF-
Luc or pJL169 (containing respective promoters for STAT or IMD inducible 
signalling pathways) were transfected prior to stimulation with heat-killed bacteria. 
The activation of STAT and IMD pathways were detected as Firefly luciferase 
expression after heat-killed bacterial stimulation.  
Effect of activation of STAT/IMD pathways on SFV gene expression 
in U4.4 cells 
To activate the STAT/IMD pathways, triplicate cultures were set up in 6-well plates 
with 5 x 10
6
 U4.4 cells in each well. E. coli JM109 was grown overnight, harvested 
and resuspended in 500 μl of SPBS. The bacterial suspension was killed by heating 
to 98
o
C for 5 minutes. Five μl of heat killed bacteria was added to each well of U4.4 
cells to stimulate their STAT/IMD pathways. An hour later, stimulated cells were 
infected (MOI=1) with SFV4(3H)-RLuc or SFV4-stRLuc. A mock-infection was 
included as a negative control.  A separate control experiment carried out by Yi Chi, 
another student in the laboratory, showed that SFV infection of U4.4 mosquito cells 
does not activate the STAT or IMD signalling pathways (Data not shown) 
(Fragkoudis et al., 2008). 
The ideal time to measure viral marker gene expression had to be determined. 
Therefore, to determine the ideal time post-infection to observe the effect of 
STAT/IMD activation on viruses, experiments were set up and cells were lysed at 1, 
2, 3, 4, 5, 6 and 12 hours post-infection and viral marker gene expression was 
determined by luciferase assay (Figure 4.3). The experiment was carried out in 
triplicate. The luciferase expression for both SFV4-stRLuc and SFV4(3H)-RLuc was 
reduced by 40% when the cells had been previously simulated with heat-killed 
bacteria at all the tested time points.  At 12 hours post infection, the luciferase 
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activities for SFV4(3H)-RLuc infected U4.4 cells and U4.4 cells stimulated with 




 respectively; for SFV4-stRLuc infected 





 respectively. In both control and heat-killed bacteria stimulated U4.4 cells, 
SFV4-stRLuc had 23-fold more luciferase activity than SFV4(3H)-RLuc. This is 
because by 12 hours post-infection the virus replication entered the late phase in 
which mature replication complexes focus on the production of positive strand and 
26S sub-genomic RNA. The large quantity of 26S sub-genomic RNA was being 
translated into structural proteins (including the marker gene).  In contrast at 6 hours 
post-infection, the luciferase activities measured from SFV4-stRLuc were only 3.6- 
and 2.2-fold more than SFV4(3H)-RLuc infected control and heat-killed bacteria-
stimulated cells respectively. This indicated that, at 6 hours post-infection, virus 
replication had just made the transition to produce positive-strand and 26S sub-
genomic RNA. This suggested that 12 hours post-infection is a more suitable time to 
measure the fully-expressed structural and non-structural marker genes. 




Figure 4.3: Effect of activation of STAT/IMD pathway on virus driven RLuc expression, 
measured between 1 and 12 hpi; U4.4 cells infected at MOI=1 with SFV4(3H)-RLuc and 
SFV4-stRLuc. 
(A) A control experiment for SFV4(3H)-RLuc, showing luciferase expression at 1, 2, 3, 4, 5, 6 
and 12 hours post-infection without prior activation of STAT/IMD. (B) Luciferase expression at 
indicated hours post-infection. STAT/IMD pathways were activated by heat killed bacteria prior 
to SFV4(3H)-RLuc infection. (C) A control experiment for SFV4-stRLuc, showing RLuc 
expression at indicated hours post-infection without prior activation of STAT/IMD. (D) 
Luciferase expression at indicated hours post-infection. STAT/IMD pathways were activated by 
heat killed bacteria prior to SFV4-stRLuc infection.  Each bar is the mean of triplicate samples.  
RLuc expression measured in activity by luminometer. The error bars indicate the standard error 
of the mean.  
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To determine the ideal MOI for infection and the effect of STAT/IMD activation on 
SFV4(3H)-RLuc and SFV4-stRLuc, three independent experiments were carried out 
with infection at MOI of 0.1, 1 and 10. SFV4 infection was carried out a as control. 
Cultures were lysed 12 hours post-infection and viral marker gene expression was 
determined by luciferase assay (Figure 4.4).  
At MOI=0.1, the mean luciferase expression of SFV-stRLuc in control U4.4 cell 
cultures was 1.4 x 10
4 
light units (Figure 4.4A bar 3). In heat-killed E. coli stimulated 
cultures, mean expression was 6.6x10
3
 light units (Figure 4.4A bar 4). For 
SFV4(3H)-RLuc, mean luciferase expression in the control experiment was 1.4x10
4 
light units (Figure 4.4A bar 5), and 8.6x10
3
 light units (Figure 4.4A bar 6) in 
stimulated cultures. At this MOI, luciferase expression controlled by the structural 
gene promoter was reduced by 54% and by 41% for the non-structural gene promoter 
after activation of STAT/IMD pathways.  At MOI=1, a 44% reduction was observed 




 light units (Figure 4.4B bars 





light units (Figure 4.4B bars 5&6).  At MOI=10, a 48% reduction was observed in 




 light units (Figure 4.4C bars 3&4) 
and a slight gain of 1.5% in SFV4(3H)-RLuc (Figure 4.4C bars 5&6).   
At MOI of 0.1 and 1, the luciferase activity expressed by both SFV-stRLuc and 
SFV4(3H)-RLuc infected cells was reduced by a similar percentage after stimulation 
with heat-killed bacteria. However, the luciferase expression from cells infected with 
SFV-stRLuc at MOI=0.1 was low (e.g. mean expression from stimulated cells was 
6.6 x 10
3
 light units) which makes measurement more prone to errors. In contrast, at 
MOI=1 luciferase expression was much higher and produced less error within 
replicate experiments. At MOI=10, the luciferase expression from SFV4(3H)-RLuc 
was not reduced in cells stimulated by heat-killed bacteria. This indicates that, at a 
higher multiplicity of infection, early virus replication could overcome the pre-
activated STAT/IMD pathways. It is interesting that although early replication had 
apparently overcome the pre-activated STAT/IMD pathways, the late replication 
stage remained suppressed as indicated by the reduction in luciferase expressed from 
SFV-stRLuc. In conclusion, infection at MOI=1 produced accurate results and 
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showed that the effect of activated STAT/IMD pathways can interfere with early and 
late SFV replication in U4.4 cells. This MOI was therefore used in subsequent 
experiments. 
  




Figure 4.4: The effect of activated STAT/IMD pathway at different multiplicity of infection. 
RLuc expression measured in light units from U4.4 cells at 12 hours post-infection at (A) 
MOI=0.1, (B) MOI=1, and (C) MOI=10 with SFV4, SFV4-stRLuc and SFV4(3H)-RLuc. 0 h and 
1 h indicates the amount of time the cell cultures had been stimulated with E. coli. RLuc 
production measured as activity by luminometer.  Each bar is the mean of triplicate samples.  The 
error bars indicate the standard error of the mean. 
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Effect of activation of STAT/IMD pathways on SFV replication in 
U4.4 cells 
To determine the effect of STAT/IMD activation on SFV replication, STAT/IMD 
pathways were activated in cultures prior to infection and progeny virus titrated. 
Triplicate cultures were set up in 6-well plates with 5x10
6
 U4.4 cells in each well. 
STAT/IMD pathways were activated on the next day with heated-killed E. coli prior 
to SFV4 infection. STAT/IMD pathways were activated by 5 μl of heat-killed 
bacteria per well of U4.4 cells for 1 hour prior to SFV4 infection (MOI=1). Control 
wells received SPBS alone followed by infection. The supernatants were collected 12 
and 24 hours after infection. All samples were titrated by plaque assay. An unpaired 
non-parametric t test indicated the virus titres between non-activated and activated 
(STAT/IMD) cultures at 12 hours post-infection were not significantly different, P = 
0.3571. However, the titres were significantly lowered by 60% at 24 hours, P = 
0.0336 (Figure 4.5). 
 
Figure 4.5: The effect of activation of the STAT/IMD pathway on SFV4 replication in U4.4 
cultures.  
The amount of virus produced in U4.4 cells was measured at 12 and 24 hours post-infection 
(MOI=1) by plaque assay. The blue bars are control cultures in which STAT/IMD were not 
activated. The yellow bars represent STAT/IMD activated cultures. Each bar is the mean of 
triplicate samples.  The error bars indicate the standard error of the mean. * p<0.05 by (unpaired 
nonparametric t tests) 
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Activation of Toll pathway in U4.4 cells 
To activate the Toll pathway in U4.4 cells, plasmid pJL195 (a construct based on the 
insect competent plasmid pIB-V5/His into which a mutated toll receptor gene 
sequence was inserted) was transfected into mosquito cells. This mutated toll 
receptor (Toll ∆ LRR) is constitutively active, recruits and phosphorylates 
downstream signalling molecules (Tauszig et al, 2000). The control experiment to 
determine the activation of Toll pathway was carried out by Rennos Fragkoudis and 
Yi Chi (Fragkoudis et al., 2008).  The Firefly luciferase expression plasmid pJM648 
(containing Toll responsive promoter for STAT or IMD inducible signalling 
pathways) were co-transfected with pJL195. Activation of the Toll pathway was 
detected as Firefly luciferase expression.  
Effect of activation of Toll pathway on SFV gene expression in U4.4 
cells 
To determine whether activation of the Toll pathway has any effect on SFV 
replication, the Toll pathway was activated in U4.4 cells prior to infection and virus 
replication was determined by the level of marker gene expression. Twelve hours 
after the pJL195 plasmid was transfected, cells were infected with SFV4(3H)-RLuc 
or SFV-stRLuc at MOI=1. A control experiment was carried out with cells 
transfected with an empty plasmid, pIB-V5/His, followed by infection with 
SFV4(3H)-RLuc or SFV4-stRLuc at MOI=1. Cells were lysed at 12 h post-infection 
and viral marker gene expression was determined by luciferase assay.  
Luciferase expression of SFV4-stRLuc and SFV4(3H)-RLuc in Toll-activated 
cultures was similar to the expression in the controls. These results showed that 
production of luciferase within infected cells was not affected by activation of the 
Toll pathway. An unpaired non-parametric test indicated that expression levels in 
non-activated and activated Toll cultures for SFV4-stRLuc and SFV4(3H)-RLuc were 
not significantly different; P = 0.7194 and 0.1399 respectively. Therefore, activation 
of the Toll pathway does not affect production of proteins encoded by either the 
structural or non-structural ORF of the viral genome. 




Figure 4.6: The effect of activation of the Toll pathway on virus-driven RLuc expression in 
U4.4 cells infected with SFV4-stRLuc and SFV4(3H)-RLuc (MOI=1) at 12 hours post-
infection. 
Y-axis legends: pIB – st(RLuc) = control non-activated culture which received a blank pIB-
V5/His plasmid, followed by infection with SFV4-stRLuc; pJL195 – st(RLuc) = activated culture 
in which Toll pathways in the cell culture were activated by transfection of plasmid pJL195, 
followed by infection with SFV4-stRLuc; pIB – (3H)-RLuc = control non-activated culture which 
received a blank pIB-V5/His plasmid, followed by infection with SFV4(3H)-RLuc; pJL195 – 
(3H)-RLuc = activated culture in which Toll pathways in the cell culture were activated by 
transfection of plasmid pJL195, followed by infection with SFV4(3H)-RLuc. Each bar is the 
mean of triplicate samples. The error bars indicate the standard error of the mean.  
Effect of activation of Toll pathway on SFV replication in U4.4 cells 
To determine the effect of activated Toll pathway on SFV titres, triplicate cultures 
were set up in 6-well plates with 5x10
6
 U4.4 cells in each well. The toll pathway was 
activated by transfection of plasmid pJL195. The plates were then incubated for 12 
hours before infection with SFV4 (MOI=1). As controls, cultures were transfected 
with an empty plasmid, pIB, prior to SFV4 infection (MOI=1). The supernatants 
from transfected and control cultures were collected 12 and 24 hours post-infection. 
The supernatants were titrated by plaque assay. The resulting titres indicated little or 
no difference between Toll activated and non-activated cultures at 12 and 24 hours 
post-infection. An unpaired non-parametric t test indicated that the virus titres in 
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non-activated and Toll-activated cultures at 12 hours and 24 hours post-infection 
were not significantly different; P = 0.4738 and 0.5455, respectively (Figure 4.7). 
 
Figure 4.7: The effect of activated Toll pathway on SFV4 titres in U4.4 cultures.  
The amount of virus produced in U4.4 cells was measured 12 and 24 hours post-infection 
(MOI=1) as plaque forming units by plaque assay. The blue bars are control cultures in which 
Toll was not activated. The yellow bars represent Toll activated cultures. Each bar is the mean of 
triplicate samples.  The error bars indicate the standard error of the mean. 
Effect of activation of STAT/IMD and Toll pathways on SFV gene 
expression in U4.4 cells 
To determine if STAT/IMD and Toll together have a combined effect on SFV viral 
gene expression, both pathways were activated in cultures prior to infection. 
Triplicate cultures were set up in 6 well plates with 5 x 10
6
 U4.4 cells in each well. 
Cells were transfected with pJL195 or pIB-V5/His as control. Plates were then 
incubated for 12 hours prior to addition of 5 μl of heat-killed bacteria followed by 
one hour of incubation. Cultures were then infected at MOI=1 with SFV4(3H)-RLuc 
or SFV4-stRLuc.  Cells were lysed at 12 hours and viral marker gene expression was 
determined by luciferase assay. An unpaired non-parametric t test indicated that, for 
SFV4-stRLuc, expression levels in STAT/IMD/Toll activated cultures were 
significantly increased by 28.9% (P = 0.0300) than in STAT/IMD only activated 
cultures, whereas for SFV4(3H)-RLuc , they were significantly reduced by 20% (P = 
0.0021) (Figure 4.8). 




Figure 4.8: Effect of Toll and STAT/IMD activation on SFV replication measured in 
luciferase light units.  
U4.4 cultures transfected with pIB-V5/His (STAT/IMD activation) or pJL195 (STAT/IMD/Toll 
activation) and treated with heat-killed E. coli prior to SFV infection. RLuc was measured in 
U4.4 cells 12 h after infection (MOI=1) with SFV4-stRLuc or SFV4(3H)-RLuc. Each bar is the 
mean of triplicate samples.  The error bars indicate the standard error of the mean. * p<0.05 
(unpaired nonparametric t tests) 
Effect of activation of STAT/IMD and Toll pathways on SFV 
replication in U4.4 cells 
To determine if STAT/IMD and Toll together have a combined effect on SFV titres, 
both pathways were activated in cultures prior to infection. Triplicate cultures of 
U4.4 cells were set up in 6-well plates (5 x 10
6
 in each well). The following day, the 
Toll pathway was activated by transfection with plasmid pJL195.  Plates were 
incubated for 12 h followed by addition of 5 μl heat killed E. coli followed by one 
hour incubation to activate STAT/IMD pathways. Pathway activated cultures, and 
control cultures in which Toll alone was activated, were then infected with SFV4 
(MOI=1).  The supernatants from test and control cells were collected 12 and 24 h 
after infection to determine virus tire. An unpaired non-parametric t test indicated 
that the virus titres in STAT/IMD only and STAT/IMD/Toll activated cultures at 12 
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hours post-infection were not significantly different (P = 0.0975). However, at 24 
hours virus titres were significantly reduced by 60% in the supernatants from the 
STAT/IMD/Toll-activated cultures (P = 0.0083) (Figure 4.9). 
 
 
Figure 4.9: The effect of Toll and STAT/IMD pathways on SFV4 replication in U4.4 
culture.  
The amount of virus produced in U4.4 cells was measured 12 and 24 hours post-infection 
(MOI=1) as plaque forming units by plaque assay. The blue bars stand for control cultures in Toll 
alone was activated. The yellow bars represent STAT/IMD and Toll activated cultures. Each bar 
is the mean of triplicate samples.  The error bars indicate the standard error of the mean. * p<0.05 
(unpaired nonparametric t tests) 
Summary of Findings 
 SFV4(3H)-RLuc and SFV4-stRLuc replicated in U4.4 cells with growth 
kinetics similar to SFV4. Both recombinant viruses had a slightly lower 
maximum virus titre which indicated marker gene insertion slightly 
attenuated virus replication. 
 Activation of the STAT/IMD pathway prior to infection reduced virus-driven 
luciferase expression by 40% between 1 and 12 hours post-infection in both 
SFV4(3H)-RLuc and SFV4-stRLuc infected cultures. 
 Activation of the STAT/IMD pathway prior to SFV4-stRLuc or SFV4(3H)-
RLuc infection reduced subsequent luciferase expression at low MOI levels 
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(0.1 or 1). However, at high MOI, non-structrual protein expression overcame 
the pre-activated STAT/IMD pathways (no luciferase reduction) but 
structural protein expression remained suppressed.  
 Activation of the STAT/IMD pathway prior to SFV4 infection reduced virus 
production.  
 Activation of the Toll pathway prior to SFV4-stRLuc or SFV4(3H)-RLuc 
infection had no effect on virus-driven luciferase expression.  
 Activation of the Toll pathway prior to SFV4 infection had no effect on virus 
production.  
 Activation of the STAT/IMD and Toll pathways prior to SFV4-stRLuc 
infection showed no further reduction of luciferase expression than activation 
of STAT/IMD alone. However, luciferase expression from SFV4(3H)-RLuc 
infected culture was further reduced when both STAT/IMD and Toll were 
activated.  
 Activation of STAT/IMD and Toll pathways prior to SFV4 infection reduced 
virus production more than activation of STAT/IMD alone.  
Discussion 
In insects, STAT/IMD and Toll have been studied predominately in the context of 
bacterial and fungal infections and have been shown to activate a number of anti-
bacterial and anti-fungal systems including anti-bacterial and anti-fungal peptides. 
However, there is a growing amount of evidence that these pathways are responding 
to virus infection. The data presented in this chapter have shown that activation of 
these pathways prior to virus infection can affect subsequent virus replication.  
The effects on SFV infection of immune responses initiated by activation of 
IMD/STAT or Toll, or both pathways, were determined using SFV4 and its 
recombinant viruses SFV4(3H)-RLuc and SFV4-stRLuc. One step growth curves 
showed that SFV4(3H)-RLuc and SFV4-stRLuc replicate in U4.4 cells with growth 
kinetics similar to SFV4 with a slightly lower maximum virus titre at 12 hours post-
infection. These viruses allowed quantitative assessment of early and late virus gene 
expression, as well as virus production and spread in mosquito cells (Flynt et al, 
Chapter 4   SFV and the innate immune pathways 
124 
 
2009; Keene et al., 2004).  The effects of immune signalling involving IMD and 
STAT on SFV gene expression are shown in figure 4.4B. Activation of host defences 
with heat-killed bacteria prior to SFV infection reduced virus-driven gene expression 
from both the genomic and the sub-genomic promoters by around 40%. This 
reduction in luciferase expression was not caused by a reduced number of infected 
cells resulting from heat-killed bacterial stimulation. Immunostaining of stimulated 
and control (PBS) cultures was carried out by Dr Rennos Fragkoudis. His results 
demonstrated that the percentage of virus-infected cells in both the bacterial-treated 
and PBS control cells were identical indicating that prior stimulation with bacteria 
did not affect the number of cells infected. As for virus production, the virus titre was 
reduced by 30% at 12 hours and 60% at 24 hours post-infection (Figure 4.5).  These 
results suggest that the IMD/STAT pathways in mosquito cells have a role in 
controlling SFV replication. This concurs with other findings involving the control of 
virus replication in other insect systems. For example, in Drosophila, mutations in 
components of the IMD pathway including relish, resulted in a higher viral load and 
enhanced replication of SINV compared to wild type (Avadhanula et al., 2009). For 
the STAT pathway, Dostert and co-workers showed that the JAK kinase Hopscotch 
was involved in the control of the DCV viral load in infected Drosophila and was 
required for the induction of some virus-regulated genes (Dostert et al., 2005). 
Souza-Neto and co-workers have shown that depletion of Dome and Hop in the JAK-
STAT pathway leads to increase in the susceptibility of Ae. aegypti mosquitoes to 
DENV infection and suppression of the JAK-STAT negative regulator PIAS leads to 
increase in the resistance to DENV infection. These authors (Souza-Neto et al) had 
depleted PIAS which resulted in up-regulation of 63 genes and down-regulation of 
66 genes. Of all the regulated genes, 14% of them were putative JAK-STAT-
regulated genes based on sequence homology, changeds in the transcription level of 
18 of these genes were induced by both PIAS depletion and DENV-2- infected 
mosquitoes. Amongst the induced genes, the putative JAK-STAT pathway-regulated 
DENV restriction factors DVRF1 and DVRF2 were identified as the effectors of 
JAK-STAT. These genes contain JAK-SAT binding sites and are regulated by JAK-
STAT activation and DENV infection. Furthermore, RNAi-mediated depletion of 
these effectors resulted in a 2-fold increase of DENV-2 infection in midgut tissue. 
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Conversely, DENV infection induced DVRF1 and DVRF2 expression by 3-6 fold 
(Souza-Neto et al., 2009).  In contrast, the present study use of heat-killed bacteria 
activates the IMD/STAT pathways from the receptor level. This may result in 
activating numerous of gene sets or even specific effector genes non-specifically. 
The results of the present study provided evidence that immune response gene 
clusters or maybe even effector genes that act as SFV restrictor factors may exist in 
mosquito cells. Through the activation of the receptors of IMD/STAT pathways, the 
viral gene expression is suppressed.  These results could be further investigated in 
the future by RNAi-mediated depletion of PIAS to determine if specific gene clusters 
under the control of the JAK-STAT pathway is responsible for the reduction of viral 
gene suppression. 
The immune responses initiated by expression of constitutively active Toll receptor 
(Toll ∆LRR) for 24 h, followed by infection with RLuc-expressing SFV constructs 
had no effect on virus gene expression at 12 hours post-infection (Figure 4.6). Virus 
titres from Toll-activated and non-activated cultures did not show any significant 
difference (Figure 4.7). Interestingly, this result concurs with the findings of SINV 
infection in Drosophila relish
-/-
 or dif 
-/-
 mutants. SINV viral RNA level was 9.3-fold 
higher in the relish
-/-
 mutant compared to the wild type, whereas dif 
-/-
 mutant has the 
same viral RNA level compared with wild type (Avadhanula et al., 2009). In 
contrast, the Toll pathway, but not the IMD pathway, plays a key role in the antiviral 
response against DXV infection in Drosophila immunity mutants (Zambon et al, 
2006). The Toll pathway has also been shown to control DENV infection, loss of 
Toll pathway activation by silencing of the MyD88 factor prior to DENV infection 
leads to increase in the virus load (Xi et al., 2008). Together, these results indicate 
that different innate immune pathways may have a differential role in controlling 
infection with viruses of different families. As the results presented here and by 
Avadhanula and co-workers indicate, alphavirus infection may be controlled by the 
IMD/STAT pathway, but not by the Toll pathway. However, Toll has antiviral effect 
on viruses of other families such as the Birnavirus DXV and Flavivirus DENV. As 
mentioned in Chapter 1, Sanders and co-workers showed that SINV infection 
induced transcription of Toll but not of the IMD pathway. However, it is not known 
whether Toll activation has an effect on SINV replication.  
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The effect of immune responses initiated by a combination of IMD/STAT and Toll 
reduced viral non-structural gene expression by 20% but increased structural gene 
expression by 30% when compared with the controls (Figure 4.8). The reason behind 
the increase in viral structural gene expression is unclear. The contradicting effects 
on the expression of subgenomic and genomic viral genes did not permit a 
conclusion of whether or not activation of both pathways has a greater effect on viral 
gene expression. SFV4 replication under the effect of both pathways was reduced 
significantly by 60% at 24 hours post-infection (Figure 4.8); this level of reduction is 
the same as observed in virus titre in IMD/STAT activated cultures (figure 4.5), 
indicating that activation of both pathways did not further reduce the virus titre.  
Interestingly, the DNA microarrays used to analyse gene expression changes in Ae. 
aegypti following infection by SINV showed that the activated Toll pathway was 
deactivated and followed by activation of the IMD pathway (Sanders et al., 2005). 
Furthermore, during this transition from Toll to IMD activation, a set of ubiquitin-
ligase genes were down-regulated. These ubiquitin-ligases may be responsible for 
Dif activation, and down-regulation of these genes may also be responsible for IMD 
pathway activation (Khush et al., 2002; Spencer et al., 1999). Therefore, it is 
possible that there is an antagonistic effect between these two pathways. This can be 
an interesting area for further investigation in the future. 
To conclude, activation of STAT and IMD, but not Toll prior to SFV infection 
inhibited virus replication. The results suggested that STAT and/or IMD pathways 
may be important mediators of antiviral effects against SFV4 in mosquito cells, but 
at the same time other immune pathways which also respond to Gram-negative 
bacterial stimulation might also be involved. This is in contrast to other reports such 
as: i) screening of Drosophila immunity mutants found that the Toll pathway, but not 
the IMD pathway plays a key role in the antiviral response against DXV infection 
(Zambon et al, 2006); ii) loss of Toll pathway activation by silencing of the MyD88 
factor prior to DENV infection leads to increase in the virus load (Xi et al., 2008). 
The reason behind these contrasting observations is not clear, however these results 
are derived from three different virus systems. This alone may provide explanation. 
The antiviral ability of other immune pathways in mosquito cells remains to be 
determined in greater detail. Despite the evolutionary distance and molecular 
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difference between Aedes and Drosophila (Christophides et al., 2002), their 
conserved immune responses and pathways enabled the use of pathogenic stimuli (E. 
coli) and an upstream mutated receptor (Toll ∆ LRR) to study the effects of these 
pathways on SFV infection. The conservation of important physiological processes 
between related insect species is an advantage for insightful research on mosquitoes 
which are of particular medical and veterinary importance.  
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Chapter 5: The biogenesis of viRNA in mosquito U4.4 cells 
infected with Semliki Forest virus. 
Introduction 
In mosquitoes, the RNAi pathway has been shown to effectively modulate the 
replication of arboviruses. Virus dissemination and replication often become more 
rapid when RNAi is being suppressed, examples include: i) the silencing of AgAgo2 
expression in A. gambiae which results in wider spread and higher virus titres in 
ONNV infection (Keene et al., 2004), ii) silencing of RNAi components in Aedes 
aegypti results in increases in SINV infection (Campbell et al., 2008), iii) use of 
small RNAs sequestering B2 protein in SINV infection in Ae. aegypti mosquitoes 
results in increased infection, dissemination, virus titre and mortality (Cirimotich et 
al., 2009; Myles et al., 2008), iv) recombinant ONNV expressing an RNAi 
suppressor leads to higher motality in Ae. aegypti infection (Myles et al., 2008), v) 
silencing RNAi components in Ae. aegypti results in increased DENV2 replication 
(Sánchez-Vargas et al., 2009) and vi) temporal impairment of RNAi in whole 
mosquitoes lead to increased infection and dissemination (Khoo et al., 2010). That 
suppression of RNAi components often leads to increase in mortality rate in 
mosquitoes suggests RNAi may function as a mechanism to keep arbovirus 
replication below a harmful level. Therefore, RNAi is believed to have a major role 
in control of arbovirus replication, spread and transmission.  Central to antiviral 
RNAi is the production of virus-derived small interfering RNAs (viRNAs) from viral 
dsRNA by the Dicer protein, and the formation of the RNA-induced silencing 
complex (RISC), followed by degradation of homologous viral RNA sequences 
(Kemp & Imler, 2009).   
In D. melanogaster and Ae. aegypti, the RNAse III enzyme and DExD/H-box RNA 
helicase Dcr-2 initiate RNAi by cleavage of virus-derived long dsRNA into double-
stranded viRNAs. There are a number of possible dsRNA substrates for this process. 
The formation of viral dsRNA could involve double-stranded regions in single viral 
genome or genome complementary RNA molecules, or two-molecule replication 
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intermediates (Lacomme, 2005; Myles et al., 2010). There are also questions on 
whether all areas of the virus genome, subgenomic and genome complementary 
RNA generate viRNAs or only specific areas. Therefore an investigation was carried 
out to characterise SFV-4 derived viRNAs in Ae. albopictus cells for better 
understanding of viRNA biogenesis in mosquito cells 
Characterisation of SFV4-derived viRNAs in Aedes albopictus-
derived U4.4 cells 
The biogenesis of viRNA was determined by Solexa Illumina deep sequencing of 
RNA extracted from SFV4 infected U4.4 cells.  U4.4 cells were used for these 
studies as they have been shown to be RNAi competent (Brackney et al., 2010). 
5x10
5
 cells per well were seeded in 6 well-plates and incubated overnight (16 hours).  
Three wells of U4.4 cultures were then infected simultaneously with SFV4 
(MOI=10).  Total RNA was extracted from the three infected cultures using Trizol 
(Invitrogen, Paisley, UK) 24 hours post-infection and pooled.  The concentrations 
and purity of RNA samples were determined using a NanoDrop 1000 (Thermo 
Scientific).  All subsequent RNA processing was performed at GenePool, University 
of Edinburgh (http://genepool.bio.ed.ac.uk/) as described in Chapter 2.  In, brief, 
small RNAs below 44 nt were purified from a 15% TBE-Urea polyacrylamide gel, 
and RNA adapters were ligated to small RNAs before sequencing according to the 
manufacturer’s instructions (Illumina Inc., USA). Small RNAs were then sequenced 
using an Illumina® Solexa Genome Analyzer. RNA of uninfected cells was 
sequenced as control. This approach has been previously shown to be a reliable way 
to analyse viRNA (Flynt et al., 2009; Szittya et al., 2010).  To identify SFV4 derived 
siRNA, sequences were aligned and filtered according to the SFV4 reference 
genome/genome complementary sequence (Genbank accession number: 
NC_003215) using SOAP software (GenePool bioinformatics support) (Li et al., 
2008).  
A total of 3.2 x 10
6
 small RNA reads were generated. Small RNA reads which, i) 
aligned to the SFV4 sequence and, ii) were 20-26 nt in length were filtered out from 
the data. The sum of all 20-26 nt viRNA was 7.5 x 10
4
. This represented 2.1% of all 
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small RNA reads. Of all the aligned SFV4-derived viRNAs, 21 nt long viRNAs were 
found to be the predominant species and accounted for 91.1% of 21-26 nt sequences.  
60% of all the 21 nt viRNAs mapped to the genome and 40% to the complementary 
genome (Figure 5.1).   
The first base of each 21 nt viRNA was mapped to its corresponding location on the 
SFV4 genome or genome complementary sequence. As shown in figure 5.2, 21 nt 
viRNAs were scattered over the entire SFV genome and genome complementary 
sequence in a non-random manner. Some areas generated high frequencies of 
viRNAs and others generated no (or only very few) viRNAs, these are referred to as 
hot spots and cold spots respectively. The biogenesis of viRNAs from genome and 
genome complementary RNA appeared to be asymmetric. SFV4-aligned viRNA 
sequences were analysed. There was no obvious skewing towards a particular base at 
the first position (28% A, 28% C, 12% G, 32% U). There was no bias in GC-content, 
and no obvious common sequence motifs.  The sequencing results from uninfected 
control cells showed 131 reads aligned to the SFV genome and 76 reads to the 
genome complementary sequence. None of these sequences are above 4 reads and 
these matches can only be interpreted as background. A small number of viRNAs 
were also found in an uninfected control experiment from subsequent experiments.   
 
Figure 5.1: Size distribution of viRNAs (21-26 nt) from SFV-infected U4.4 cells at 24 hours 
post-infection.  
Positive numbers on the Y axis indicate the frequency of viRNAs of various sizes mapping to the 
SFV genome; negative numbers on the Y axis indicate the frequency of viRNAs mapping to SFV 
complementary genome. 




Figure 5.2: Frequency distribution of 21 nt viRNA-generating loci in SFV genome.  
Total RNA was extracted from SFV4 infected U4.4 cultures 24 hours post-infection and small 
RNAs were sequenced and aligned to: SFV genome (5’-3’; viRNAs starting with 5’ terminal 
nucleotide) or genome complementary sequence (3’-5’; viRNAs starting with 3’ terminal 
nucleotide) starting at nucleotide 1 on the X axis. Numbers on the Y axis correspond to 
frequencies of viRNAs mapping to SFV genome (positive) or genome complementary sequence 
(negative). Blue peaks indicate loci of viRNAs mapping to SFV genome, red peaks indicate loci 
of viRNAs mapping to SFV antigenome. A representative section is magnified (panel B), to 
illustrate hot and cold spots visually.  
The experiment was repeated to determine if the frequency pattern of viRNA 
biogenesis remained similar between studies.  The repeat experiment showed a 
viRNA distribution patterns that resembled the initial pattern with little variation 
(Figure 5.3B). The major difference between repeat experiments was the depth of 
read frequency due to several upgrades and replacements of the sequencer 
(Illumina® Solexa Genome Analyzer) through the course of the project. Upgrades 
resulted in overall enrichment of read frequency as shown by the Y-axis values 
(Figure 5.3). Despite the depth of the frequency, the overall pattern in the two 
experiments was very similar, and there were many identical peaks sharing the same 
loci. 




Figure 5.3: Frequency distribution of 21 nt viRNA-generating loci in the SFV genome in 
initial and repeat experiments.  
A. Produced in late 2008 with maximum depth of 400 reads. B. Produced in early 2009 with 
maximum depth of 400 reads.   
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Characterisation of SFV-derived viRNAs in Aedes aegypti-derived 
Aag2 cells 
Aag2 cells have previously been shown to be RNAi competent (Scott et al., 2010) 
and can mount an RNAi response to Dengue virus (Sánchez-Vargas et al., 2009). In 
addition, Ae. aegypti and Ae. albopictus share 80% sequence identity in Dicer 2, (J. 
Rodriguez and A. Kohl personal communication).  To determine the influence of a 
different host species on viRNA biogenesis, Aag2 cells from embryonic tissues of 
Ae. aegypti (Peleg, 1968) were infected with SFV4. A culture of U4.4 cells was 
infected in parallel with the same stock of virus as control. 24 hours post-infection 
RNA extraction was performed. Aag2 and U4.4 viRNA sequences were determined 
synchronously in the same Illumina Solexa sequencing flow cell as described 
previously for U4.4 cells. This was carried out to eliminate any variability that might 
exist between flow cells. 97.6% of viRNAs were 21 nt in length, which was similar 
to U4.4 cells. 59.6% of all 21nt viRNA mapped to the SFV genome RNA and 40.4% 
mapped to the genome complementary RNA (Figure 5.4). Unfortunately, Gene Pool 
(sequencing service) had changed their isolation protocol for small RNA species and 
excluded 26 nt species (unknown to me). Therefore only 20-25 nt species are 
displayed in the size distribution. The viRNAs from Aag2 cells and U4.4 cells 
infected in parallel were mapped along the SFV4 genome and genome 
complementary sequence (Figure 5.5a and 5.5b respectively). The results once again 
emphasised the non random distribution of viRNA which generates hot and cold spot 
viRNA.  The biogenesis of viRNAs from genome and genome complementary also 
appeared to be asymmetric in Aag2. viRNA sequence analysis showed no obvious 
skewing towards a particular base at the first position (28% A, 28% C, 22% G, 22% 
U). There was no bias in GC-content, and no obvious common sequence motifs 
(GenePool bioinformatics support).   
However, the overall Aag2 viRNA frequency pattern differed from that of U4.4 cells.  
The Aag2 pattern had peaks solely focused on the structural region of the genome, 
whereas peaks were spread throughout the length of the whole genome in the U4.4 
cells. This result suggested that different protein interaction partners or perhaps the 
slight change in the Dicer 2 sequence identity have an effect on viRNA generation.  





Figure 5.4: Size distribution of viRNAs in SFV-infected Aag2 cells at 24 h p.i. 
Positive numbers on the Y axis indicate the frequency of viRNAs mapping to the SFV genome 
(black boxes); negative numbers on the Y axis indicate the frequency of viRNAs mapping to the 
SFV antigenome (grey boxes). 





Figure 5.5: Frequency distribution of 21 nt viRNA-generating loci in SFV genome. 
Total RNA was extracted from SFV4 infected (A) Aag2 and (B) U4.4 cultures 24 hours post-
infection and small RNAs were sequenced and aligned to: SFV genome (5’-3’; viRNAs starting 
with 5’ terminal nucleotide) or antigenome (3’-5’; viRNAs starting with 3’ terminal nucleotide) 
starting at nucleotide 1 on the X axis. Numbers on the Y axis correspond to frequencies of 
viRNAs mapping to SFV genome (positive) or complementary genome (negative). Blue peaks 
indicate loci of viRNAs mapping to SFV genome, red peaks indicate loci of viRNAs mapping to 
SFV antigenome. A representative section is magnified (right panel), to highlight hot and cold 
spots in more detail.  
Chapter 5   RNAi in Aedes albopictus 
137 
 
The characterisation of viRNA origins in mosquito U4.4 cells. 
RNAi occurs when dsRNA structures are recognised in the cytoplasm by Dicer.  
Dicer binds to dsRNA and cleaves it into siRNA duplexes.  In virus infection, 
dsRNA can arise from at least three different sources i) double-stranded regions in 
the single viral genome, ii) in genome complementary RNA molecules, or iii) the 
replication intermediate duplex (Myles et al, 2010). To determine the origins of 
viRNAs generated by U4.4 cells, replication-deficient SFV genomes were introduced 
into the cytoplasm. This eliminated viRNAs generated from double-stranded 
replication intermediates; any viRNAs remaining would be generated from double-
stranded structures on the introduced single stranded genomic RNA.  To do this, a 
strategy is required to efficiently deliver a large amount of replication-deficient SFV 
genomic RNA into all the cells in U4.4 cell culture. 
There are multiple strategies to produce replication-deficient SFV genomic RNA, 
including introduction of a point mutation or a stop codon in the virus replicase 
sequence or use uncapped SFV genomic transcripts. However, these methods require 
transfection in order to introduce the replication-deficient genomic RNA into cells. 
First of all, transfection is not an ideal method to introduce a large amount of RNA in 
every cell in the cell culture as transfection has a limited efficiency. Second of all, 
these methods rely on the limited amount of replication-deficient transcripts 
produced by in vitro transcription.  To overcome these disadvantages, a SFV replicon 
SFV1(3F)-IRES-ZsGreen, with an IRES element at the 5’ end of the genome was 
constructed by Prof. Andres Merits (Figure 5.6). The IRES of encephalomyocarditis 
virus (EMCV) was inserted between the duplicated nsP1 sequences.  IRES element 
has been used by other to mediate cap-independent translation of alphavirus 
constructs in mammalian cells (Wiley et al., 2010), however, the IRES of EMCV has 
previously been shown to attenuate alphavirus replicon expression in insect cells 
(Finkelstein et al., 1999; Volkova et al., 2008; Woolaway et al., 2001). Furthermore, 
complete attenuation of SFV replication by EMCV IRES was observed in mosquito 
cells by Prof. Andres Mertis (Prof. Andres Mertis, personal communication).  This 
construct allows a large amount of SFV genomic RNA to be produced in mammalian 
cells through virus replication (EMCV IRES permits translation in mammalian cells) 
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and these SFV genomic RNA can be packaged into VRPs when viral structural 
sequences are provided in trans. The purified VRPs can be used to infect U4.4 cells 
at high MOI as an efficient and effective way to deliver multiple copies of 
replication-deficient genome (EMCV IRES does not permit translation in mosquito 
cells) into all the cells in the culture. 
SFV1(3F)-IRES-ZsGreen cDNA was created by inserting an IRES element at the 5’ 
untranslated region under the duplicated N-terminus of nsP1 sequence and fusing a 
ZsGreen fluorescent protein sequence to the 3’ end of nsp3. An SFV1(3F)-ZsGreen 
construct which does not contain IRES was used as a control. To deliver the largest 
possible amount of non-replicating SFV1 genome to cells in order to generate 
viRNAs for analysis, VRPs were generated and used to infect U4.4 cells at 100 IU 
(infectious units) per cell. The experiment was also attempted at 1000 IU but this 
proved lethal to the U4.4 culture. 
 
 
Figure 5.6: A Schematic representation of the SFV1(3F)-IRES-ZsGreen. 
SFV1(3F)-IRES-ZsGreen is based on SFV1 construct with ZsGreen protein gene inserted and 
fused with the 3’ end of the nsP3 sequence. The N-terminus of nsP1 was duplicated (highlighted 
in blue). IRES element was inserted between the duplicated region, at 276 – 853 nt (highlighted 
in green).  
 
Unfortunately, 50% of the U4.4 culture infected with SFV1(3F)-IRES-ZsGreen 
appeared to be green indicating that replicon replication or at least translation of the 
input RNA had occurred. In the control experiment, all cells in the U4.4 culture 
infected with SFV1(3F)-ZsGreen expressed green fluorescence protein. This showed 
that the EMCV IRES does attenuate virus replication in insect cells as reported by 
others but that this is an incomplete block.  
That all the cells in the control experiment were green indicted that at 100 IU all cells 
were infected. Therefore in the SFV1(3F)-IRES-ZsGreen infected culture, the non-
3'5' nsP1 nsP2 nsP3CAP nsP4 AAAAZsGreenIRES
Chapter 5   RNAi in Aedes albopictus 
139 
 
green 50% of the cells should contain copies of non-replicating genomes. To isolate 
the non-green cells, an infected culture was sorted by fluorescence-activated cell 
sorting (FACS).  Total RNA of the non-green population of cells was extracted and 
sequenced. SFV1(3F)-IRES-ZsGreen and SFV1(3F)-ZsGreen sequences were used 
respectively as the reference sequence for SFV1(3F)-IRES-ZsGreen and SFV1(3F)-
ZsGreen derived viRNAs (Figure 5.7A&B). The results showed that biogenesis of 
viRNAs from genome and genome complementary RNA of SFV1(3F)-IRES-
ZsGreen was asymmetric with 69.7% of all the 21 nt viRNAs mapped to the genome 
and 30.3% to the complementary genome.  SFV1(3F)-ZsGreen showed a very 
similar asymmetry, with 70.6% of all the 21 nt viRNAs mapped to the genome and 
29.4% to the complementary genome.  
In the SFV1(3F)-IRES-ZsGreen viRNA distribution map (Figure 5.7A), no viRNA 
appeared to align to region 250 to 990 nt. This region is where the IRES was inserted 
(Appendix II). The exact location of the IRES sequence is between 276 -853 nt. The 
Solexa sequencing data of SFV1(3F)-IRES-ZsGreen infected U4.4 cells over that 
region (including the 5’ and 3’ junctions), showed that there are four viRNA reads 
(one read for each of the four different locations) within the IRES region on the 
genomic sequence and no viRNA read matched to the IRES region from the genome 
complementary sequence (Table 5.1 & 5.2). The four individual sequences that 
aligned to the IRES region on the genomic sequences were below the control 
threshold of four reads, therefore they can only be considered as background.  
The observation that no viRNAs were generated from the IRES region in the isolated 
non-green cells suggested that IRES was absent from the replicon. In addition, the 
absence of the IRES was unlikely to caused by deletion in the SFV1(3F)-IRES-
ZsGreen sequence because no viRNA read was identified at the IRES-nsP1 
junctions. The presence of zsGreen viRNA in the SFV1(3F)-IRES-ZsGreen infected 
U4.4 cells sequencing data suggested SFV1(3F)-IRES-ZsGreen VRP stock was 
contaminated by SFV1(3F)-ZsGreen VRPs. This contamination was likely to come 
from residual unmodified SFV1(3F)- ZsGreen during the insertion of the IRES.  
To conclude, the results showed non-green SFV1(3F)-IRES-ZsGreen infected cells 
isolated by FACS did not contain any SFV1(3F)-IRES-ZsGreen derived viRNA. 
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This could mean that SFV1(3F)-IRES-ZsGreen is not a viable replicon and a low 
level of SFV1(3F)-ZsGreen replication was occurring in non-green cells. 
 
Figure 5.7: Characterisation of viRNAs in Ae. albopictus-derived U4.4 cells  24 hours after 
infection with SFV1(3F)-IRES-ZsGreen or SFV1(3F)- ZsGreen VRPs. 
Frequency distribution of 21 nt viRNA-generating loci in the SFV VRP genome (5’-3’; viRNAs 
starting with 5’ terminal nucleotide) or antigenome (3’-5’; viRNAs starting with 3’ terminal 
nucleotide) starting at nucleotide 1 on the X axis. Numbers on the Y axis correspond to 
frequencies of viRNAs mapping to SFV genome (positive) or antigenome (negative). Blue peaks 
indicate loci of viRNAs mapping to SFV genome, red peaks indicate loci of viRNAs mapping to 
SFV antigenome. (A) viRNA profile of SFV1(3F)-IRES-ZsGreen. (B) viRNA profile of 
SFV1(3F)-ZsGreen.  
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First base location (nt) Nucleotide sequence Frequency 
256 ACAAAGACACACTCATCTTGG 1 
258 AAAGACACACTCATCTTGGAT 1 
610 ATTCAACAAGGGGCTGAAGGA 1 
691 TTCAACAAGGGGCTGAAGGAT 1 
738 ATCTGATCTGGGGCCTCGGTG 1 
839 AAACACGATGATAATATGGCC 1 
864 AAGTGCATGTTGATATTGAGG 1 
869 CATGTTGATATTGAGGCTGA 2 
Table 5.1: Solexa sequencing data of viRNAs aligned to positive strand of SFV1(3F)-IRES-
ZsGreen from 255 - 868 nt. 
This segment of data shows the solexa sequencing data from the 5’ to the 3’ junction of the IRES 
insert. The IRES insert is located at 276 – 853 nt. There are 4 individual reads scattered at 4 
different location within this region and no viRNA were located overlapping the insertion 
junction. 
 
First base location (nt) Nucleotide sequence Frequency 
225 CTGGCTACCAAATTGATCGAG 1 
254 TGACAAAGACACACTCATCTT 1 
854 ATGGCCGCCAAAGTGCATGTT 4 
867 TGCATGTTGATATTGAGGCT 1 
Table 5.2: Solexa sequencing data of viRNAs aligned to the complementary sequence of 
SFV1(3F)-IRES-ZsGreen from 255 - 868 nt. 
This segment of data shows the solexa sequencing data from the 5’ to the 3’ junction of the IRES 
insert. The IRES insert is located at 276 – 853 nt. No viRNA was sequenced and aligned to the 
IRES region. 
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Characterisation of viRNA biogenesis in mosquito U4.4 cells - 
structural analysis of SFV genomic RNA and role of RNA structures 
in viRNA generation by Minimal Folding Energy (MFE) 
Central to biogenesis of viRNA is the source of virus-derived dsRNA. As mentioned 
previously, formation of viral dsRNA could involve double-stranded regions in 
single-stranded viral genome or antigenome RNA molecules, or two-molecule 
replication intermediates (Myles et al., 2010).  One way to assess the likely origin of 
the viRNAs is to determine whether frequency of viRNA generation has any 
correlation to secondary structure of the RNA. The secondary structure of an RNA 
molecule should form according to the base sequence and given thermo-dynamics. In 
theory, two separate RNAs molecules should form the same secondary structure if 
given variables remain the same in two separate instances i.e. base sequence, thermo-
dynamics of the environment and interacting partners. Therefore, an RNA molecule 
will fold up according to its’ sequence and surrounding environment. Bioinformatics 
and advances in computing power have allowed secondary structure predictions on 
single molecules of RNA (Zuker & Stiegler, 1980).  
One of the methods to predict RNA secondary structure is comparative sequence 
analysis. This method determines common Watson-Crick base-pairing between 
multiple homologue sequences. By comparing between homologue sequences, 
locations which tend to have specific pairings can be found. For example, a CG pair 
in one sequence is replaced by an AU pair in another, showing pairing takes place at 
that location.  Comparative analysis is reasonably robust when there are enough 
homologous sequences available to make it statistically relevant. The robustness of 
this method is shown, in that over 97% of predicted base pairs in ribosomal RNA 
were proven by subsequent crystal structures.  Another secondary structure 
prediction method involves calculation of free energy of base-pairing. This method 
predicts the most stable secondary structure of a given RNA sequence by using a 
mathematical algorithm (based on empirically determined stacking and destabilising 
energy values for the various base pairs that form simple stem loops) to find a 
conformation of minimum free energy (MFE). This method involves a dynamic 
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programming algorithm from applied mathematics and is widely used in RNA fold 
prediction programmes like MFOLD and RNAFold (Mathews et al, 1999; Zuker & 
Stiegler, 1980).  However, the accuracy of RNA secondary structure prediction by 
free energy minimisation alone has several drawbacks because dynamic 
programming algorithms do not anticipate some strong sequence-dependent stability 
of motifs. Therefore, control sequences (e.g. the analysed sequence is SFV4 and its 
control would be genetic variants within the same genus) would be used to generate a 
mean scramble (MFE of sequence-order randomized controls) as a reference scale to 
predict genome-scale ordered RNA structure (GORS) (Simmonds et al., 2008; 
Simmonds et al, 2004).   
RNA structure can also predicted by covariance analysis. For example, alignments of 
published virus genome sequences can be used to generate a consensus sequence. 
This consensus sequence will then be used to calculate the most energetically-
favoured folding by MFOLD. Each sequence in the alignment would be scored for 
frequencies of substitutions that maintained or disrupted predicted base-pairing in the 
consensus predicted RNA structure. Sequence changes that maintained RNA 
structure would be divided into those that occurred at covariant sites (associated with 
paired changes in the base-paired nucleotide to maintain binding) and semi-covariant 
changes (where base-pairing was maintained without compensatory changes, 
corresponding to changes between G–C and G–U binding). For calculation of the 
null expectation (i.e. randomly occurring) frequencies of each type of sequence 
change, Perl scripts (Zuker, 2003) were used to generate all synonymous variants of 
the consensus sequence (or 10 000 unique sequences that were selected at random if 
the possible number of synonymous variants exceeded this number) that were 
maximally 10% divergent from the input sequence. By using the connect file as a 
framework, the number of base-paired (identical or covariant) or unpaired sites in the 
dataset, generated in silico, were determined (Tuplin et al, 2004). The prediction of 
specific structures using the available comparative sequence data was done by using 
the programme StructureDist v.1.3 in the Simmonics package (Simmonds et al., 
2004). This programme compares minimum energy structures from sequence data 
sets and computes phylogenetically conserved pairings and secondary structures. The 
results were expressed in the form of pairing frequencies, which were calculated 
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from the proportion of pairwise comparisons of connect files for each sequence with 
the same pairing predictions. 
An analysis of the SFV4 sequence for secondary structure has not been carried out 
previously, but alphavirus genomes have been reported to contain overall few areas 
of secondary structure (Davis et al., 2008). The only known structured region in 
alphaviruses is in the 5’ untranslated region of the genome, including Venezuelan 
equine encephalitis, Sindbis viruses and SFV (Jing-Hsiung et al., 1983; Kulasegaran-
Shylini et al, 2009; Logue et al., 2008; Nickens & Hardy, 2008). Under the 
supervision of Prof. Peter Simmonds, the SFV4 genome (GenBank accession number 
AJ251359) was fully analysed and thermodynamic minimum free energy (MFE) was 
calculated at each nucleotide position using UNAFold. MFE values were calculated 
in frames of 150 nucleotides (75 nucleotides up and 74 downstream), and the frame 
incremented by 1 nucleotide across the complete SFV genome. The folding energies 
were then compared with 50 copies of fragments whose sequence order was 
scrambled using the algorithm NDR, which preserves dinucleotide frequencies of the 
native sequence automated using the programme Folding Energy Scan as 
implemented in the Simmonic2005 v1.8 package (Simmonds et al., 2008). The 
minimum free energies (MFEs) of each native sequence fragment were compared 
with the mean MFE of the NDR-scrambled controls to produce an MFE difference 
(MFED), which is the percentage difference between the MFE of the native sequence 
and the mean of a scrambled control of the same sequence, as in the formula below 
(Simmonds et al., 2004). MFED values for each fragment were averaged across the 4 
available SFV complete genome sequences (GenBank accession numbers EU350586, 
DQ189086, and Z48163). 
MFED (%)  = [(MFEnative/MFEscrambled) – 1] x 100 
The MFED value provides a scale to quantify sequence order-dependent RNA 
structure formation over the length of the genome.  The MFED values for each 
position of the SFV4 genome were calculated and plotted in figure 5.8A. The red line 
represents mean values of five consecutive prediction fragments. The result showed 
MFED values close to zero along the entire SFV genome, which indicated an 
absence of structured RNA, with the exception of the 5’ untranslated region.  The 
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frequency pattern of 21-nt genome-derived viRNAs was aligned and compared with 
the pairing and MFED values (Figure 5.8A, red).  Paired regions (high probability of 
pairing indicated by values close or equal to 1) in the SFV4 genome were predicted 
by using StructureDist (Figure 5.8A, green).  
  




Figure 5.8: Prediction of RNA secondary structures (MFED) and pairing within the SFV 
genome, and correlation to 21 nt viRNA frequency in U4.4 cells. 
Genomic viRNAs described in Fig. 3 were used for this analysis. (A) Distribution of MFED 
values (right Y axis; indicating probability of secondary structure) and pairing values (right Y 
axis, indicating probability of paired regions) along the SFV genome (X axis, starting at 
nucleotide 1) as red line and green shadow, respectively. High positive MFED values suggest 
areas with RNA secondary structures, respectively while values around 0 or negative do not. 
Pairing values close to, or equal to 1 suggest paired regions whereas low pairing values indicate 
absence of pairing. For clarity of the figure, ascending values on the right Y axis are indicated 
from top to bottom. viRNA frequencies on locations along the SFV genome (blue peaks) are 
indicated on the left Y axis. Bottom three panels (B, C, D) represent magnifications of selected 
regions from the top panel (A). The diagram was generated using data produced by Prof. Peter 
Simmonds. 
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The alignment of MFED values to their nucleotide positions enabled categorisation 
of viRNA frequencies to compare mean MFED values between each category.  
viRNA frequencies were put into four ordered catagories according to the frequency 
of their appearence, 1, <10, 10 to 100, and >100. An analysis of variance (ANOVA) 
(Minitab, version 15) was carried out to determine any relationship between MFED 
values and viRNA frequency catagories. The results showed that there are no 
significant differences in MFED values across all designated levels of viRNAs (F = 
0.56; df = 3, 10,882; P = 0.643). The relationship was also determined when viRNA 
frequency catagories were narrowed down into 7 ranges: 0, 1-10, 11-50, 51-100, 
101-200, 201-300 and 301-400 (Figure 5.9). One way ANOVA was used to 
determine significant difference across all 7 groups and showed that the means are 
not significantly different from each other (P = 0.6964). 
 
Figure 5.9: MFED prediction value distribution in different read frequency catagories. 
A plot of ordered viRNA frequency groups against the MFED values of all of its group members. 
MFED value were assigned to each viRNAs by shifting 11 bases down to centre the MFED value 
prediction to the middle of each viRNAs. viRNAs were put into 7 ordered catagories according 
to the frequency of their appearence, 0, 1-10, 11-50, 51-100, 101-200, 201-300 and 301-400. 
MFED values (right Y axis) along different groups of viRNA frequency groups (X axis, starting 
with viRNAs having 301 to 400 reads). Number of members increase exponentially as X axis 
reduce to smaller read groups. The line in the middle of each group indicates the mean MFED 
value of each group. 
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Furthermore, the relationships between pairing values and viRNA frequency 
catagories (as described above) were analysed by using Fisher’s exact tests (StatXact 
v8; Cytel Software Corp., Cambridge, MA). The pairing values were categorized 
above or below cutoff values of 0.4 or 0.6 in two separate tests. The results showed 
that there was no significant association between pairing values and levels of 
viRNAs (P = 0.286 for a cutoff of 0.4; P = 0.1147 for a cutoff of 0.6).  
Althought the statistical analysis showed no correlation between predicted secondary 
structures and viRNA frequencies, there were however regions where predicted 
secondary structures in the genomic RNA were associated with interesting viRNA 
patterns. For example, the viRNA peaks at nucleotides 204 to 258 mapped on a 
trough of MFED value where secondary structure is likely to be present and also 
mapped between two pairing values close or equal to 1, suggesting presence of a 
stem-loop structure (Figure 5.8B). Unfortunately, there were also regions with 
consistant pairing and MFED predictions which did not associate with a viRNA peak 
and vice versa. For example, figure 5.8C showed a high viRNA frequency (1100-
1140 nt) which did not coincide with high pairing or high MFED values; figure 5.8D 
showed a structured region predicted by both MFED and pairing values (7000-7100 
nt) but this did not appear to produce any viRNAs. A long-distance pairing analysis 
of the genome identified 22 regions with complementary sequences which could 
allow folding back to form secondary structures. Analysis of the viRNA frequency at 
these 22 regions showed that these regions produced no viRNAs or only a low 
frequency of viRNAs. 
Analysis of the ability of hot spot- and cold spot-derived viRNAs to 
inhibit SFV replication 
The non-random generation of viRNAs along the SFV genome gave rise to hot- and 
cold-spots for viRNA generation. “Hot spots” refers to areas that gave rise to a high 
frequency of viRNA and “cold spots” refers to areas that produced few or no viRNA. 
It is unclear whether this non-randomised generation serve any purpose. To answer 
this question, the ability of hot spot- and cold spot-derived viRNAs to inhibit SFV 
replication was determined. To determine if hot spot- and cold spot-derived viRNAs 
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differ in their ability to inhibit SFV replication, 21 nt artificial siRNAs derived from 
hot (areas of high frequency) or cold (areas produced no viRNA) spots on the SFV4 
genome were tested using SFV4 expressing an RLuc reporter gene, SFV4(3H)-RLuc 
(Figure 4.1B). As explained in chapter 4, RLuc activity provides a quantitative 
measure of early and late viral gene expression, SFV4 replication and virus 
production. Seven hot- and cold-spot siRNA mimics of viRNAs were selected from 
comparison of the U4.4 and Aag2 viRNA frequency maps (figure 5.2 and 5.5A). 
Selected sequences were complemented with their natural opposite stand, and 
designed to become duplexes with 3’ 2nt overhang on both ends. These viRNA 
mimics were then ordered from Ambion with no chemical alterations for enhanced 
stability.  
The viRNA mimics were introduced into RNAi competent U4.4 cells followed by 
SFV4 infection and measurement of luciferase activity. The viRNA mimics should 
function like natural viRNAs by mediating degradation of viral RNA and in turn 
reduce RLuc expression. Through degradation of viral genome, the RLuc expression 
is reduced. The efficiency of each viRNA mimic can be determined by the level of 
reduction in RLuc expression.  
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Negative control siRNA (Ambion AM4635) N/A 100 
Positive 
control 
RLuc siRNA (Ambion AM4630) N/A 30.5/23.8 
1016 
(cold) 
5’ –GAGGGAUUCCUAGUGUGCAAG -3’ 




5’ –UGGGCGAGGGAAUACAAGGCA -3’ 




5’ –UCCGGGAUCAGGCAAGUCUGC -3’ 




5’ –UCGCUUGCCAUUCCGGUACUC -3’ 




5’ –UCGCAGAAAGAAAAAUCCAAC -3’ 




5’ –CGGUUAAAGGCAGUAGGGUUG -3’ 




5’ –GACTCGTCTTCCACTGCCAGC -3’ 




5’ –GUUUAUUAACACUGUUUUGAA -3’ 




5’ –UGGCGAGGGACAUUAAGGCGU -3’ 




5’ –CGAGGAUAACGUGGAUAGGCC -3’ 




5’ -UGCCGAACGUGGUGGGGUUCC -3’ 




5’ –AGGCGUACGUCGAUCGAUCGG -3’ 




5’ –ACGACCUGUACGCGAACACGG -3’ 
3’ –AUUGCUGGACAUGCGCUUGUG -5’ 
252/1,116 89.7/97.7 





5’ –CAAAUCAAAACGAACCCUGUC -3’ 
3’ –CGGUUUAGUUUUGCUUGGGAC -5’ 
0/1 81.7/102.4 
Table 5.3 List of siRNA mimics. 
Summary of siRNA mimics location, sequence and ability to inhibit viral marker gene 
expression. 
  
Chapter 5   RNAi in Aedes albopictus 
152 
 
The optimum concentration of viRNA mimic for silencing SFV4(3H)-RLuc was 
determined. 1.25 x 10
5
 U4.4 cells per well were cultured in 24-well plates overnight 
before transfection with hot- and cold-spot viRNA mimics (4 each of hot or cold 
spots). The cultures were then infected with SFV4(3H)-RLuc (MOI=1) 24 hours 
post-transfection. Luciferase activities were measured at 12 hours post-infection. The 
experiment was carried out at 6 different final concentrations of viRNA: 3, 6, 12, 25, 
50, and 100 nM. Every concentration tested was carried out in triplicate (figure 5.10). 
The results showed a general silencing efficiency pattern where positive control 
siRNA against RLuc silenced RLuc expression most efficiently at all concentrations. 
Cold-spot viRNA mimics (blue lines) were the next most efficient, then hot-spot 
mimics and then the negative control.  
 
Figure 5.10: The ability to silence RLuc expression of viRNA mimics and controls siRNAs 
in different concentrations. 
U4.4 cultures were transfected with siRNA duplexes including: a positive control siRNA 
targeting RLuc, a negative control scrambled siRNA and 4 cold- and 4 hot- viRNA mimics for 24 
h at final concentrations of 3, 6, 12, 25, 50 or 100 nM (X-axis), then infected with SFV4(3H)-
RLuc (MOI=1). RLuc activities (Y axis) were determined at 12 hours post-infection. The 
experiment was carried out in triplicate and error bars represent standard error. 
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There was no clear dose response and a second experiment was therefore carried out 
using lower concentrations of siRNAs. This dose response showed cold spot-derived 
viRNAs have a similar silencing ability to that of the positive control siRNA. In 
contrast, hot spot-derived viRNA mimics resembled the negative siRNA. As the 
concentration of siRNAs used rose, the luciferase activity decreased (figure 5.11). 10 
nM was chosen as the standard concentration for testing different viRNA mimics. 
 
Figure 5.11: Investigation of siNRA dosage and ability to silence RLuc expression.  
U4.4 cultures were transfected with siRNA duplexes including: a positive control siRNA 
targeting RLuc, a negative control scrambled siRNA, 1 cold-spot and 1 hot-spot viRNA mimics 
for 24 h at final concentrations ranging from 0.01 to 25 nM (X-axis), then infected with 
SFV4(3H)-RLuc (MOI=1). RLuc activities were determined at 12 hours post-infection (Y axis). 
The experiment was carried out in triplicate and error bars represent standard error. 
Once the optimum concentration was determined, all 7 hot- and 7 cold-spot viRNA 
mimics (Table 5.3) were compared. As described above, cultures were tranfected 
with siRNA in 24-well plates for 24 hours followed by infection with SFV4(3H)-
RLuc (MOI=1). Luciferase activities were measured at 12 hours post-infection. The 
experiment was carried out in triplicate (figure 5.12). All luciferase measurements 
were normalised to the negative control (100%). The results indicated that the overall 
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ability of cold-spot viRNA mimics to target SFV4 viral RNA is significantly higher 
than hot-spot viRNA mimics (P = 0.0379 by a statistical comparison of hot and cold 
groups with a Mann-Whitney U test). The findings support the earlier results shown 
in figure 5.10 and 5.11. 
 
Figure 5.12: Synthetic siRNA mimics of SFV genome hot and cold spot viRNAs and their 
effect on virus replication in U4.4 cells.  
Ae. albopictus-derived U4.4 cells were transfected with viRNA mimics (10 nM, Table 5.3) for 24 
h, followed by reporter SFV4(3H)-RLuc infection (MOI=1). RLuc activities (read-out for SFV 
replication) were determined at 12 hours post-infection and normalised to negative-control 
scrambled siRNA (100% relative RLuc expression). Statistical analysis was performed by 
comparing the activities of hot and cold spot mimic siRNA groups (Mann-Whitney Test, P = 
0.0379). This experiment was performed in triplicate for each siRNA and repeated three times; 
bars show the average relative RLuc activities for each siRNA from all three experiments, and 
error bars represent standard errors. 
This experiment was repeated with Ae. aegypti-derived Aag2 cells as described 
above, with the same selection of viRNAs mimics (Table 5.3, column 3). The same 
silencing effects were observed, with cold-spot viRNAs mimics being significantly 
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more efficient than hot-spot mimics (P = 0.0379 by Mann-Whitney U test) at 
inhibiting SFV replication (Figure 5.13). This result suggests cold spot viRNAs are 
more efficient at mediating RNAi silencing than hot spot viRNAs in mosquito cells 
of different species. 
 
Figure 5.13: Synthetic siRNA mimics of SFV genome hot and cold spot viRNAs and their 
effect on virus replication in Aag2 cells.  
Ae. aegypti-derived Aag2 cells were transfected with viRNA mimics (10 nM, Table 5.3) for 24 h, 
followed by reporter SFV4(3H)-RLuc infection (MOI=1). RLuc activities (read-out for SFV 
replication) were determined at 12 hours post-infection and normalised to negative-control 
scrambled siRNA (100% relative RLuc expression). Statistical analysis was performed by 
comparing the activities of hot and cold spot mimic siRNAs groups (Mann-Whitney Test, P = 
0.0379). This experiment was performed in triplicate for each siRNA and repeated three times; 
bars show the average relative RLuc activities for each siRNA from all three experiments, and 
error bars represent standard errors. 
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Summary of Findings 
SFV4-derived viRNAs in Aedes albopictus-derived U4.4 cells 
 viRNAs derived from SFV4 infected U4.4 cells were sequenced by Solexa 
Illumina deep sequencing technology. A total of 3.2 x 10
6
 small RNA were 
sequenced. 7.5 x 10
4 
reads were derived from viral nucleic acid. This 
represents 2.1% of all small RNA isolated from U4.4 cells. 
 viRNA were 20-26 nt in length. 21 nt long viRNAs were found to be the 
predominant species and accounted for 91.1% of all 20-26 nt sequences. 
 The biogenesis of viRNAs from genome and genome complementary RNA 
was asymmetric. 60% of all the 21 nt viRNAs mapped to the genome and 
40% to the complementary genome. 
 There was no obvious skewing towards a particular base at the first position. 
There was no bias in GC-content and no obvious common sequence motifs.   
 21 nt viRNAs were generated over the entire SFV genome and genome 
complement in a non-random manner. Some areas generated high frequencies 
of viRNAs and other areas no or very few viRNAs; these are referred to ‘hot 
spots’ and ‘cold spots’ respectively. The hot and cold spots were spread 
throughout the length of the whole genome. 
 Replicate experiments showed similar patterns of viRNA frequency with 
some identical hot and cold spots but also some variation.  
SFV-derived viRNAs in Aedes aegypti-derived Aag2 cells 
 viRNA identified were 20-25 nt in length. 21 nt long viRNAs were found to 
be the predominant species and accounted for 97.6% of these sequences. 
 59.6% of all 21 nt viRNA mapped to the SFV genome and 40.4% mapped to 
the genome complement. 
 The biogenesis of viRNAs from genome and genome complementary RNAs 
was asymmetric. 59.6% of all the 21 nt viRNAs mapped to the genome and 
40.4% to the complementary genome. 
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 There was no obvious skewing towards a particular base at the first position. 
There was no bias in GC-content and no obvious common sequence motifs. 
 21 nt viRNAs were also generated over the entire SFV genome and genome 
complement in a non-random manner. However, many hot spots mapped to 
the structural region of the genome. 
 Comparison of the viRNA frequencies between U4.4 and Aag2 cells showed 
that there were identical hot and cold spots but also some differences.  
viRNA origins in mosquito U4.4 cells 
 Infection with SFV1(3F)-IRES-ZsGreen VRPs resulted in 50% of the cells 
being green indicating that replicon replication had occurred and that the 
EMCV IRES did not produce a viable replicon. Unfortunately, therefore this 
did not provide a system to analyse viRNA production in the absence of 
virus/replicon replication. 
 Non-green cells in the SFV1(3F)-IRES-ZsGreen infected culture were 
successfully sorted into a separate population by FACS. The viRNA 
population in these cells was compared to that in the SFV1(3F)- ZsGreen 
infected culture. 
 There was an approximately 21-fold reduction in viRNAs in the (non-green) 
SFV1(3F)-IRES-ZsGreen infected cells compared to the SFV1(3F)-ZsGreen 
infected cells. However the absence of IRES derived viRNAs suggest 
SFV1(3F)-IRES-ZsGreen stock contained contaminating of SFV1(3F)-
ZsGreen replicons. 
 In both cultures approximately 70% of 21 nt RNA mapped to the genomic 
RNA. 
 In comparison to biogenesis of viRNAs from SFV4 infected cells. There was 
a 10% bias towards viRNAs generated from the genomic RNA in the replicon 
infected cells.  
 MFED values generated by secondary structure prediction were close to zero 
along the entire SFV genome, which indicated an absence of structured RNA, 
with the exception of the 5’ untranslated region. 
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 The frequency pattern of 21-nt genome-derived viRNAs was aligned and 
compared with the pairing and MFED values.  
 viRNA frequencies were put into ordered catagories. There was no 
correlation with MFED values.  
 The relationship between pairing values and viRNA frequency catagories was 
analysed, again there was no significant association. 
 A long-distance pairing analysis of the genome identified 22 regions with 
complementary sequences which could allow folding back to form secondary 
structures. These regions produced no viRNAs or only a low frequency of 
viRNAs. 
Ability of hot spot- and cold spot-derived viRNAs to inhibit SFV replication 
 Transfection of U4.4 cells with hot- and cold-spot viRNA mimics for 24 
hours followed by infection with SFV4(3H)-RLuc indicated that the overall 
ability of cold-spot viRNA mimics to target SFV4 viral RNA was 
significantly higher than of hot-spot viRNAs. 
 The same viRNA mimics were studied in Aag2 cells. The same silencing 
effects were observed, with cold-spot viRNAs mimics being significantly 
more efficient than hot-spot mimics. 
Discussion 
RNAi is the most direct form of defence against arboviruses in mosquitoes. The 
mechanism of RNAi has been well studied. However, there is little insight on i) viral 
dsRNA substrate for Dicer ii) dicer’s preference of viral dsRNA substrate and iii) 
whether dsRNA processing is identical in different host species of the same genus. 
This study has addressed some of these questions.  To answer these questions, 
Illumina Solexa, a new powerful sequencing technology was used to characterise 
SFV-derived viRNAs produced during the acute phase of infection in SFV4 infected 
Ae. albopictus U4.4 cells. The technology sequenced 3 million (and later 12 M) 
pieces of small RNA. 2.1% of these small RNA sequences were derived from 21-26 
nt viral RNA. The predominant viRNA species was 21 nt in length; they were 
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generated asymmetrically from the SFV genome (60%) and genome complement 
(40%); and distributed along the length of the SFV genome and complement in a 
non-random manner. The loci on the genome/genome complementary RNA 
generating high frequency of viRNAs were named “hot-spots”, whilst “cold-spots” 
referred to areas that generated few or no detectable viRNAs.  This finding is in 
perfect agreement with previous findings form Ae. aegypti infected with Sindbis 
virus (Myles et al., 2008). These authors (Myles 2008, figure 1b and c) also showed 
that the predominating viRNA is 21 nt and that viRNA distribution across the 
genome and complementary genome is non-random with hot- and cold- spots. These 
findings indicated that key features of alphavirus-induced antiviral RNAi are 
conserved across aedine and anopheline mosquitoes (Myles et al., 2010).  In the 
present study, the 21 nt viRNAs showed no obvious skewing towards a particular 
base at the first base position, no bias in GC-content and no obvious common 
sequence motifs. This indicated that Dicer in U4.4 cells does not have a preference of 
viral dsRNA substrate. This finding is very different from siRNA derived from 
Brassica juncea infected with plant virus turnip mosaic virus (TuMV) which shows a 
GC preference in siRNA hotspots (Ho, 2007). This suggests that differences in host 
species and Dicer affect the biogenesis of viRNA. The difference in viRNA 
generation was also apparent when a similar experiment was carried out on a 
mosquito of a different genus, Culex pipiens quinquefasciatus and a non-alphavirus 
(West Nile Virus) (Brackney et al., 2009). Their viRNA species were more evenly 
distributed (from 19-23 nt) instead of a single predominant species as observed in the 
present study. Nevertheless, the viRNA frequency pattern remains in agreement with 
non-random distribution of viRNAs (Brackney et al., 2009).  Therefore, the 
biogenesis of viRNA in Ae. aegypti-derived Aag2 cells was investigated to determine 
whether dsRNA processing is identical in different species of the same mosquito 
genus. The predominant viRNA species in Aag2 was also 21 nt in length; generated 
asymmetrically from the SFV genome (60%) and genome complement (40%); and 
distributed along the length of the SFV genome and genome complement in a non-
random manner with hot- and cold-spots. Comparison of the viRNA frequencies 
between U4.4 and Aag2 cells showed that they shared identity in hot and cold spots. 
However, the distribution made up an overall pattern with many hot spots mapped to 
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the structural region of the genome. This could suggest that replication of SFV had 
entered the late phase in Aag2 cells at 24 hours post-infection which would lead to a 
higher level of subgenomic RNA as substrate for Dicer.  
The non-random distribution of U4.4 and Aag2 derived viRNAs along the SFV 
genome and genome complementary RNA had raised questions on i) what 
substrate/origin gave rise to robust generation of hot-spot viRNAs, and ii) how 
different viRNAs differ in their abilities in mediating RNAi.  In virus infection, it is 
highly likely that viRNAs are derived from all three sources: i) double-stranded 
regions in single-stranded viral genome, ii) in genome complementary RNA 
molecules, and iii) replication intermediate duplex. In an attempt to gain insight into 
viRNA generation from replication intermediates, non-replicating VRP SFV1(3F)-
IRES-ZsGreen was used. This was designed to locate viRNA peaks that would be 
eliminated when replication was eliminated. Unlike insect-only viruses, SFV does 
not possess RNAi inhibitor proteins and replication intermediates are not being 
protected, so it is believed that replication intermediates may be a major source of 
viRNA (Myles et al., 2010). Unfortunately, the EMCV IRES element did not provide 
a system to analyse viRNA production in the absence of virus/replicon replication. 
According to the Solexa sequencing data, IRES was absent in the isolated non-green 
cells (Table 5.1 & 5.2). The reason why these cells are non-green but not containing 
any detectable IRES sequence is unclear. However, the presence of ZsGreen 
viRNAs, similar viRNA distribution pattern between SFV1(3F)-IRES-ZsGreen and 
SFV1(3F)-ZsGreen (Figure 5.7A&B) and 21-fold less viRNAs in the non-green 
isolated cell infected SFV1(3F)-IRES-ZsGreen compared with SFV1(3F)-ZsGreen 
infected cells suggested that a low level of SFV1(3F)-ZsGreen replication was 
occurring in non-green cells.  A simpler strategy such as introduction of a point 
mutation or a stop codon in the virus replicase sequence or use uncapped SFV 
genomic transcripts and transfection could be used. However these strategies do not 
provide a large amount of SFV genomic transcripts to produce a viRNA for analysis. 
Alternately, establishing a stable cell line constitutively expressing SFV genomic 
RNA which contains a mutation in the replicase sequence may provide a viable 
system to address this investigation.  In both replicon (SFV1(3F)-IRES-ZsGreen & 
SFV1(3F)-ZsGreen) infected cultures, approximately 70% of 21 nt viRNAs were 
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mapped to the genome RNA which is 10% more than in virus infected cultures. 
However, the reason behind this observation is unclear. 
The second approach to identify the substrate/origin of hot spot viRNAs was to 
estimate RNA secondary structures on the single-stranded viral genome and 
determine if those highly structured areas were correlated to viRNA hot-spots.  SFV 
is not known to have any inverted repeats or functional RNA structures, unlike some 
plant viruses where genomic RNA is highly structure and perfectly paired, which 
could serve as substrates for Dicer (Ho et al., 2006). MFED and pairing analyses 
predicted possible secondary structures on SFV4 genomic RNA. Like other 
alphavirus, the most likely secondary structure is at the 5’ end of the genome and the 
rest of the genome contains only a few areas with a high probability of secondary 
structures. These powerful secondary structure prediction methods allowed analyses 
to determine whether predicted secondary structure locations had any correlation 
with observed viRNA hot-spots. Unfortunately, no correlation was found between: i) 
means of MFED values and different categories of viRNA frequencies; ii) pairing 
values and different categories of viRNA frequencies; iii) specific distant-pairing 
regions of the genomic RNA and high viRNA frequency. These (i & ii) suggested 
within each category, locations with similar levels of viRNA generation did not have 
a similar probability of secondary structure formation and (iii) viRNA hot-spots were 
not generated from locations where long-distance pairing could take place on the 
SFV genome. The lack of any correlation indicated that the vast majority of viRNAs 
are not specifically generated from genomic secondary structures.  Like the 5’ region 
of the alphavirus, the 3’ terminus of the flavivirus genome contains secondary 
structure, and these structures do not appear to be a target to generate excess viRNAs 
during mosquito infection by West Nile virus (Brackney et al., 2009).  Therefore, the 
origin of alphavirus-induced dsRNA remains inconclusive.  
Areas that generated high frequency of viRNA (hot-spots), and reappeared in 
different sequencing experiments must be in a conformation, position or replication 
state that increases the chance of access by Dcr-2. For example, the genomic RNA 
nucleotide position 10499 and genome complementary position 461 and 9769 nt 
consistently generated high viRNA frequency throughout all four U4.4 sequencing 
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experiments (figure 5.14). Those locations that consistently generate few or no 
viRNAs may not provide much access to Dcr-2, or alternatively they could be less 
available, either temporally or spatially during replication. For example, newly 
synthesized RNAs remain closely associated and protected by replication complexes 
(Frolova et al, 2010; Geiss et al., 2005).  
 
Figure 5.14: Comparison of 21 nt viRNA distributions from SFV4-infected U4.4 cells. 
(A) Produced in late 2008 with maximum depth of 400 reads.  (B) Produced in early 2009 with 
maximum depth of 400 reads.  (C) Produced in early 2010 with maximum depth of 3000 reads.  
(D) Produced in 2010 following C with maximum depth of 10000 reads.  Circles indicate exact 
locations where high amounts of viRNA were generated in the majority of the different 
sequencing experiments. 
The robust generation of hot- or cold-spots at exactly the same location of the SFV 
genome raised the question of how different viRNAs differ in their ability to mediate 
RNAi. It is unclear whether this non-randomised generation serves any purpose.  The 
results showed that the overall ability of cold-spot viRNA mimics to target SFV4 
viral RNA was significantly higher than for hot-spot viRNAs in both U4.4 and Aag2 
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cells (P = 0.0379 and P = 0.0379, respectively by a statistical comparison of hot and 
cold groups with a Mann-Whitney U test). This suggests that Dicer and the RISC 
complex vary in their specificity or ability to bind and process RNA. Hot-spot 
viRNAs could be generated from areas which are structured (secondary + tertiary + 
quaternary) but remain accessible to the small ds-RNA binding protein Dicer. 
However, the larger RISC complex may not find the same site to be as accessible. 
Therefore hot-spot viRNAs may not be very effective for target degradation. The 
converse may be applied in that areas that are easy for RISC to access (big open area 
and single-stranded) may not be a good substrate for Dicer (non-structured single 
stranded area).  A similar phenomenon was observed in Potato spindle tuber viroid 
(PSTVd) where secondary structures within the viroid generate most siRNA but at 
the same time these secondary structures are highly resistant to RISC-mediated 
cleavage (Itaya et al., 2007).  To date, evidence of viRNA-based RNAi diversion has 
been described in Cauliflower mosaic pararetrovirus (CaMV) in which the non-
coding part of the virus genome spawns massive quantities of viRNAs to prevent less 
abundant viRNAs produced from other genome regions from being assembled into 
AGO-RISCs. The expression of this non-coding part of CaMV on an attenuated 
geminivirus rescued infectivity and accumulated higher DNA titres (Blevins et al., 
2011). Also, in human adenovirus, highly structured virus-associated RNAs appear 
to function as suppressors of RNAi by acting as competitive substrates and 
antagonists of Dicer (Andersson et al., 2005; Lu & Cullen, 2004). The two results 
(precise hot-spot generation and difference in hot/cold spot silencing efficiency) and 
the fact that alphaviruses lack an RNAi inhibitor, suggested that alphaviruses have 
been under selective pressure by RNAi and their genomes have been selected to 
allow more viRNA generation at areas that may least compromise virus replication. 
We will not know if this is true until we have mutated the hot viRNA generation area 
and compared the attenuation effect with a mutation in the cold area, but natural 
selection definitely would not allow an RNAi susceptible strain to be the 
predominant genotype when the host cell of the virus has RNAi as a viral defence 
mechanism. Perhaps acquiring a viral suppressor of RNAi (VSR) may seem more 
sensible than sacrificing replication rate through evolution. However, alphaviruses 
require persistent infection in order to complete their life cycle, experiments have 
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demonstrated that the co-expression of RNAi-inhibitory protein B2 of Flock House 
virus (Nodaviridae, insect virus) in Sindbis virus during infection in Ae. aegypti 
dramatically increased the mortality rate of the mosquito (Cirimotich et al., 2009; 
Myles et al., 2008). Therefore, a viRNA-based diversion mechanism may lead to a 
better balance between virus and host survival and persistence. 
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Chapter 6: RNAi in Aedes aegypti mosquitoes 
Introduction 
The ability of alphaviruses to infect cells of the mosquito Ae. albopictus has 
previously been studied in three cell lines, C6/36, C7-10, and U4.4 derived from 
larvae (Singh, 1967). C6/36 is one of twenty clones (C6, clone 6) isolated from 
cultured Ae. albopictus cells, one characteristic of this clone is the ability to produce 
high virus yield up to 7 days after dengue and Chikungunya virus infections. Sub-
clone 36, one of the 43 sub-clones of C6, showed mild to extensive cytopathic effects 
several days post-infection with Chikungunya or Dengue viruses (Igarashi, 1978).  
C7-10 cells are also a sub-cloned population originating from Singh’s cells and 
display cytopathic effect upon Sindbis virus infection (Sarver & Stollar, 1977). In the 
previous chapters of this thesis I studied SFV in these three cell lines and then 
studied the detailed reponse of one cell line, U4.4, to SFV infection. Given the 
variability between cell lines and the observations with different constructs of SFV, I 
wanted to investigate events in vivo in mosquitoes. To do this, protocols had to be 
developed to keep, infect and study the course of infection in mosquitoes. This 
chapter describes the establishment of these systems and their use. 
SFV1 VRP infection of Aedes aegypti mosquitoes 
Due to lack of an insectary to allow infection of live mosquitoes with propagating 
virus, this experiment was designed to infect live mosquitoes with non-propagating 
SFV1-d1eGFP VRPs. The SFV1-d1eGFP construct is as described in Chapter 1 and 
in Figure 1.7B. The expression of eGFP is driven by subgenomic promoter to 
provide a high level of expression.  The infection of mosquitoes with SFV was 
designed to be carried out with droplets of mouse blood mixed with SFV1-d1eGFP 
VRPs placed on the top of the nylon mesh of the feeding container (open air 
environment). SFV is relatively stable in aerosols of tissue homogenates (Benbough, 
1969), however aerosols of purified virus are rapidly inactivated (de Jong et al., 
1976). Therefore, the stability of purified SFV in mouse blood was determined. To 
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determine the stability of the infectivity of SFV in this open air environment, a 
naturally occurring strain of SFV, A7(74), was mixed with fresh mouse blood (final 
conc. 1 x 10
5
 PFU/ml) at 28
o
C and allowed to rest in an opened eppendorf tube for 
up to 3 hours.  Virus titres were determined at 0, 0.5, 1, 1.5, 2, and 3 hours by plaque 
assays. SFV A7(74) was mixed with 10% fructose PBSA as a control (final conc. 2.5 
x 10
7
 PFU/ml). The experiment was carried out in triplicate. The experiment showed 
that the SFV A7(74) titre did not decrease over the course of 3 hours (Figure 6.1A). 
This indicates mouse blood is suitable for maintaining SFV infectivity for up to 3 
hours in open air. In the control suspension of virus without mouse blood the SFV 
titre steadily declined from 7 x 10
6
 to 2.5 x 10
4
 PFU/ml (Figure 6.1B).  
 
Figure 6.1: Infectivity of SFV A7(74) in open air in mouse blood. 
The infectivity of SFV A7(74) determined in (A) fresh mouse blood and (B) 10% fructose PBSA. 
SFV A7(74) was added to three replicate tubes of fresh mouse blood (final conc. 1 x 10
5
 PFU/ml) 
or 10% fructose PBSA (final conc. 2.5 x 10
7
 PFU/ml). The tubes were left open for 3 hours and 
samples were taken for plaque assay at various times.  Each point represents the mean titre from 
the three replicate tubes and the error bars show the standard error of the mean.   
To infect and visualise SFV infection in the live mosquito, mosquitoes were fed with 
SFV VRP-spiked blood meals containing 10
5 
infectious units (IU)/l of SFV1-
d1eGFP VRPs. Mosquitoes were kept alive for 5 days before they were dissected. To 
search for evidence of infection, midguts were observed under UV microscopy. Out 
of the 50 infected mosquitoes, none showed obvious expression of eGFP in the 
midgut. Figure 6.2A shows the midgut of a control mosquito which is highly 
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autofluorescent. Figure 6.2B shows the midgut of a SFV1-eGFP VRP-fed mosquito. 
There is a possible focus of fluorescence (location enlarged in Figure 6.2C). It is 
difficult to draw conclusions from this study, either infection was difficult to 
establish, or the time after infection that the midgets were examined was not 
appropriate, or the eGFP signal was too weak to observe given the high background 
autofluoresence. 









of Ae. aegypti 
midgut dissected at 
day 5 post-infection, 
fixed with 4% 
paraformaldehyde 
under UV spectrum 
at 10X 
magnification. (A) 





infected midgut. (C) 
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Immunostaining of paraffin sections of mosquitoes 
As an alternative to fluorescence microscopy and to avoid the problem with auto-
fluorescence, immunostaining of paraffin processed sections was carried out. 
Mosquitoes fed with SFV1-d1eGFP VRP spiked blood meals (1x10
5 
(IU)/l) were 
kept alive for 5 days and then fixed in 4% paraformaldehyde. Fixed mosquitoes were 
processed and sectioned. Sections were then stained with an antibody against the 
viral protein nsP3. Both fluorochrome and diaminobenzidine (DAB) immunostaining 
were used (Figure 6.3A and B). The fixed paraffin section also showed a high degree 
of autofluorescence at 230-260 nm. There is a possibility that the autofluorescence 
would mask the fluorescence signal coming from the fluorochrome. DAB staining 
avoided autofluorescence and brown staining was located in the thorax of the 
sectioned mosquito (Figure 6.3B). However, blood contains peroxidise and that 
could also break down DAB to produce brown pigment. 
  





Figure 6.3: Immuno-staining of paraffin sectioned Ae. aegypti on day 5 post-infection with 
SFV1-d1eGFP. 
A polyclonal rabbit antibody against SFV nsP3 was used on paraffin sectioned SFV1-d1eGFP 
infected Ae. Aegypti on day 5 post-infection (A) A photomicrograph of a paraffin sectioned 
mosquito under 230-260 nm. A secondary antibody bound to a fluorochrome was used.  No 
specific fluorescence was observed within any cells.  There was a high degree of 
autofluorescence. (B) A photomicrograph of a paraffin sectioned mosquito under visible light. A 
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Characterisation of a new virus, SFV4(3H)-RLuc-p19. 
The next approach was not to optimise visualisation of virus in the midgut but to first 
seek evidence of virus infection and replication in this tissue using viruses containing 
Renilla luciferase. It was also planned to use a virus containing an RNAi inhibitor as 
well as luciferase to overcome the host RNAi response which could be restricting the 
infection. SFV4(3H)-RLuc and SFV4(3H)-RLuc-p19 which express Renilla 
luciferase and in the latter virus also expresses the RNAi inhibitor p19, were used to 
infect mosquitoes. The p19 protein was from Cymbidium ringspot virus (CymRSV) 
and is a well-characterised inhibitor of RNA silencing which sequesters small RNA 
duplex. To ensure a high level of P19 expression to accommodate amount of viRNA 
generated in virus infection, the gene was cloned at the 3’-end of a duplicated 
subgenomic promoter (Figure 6.4. However, this means P19 under the control of a 
subgenomic promoter would only provide the counter RNAi effect late in infection. 
This virus was generated in the laboratory of Professor Andres Merits (University of 
Tartu) but it had not been characterised.  To characterise SFV4(3H)-RLuc-p19, a 
virus growth curve was produced. Aliquots of 5 x 10
5
 U4.4 cells were infected 
synchronously at MOI of 10 and 100 μl of supernatant was collected at 12, 24, 48, 
72, 96 and 120 h post-infection. The supernatant in the cultures was completely 
replaced with fresh media each time after the supernatant was collected. Supernatant 
samples were kept in eppendorf tubes at -80
o
C and titrated by plaque assay. In figure 
6.5, the results are compared to figure 3.4 (production of infectious SFV4 virus in 
U4.4 cells), showing that the pattern is very similar with high levels of virus 
production observed from 0 to 24 hours post-infection. Thereafter, virus production 
dropped to low levels as the culture entered the persistent phase of infection. This 
indicated that the recombinant SFV4(3H)-RLuc-p19 virus replicated well in U4.4 
cells.  
  




Figure 6.4: A Schematic representation of the SFV4(3H)-RLuc-P19. 
SFV4(3H)-RLuc-p19 is based on SFV4 construct with RLuc protein gene inserted between nsP3 
and nsP4 sequence. A subgenomic promoter is duplicated at the 3’ end of the structural genes 
followed by an insertion of RNAi inhibitor P19.  
 
 
Figure 6.5: SFV4(3H)-RLuc-p19 production between time intervals up to 120 hours post-
infection. 
U4.4 cells were infected synchronously with SFV4(3H)-RLuc-p19 (▲)(MOI=10). Supernatants 
were collected for titration at 12, 24, 48, 72, 96 and 120 h post-infection. Virus titre (Y axis) is 
represented in Log10(PFU). Each time point is the mean of triplicate samples.  The error bars 
indicate the standard error of the mean. Data for SFV4 production in U4.4 cells (■) was taken 
from Figure 3.4 and used here for comparison. 
 
The effect of the p19 RNAi inhibitor was first tested in vitro, U4.4 cultures were 
infected with SFV4(3H)-RLuc-p19 (MOI= 0.001 or 10) and virus titre determined at 
24 and 48 hours post-infection. Parallel cultures were infected with SFV4(3H)-RLuc 
or SFV4 as controls. In the case of infection with MOI of 0.001, titres of all three 
viruses increased from 24-48 hours. SFV4 produced the higher titre out of the three 
viruses followed by SFV4(3H)-RLuc-p19 and SFV(3H)-RLuc (Figure 6.6). That 
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SFV4(3H)-RLuc produced the lowest titre, suggests that insertion of the foreign 
marker gene attenuates virus replication. Interestingly, SFV4(3H)-RLuc-p19 had a 
higher titre than SFV4(3H)-RLuc at both MOI 0.001 and 10, indicating that insertion 
of p19 partially rescues the phenotype.  After the discussion during the PhD viva, a 
statistic analysis between the virus titres was decided to be determined, however this 
particular data file on the harddrive was corrupted beyond repair. 
 
 
Figure 6.6: Virus titres of SFV4(3H)-RLuc-p19, SFV4(3H)-RLuc and SFV4 at 24 and 48 
hours post-infection 
U4.4 cultures were infected with the indicated viruses at (A) MOI 0.001 (B) MOI 10. Virus titres 
were determined at 24 and 48 hours by plaque assay. Each point is the mean of triplicate samples.  
The error bars indicate the standard error of the mean.  
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Infection of Aedes aegypti mosquitoes with SFV4(3H)-RLuc-p19 and 
SFV4(3H)-RLuc 
To see the effect of p19 on SFV replication in whole mosquitoes, Ae. aegypti were 
orally infected with SFV4(3H)-RLuc-p19 or SFV4(3H)-RLuc as control. To prepare 
mosquitoes for oral infection, sugar and water sources were removed 24 hours prior 
to infection. Twenty female mosquitoes were transferred to infection containers. 
SFV4(3H)-RLuc-p19 was mixed with blood and ATP to a final concentration of 10
7
 
PFU/ml. Five drops (10 ul each) of blood mix were placed on top of the nylon mesh 
of the feeding container. Eighty female mosquitoes (divided between four containers) 
were given SFV4(3H)-RLuc-p19 blood mix. SFV4(3H)-RLuc blood mix was used to 
infect 80 female mosquitoes as a control. One hour was allowed for blood feeding at 
28
o
C. After feeding was finished, unfed mosquitoes were removed and discarded. To 
determine virus replication, whole mosquitoes were ground and lysed in an 
eppendorf tube with a disposable tissue homogeniser in passive lysis buffer on post-
infection days (PID) 2, 3, 4, and 5, and viral marker gene expression was determined 
by luciferase assay. The results are showed in table 6.1. In the SFV4(3H)-RLuc 
group only one mosquito had detectable luciferase activity. This was detected on PID 
5. In the SFV4(3H)-RLuc-p19 group, 2 mosquitoes were luciferase positive, one at 
day 2 and one at day 4. The luciferase activity was noticeably higher in SFV4(3H)-
RLuc-p19 infected mosquitoes; the luciferease activity detected on PID 2 and 4 of 
SFV4(3H)-RLuc-p19 infected mosquitoes were 6.5 times and 43 times higher than 
the activity detected in the  SFV4(3H)-RLuc infected mosquito on PID 5. However, 
numbers are too small to determine whether or not this was significant.  
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 SFV4(3H)-RLuc SFV4(3H)-RLuc-p19 












2 0/11 NA/252 1/10 9117/230 
3 0/10 NA/198 0/8 NA/211 
4 0/9 NA/148 1/14 60319/148 
5 1/9 1395/232 0/11 NA/213 
Table 6.1 Renilla luciferase detection in mosquitoes fed with SFV4(3H)-RLuc or SFV4(3H)-
RLuc-p19 infected blood meals.  
Luciferase expression in SFV4(3H)-RLuc-p19 and SFV4(3H)-RLuc blood fed mosquitoes was 
determined on PID 2, 3, 4 and 5. Average RLuc activity (+ve/ve): average of Rluc activity 
between RLuc positive mosquitoes and RLuc negative (background) mosquitoes, respectively. 
Infection of Aedes aegypti mosquitoes with SFV4(3H)-RLuc and 
SFV4-stRLuc viruses 
In an attempt to make the assay more sensitive a virus expressing higher levels of 
luciferase (SFV4-stRLuc in which the expression of  luciferase is under the control of 
subgenomic promoter) was used. Ae. aegypti were given SFV4(3H)-RLuc  and 
SFV4-stRLuc blood meals as described above. Twenty mosquitoes were fed and 
unfed mosquitoes were removed. Fed mosquitoes were ground and lysed in an 
eppendorf tube with disposable tissue homogenisers in passive lysis buffer on post-
infection day (PID) 7 and viral marker gene expression was determined by luciferase 
assay (Table 6.2). In the SFV4(3H)-RLuc group only 2 out of 9 mosquitoes had 
detectable luciferase activity. None was detected from mosquitoes fed with SFV4-
stRLuc virus. The use of SFV4-stRLuc virus did not infect mosquitoes more 
successfully than SFV4(3H)-RLuc virus, therefore it is inconclusive that whether 
luciferase unders the control of the subgenomic promoter (SFV4-stRLuc) is more 
readily detectable than that luciferase in the replicase genes in live mosquitoes. 
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 SFV4(3H)-RLuc SFV4-stRLuc 












7 2/9 63874/310 0/14 NA/292 
Table 6.2 Renilla luciferase detection in mosquitoes fed with SFV4(3H)-RLuc or SFV4-
stRLuc infected blood meals.  
SFV4(3H)-RLuc and SFV4-stRLuc blood fed mosquitoes were kept alive and luciferase 
expression was determined on PID 7. Average RLuc activity (+ve/ve): average of Rluc activity 
between RLuc positive mosquitoes and RLuc negative (background) mosquitoes, respectively.  
Summary of Findings 
Infection of mosquitoes with SFV 
 SFV was found to be stable in blood on exposure to open air environment for 
at least 3 hours.  
 The midgut of a mosquito is highly auto-fluorescent. 
 Fluorescence microscopy found no obvious expression of eGFP in the 
midguts of 50 mosquitoes fed with SFV1-d1eGFP VRP blood meal.  
 Immunostaining of paraffin-processed sections of mosquitoes fed with SFV1-
d1eGFP VRP blood meals did not identify any infection in the midgut of 
mosquitoes. 
Characterisation of SFV4(3H)-RLuc-p19 virus 
 Virus production of SFV4(3H)-RLuc-p19 in U4.4 cells was very similar to 
SFV4.  
 Addition of p19 to SFV4(3H)-RLuc significantly increased virus production. 
Infection of Aedes aegypti with SFV4(3H)-RLuc-p19 and SFV4(3H)-RLuc 
 Infection was difficult to establish. 
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 Only 2/80 mosquitoes had detectable luciferase activity after being fed with 
SFV4(3H)-RLuc-p19 and 1/80 mosquitoes had detectable luciferase activity 
after being fed with SFV4(3H)-RLuc. 
 The luciferease activities detected on PIDs 2 and 4 from SFV4(3H)-RLuc-p19 
infected mosquitoes were higher than that detected in the SFV4(3H)-RLuc 
infected mosquito on PID 5.  
Infection of Aedes aegypti with SFV4(3H)-RLuc and SFV4-stRLuc viruses 
 Two out of nine mosquitoes fed with SFV4(3H)-RLuc had detectable 
luciferase activity at PID 7.  
 No mosquito fed with SFV4-stRLuc virus had detectable luciferase activity at 
PID 7. 
 SFV4-stRLuc virus did not infect mosquitoes more successfully than 
SFV4(3H)-RLuc virus.  
Discussion 
The goal of this series of experiment was to use SFV1-d1eGFP to establish and 
visualise SFV infection in the midgut of Ae. aegypti, and then to assess the effect on 
SFV infection of the p19 protein of CymRSV, a protein that inhibits RNAi, with 
SFV4(3H)-RLuc, SFV4(3H)-RLuc-p19 and SFV4-stRLuc viruses.  Fifty female 
mosquitoes were fed with SFV1-d1eGFP VRP but none produced any obvious 
expression of eGFP in the midgets (PID 5). The absence of observable eGFP signal 
could be explained by non-propagating VRP not producing a strong signal or by 
infection itself being difficult to establish by non-propagating VRPs. Therefore, 
paraffin sections of SFV1-d1eGFP VRP infected mosquitoes were produced. 
Unfortunately, immunostaining of paraffin-processed sections of mosquitoes also did 
not identify any infection in the midguts. Although infection of Ae. aegypti with SFV 
VRPs was unsuccessful, successful infection (by intrathoracic injection) and 
immunostaining of Sindbis virus infected Ae. albopictus has been demonstrated by 
Myles and co-worker. Immunofluorescence assay showed that anterior and posterior 
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midguts of Sindbis infected mosquitoes were intensively stained on day 2 post-
infection (Myles et al., 2004). 
The characterisation of SFV4(3H)-RLuc-P19 showed a very similar level of virus 
production to SFV4 with a high amount of virus being produced up to 24 hours post-
infection, followed by low virus production from 72 hours onwards. This indicated 
that the p19 RNAi inhibitor did not have an obvious effect on the time of transition 
from acute to persistent phase of infection (Figure 6.5). The effect of the p19 RNAi 
inhibitor was then tested in U4.4 cultures at low and high MOI (MOI= 0.001 or 10) 
at 24 and 48 hours post-infection (Figure 6.6). The results showed SFV4 had the 
highest titre and SFV4(3H)-RLuc-p19 had a higher titre than SFV4(3H)-RLuc at 
MOI 0.001. This appeared to be the same at MOI =10 however statistical analysis 
could not be carried out deal to data corruption.  This indicated that SFV4(3H)-RLuc-
p19 had a less compromised replication rate than SFV4(3H)-RLuc, suggesting p19 
partially rescued the SFV4(3H)-RLuc phenotype by reducing the RNAi pressure on 
virus replication. Interestingly, in the case of infection with MOI of 0.001, titres of 
all three viruses increased from 24-48 hours, whereas the titre appeared to decrease 
from 24 to 48 hours in infection with MOI of 10. Once again, this decrease at 
MOI=10 could not be confirmed by statistical analysis because the data file is 
corrupted beyond repair.  It is unlikely that virus particles disappeared or eliminated 
from 24 to 48 hours post-infection.  
Infection of Ae. aegypti with SFV4(3H)-RLuc, SFV4(3H)-RLuc-p19 and SFV4-
stRLuc was established. However, the number of mosquitoes which became infected 
and expressed viral marker genes was too little to carry out statistical analysis to 
show whether replication of SFV4(3H)-RLuc-p19 is different from SFV4(3H)-RLuc. 
This study was recently continued by another student (Julio Rodriguez) in our 
laboratory with a Hemotek feeding apparatus (Discovery Workshops, UK). The new 
feeding apparatus greatly increased the proportion of mosquitoes which fed on the 
blood meal and 50-60% of the fed mosquitoes were infected. This suggested that 
feeding mosquitoes with an infected blood meal at 28
o
C is inefficient. It is essential 
to have equipment to keep the blood meal warm for future experiments.  
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Infection of mosquitoes with SFV4(3H)-RLuc-p19 and SFV4(3H)-RLuc only 
produced three mosquitoes that expressed luciferase. Two became infected with 
SFV4(3H)-RLuc-p19 and luciferase expression was detected one each on PID 2 and 
4. The luciferase activity of these two SFV4(3H)-RLuc-p19 infected mosquitoes 
were 6.5 and 43 times (PID 2 & 4, respectively) higher than the one infected with 
SFV4(3H)-RLuc detected on PID 5.  Although the number of infected mosquitoes 
was too few to make a significant comparison, the increase of luciferase activity in 
SFV4(3H)-RLuc-p19 infected mosquitoes indicated an increase in infection level 
which has been previously reported by Cirimotich and co-workers.  They described 
the use of a recombinant SINV that expresses a Flock house virus (FHV) B2 protein 
to study the effects of RNAi on mosquito infection. The report showed the level of 
infection and dissemination rate were increased when mosquitoes were infected with 
SINV-B2, and that inhibition of RNAi during infection was highly pathogenic and 
significantly shortened the mosquitoes’ lifespan (Cirimotich et al., 2009).  P19 and 
B2 are of different origins and act differently; P19 is from Tombusviruses of the 
Tombusviridae (plant virus) and binds and sequesters only 21 nt double stranded 
small RNAs, whereas B2 is from FHV of the Nodaviridae (insect virus) and binds to 
siRNAs and longer dsRNAs (Lingel et al., 2005; Mérai et al., 2006); however they 
both function to prevent small RNAs from being incorporated into the RISC.  
By understanding the effect of the RNAi inhibitor in SINV-P19 infection in Ae. 
aegypti (Cirimotich et al., 2009), and the enhanced spread of SFV expressing P19 in 
U4.4 mosquito cell culture (Attarzadeh-Yazdi et al., 2009), it is intriguing to 
speculate that the outcome of a more successful SFV4(3H)-RLuc-p19 infection in Ae. 
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Appendix I: Common Solutions and Reagents 
Common solutions and reagents used in this thesis are appended here: 
TNE buffer 
To make 10X TNE buffer for long-term storage of viruses and virus-like particles the 
following recipe was followed: 
In 800 ml of dH2O 12.1 g of Trizma Base (Sigma, UK), 3.7 g of disodium EDTA 
(Sigma, UK) and 116.8 g NaCl (Sigma, UK) were added. The pH was adjusted to 7.4 
and the solution was made up to a final volume of 1 L. Following autoclaving 10X 
TNE buffer was diluted with nuclease-free water (Sigma, UK) to give 1X TNE and 
used. 
In vitro transcription 
Reagents used in the in vitro transcription reaction were 
10X SP6 buffer. This was custom made and it contained the following: 
400 mM HEPES potassium salt (Sigma, UK) pH adjusted to 7.4. 
60 mM magnesium acetate tetrahydrate (Sigma, UK). 
20 mM Spermidine trihydrochoride (Sigma, UK). 




GpppG (cap analog) was purchased from Amersham Biosciences, UK. 
DTT was purchased from Sigma, UK. 
rNTPs used were purchased from Amersham Biosciences, UK in the form of stock 
solutions (40 mM) ATP, CTP, UTP and GTP. 
H2O (DNase, RNase-free water) was purchased from Sigma, UK. 




SP6 RNA polymerase was purchased from Amersham Biosciences, UK.  
Immunostaining 
Triton X-100 was purchased from BDH, UK. 
Proteinase K was purchased from Sigma, UK. 
To-Pro nuclear marker was a Molecular Probes product (Invitrogen, UK). 
Propidium iodide containing mounting medium was purchased from VectorLabs, 
USA. 
PBS was purchased in the form of tablets from VWR international (UK branch). 
CAS block is a Zymed, US product. The company is now part of Invitrogen, UK. 
Cell Lines 
All media used in this thesis were purchased from Gibco, UK. The company is now 
part of Invitrogen, UK.  
Reverse transcription and Polymerase Chain Reaction (PCR) 
For RT-PCR the SuperScript II RNase H
+
 reverse transcriptase enzyme kit 
(Invitrogen, UK) was used. OligodT primer, dNTPs and RNasin inhibitor were 
purchased from Promega, UK. Nuclease-free water was purchased from Sigma, UK.  
For PCR, Pfx DNA polymerase was purchased from Invitrogen, UK. Taq polymerase 
was purchased from Promega.  
Agarose Gel Electrophoresis 
Agarose gels were made using 0.5M TBE buffer and agarose powder purchased from 
Promega, UK. The synthesis of the TBE buffer was: 
1 litre 5X TBE buffer stock  
54 g Tris Base 




20 ml 0.5M EDTA (pH 8) 
All reagents were from Sigma, UK. 
DNA ladders used for size comparisons were purchased from New England Biolabs, 
UK. 
Bacterial Techniques 
Two different strains of recombinant E. coli bacteria were used during this project. 
DH5(Invitrogen, UK) and XL-10 gold (Stratagene, UK). To grow liquid cultures 
LB (Luria-Bertani) medium was used. The composition of LB medium was 10 grams 
tryptone, 5 grams of yeast extract, 10 grams of NaCl. This was purchased as 
premixed powder from Fischer, UK and 15 grams of the powder mix were added to 
500 ml of dH2O. The medium was then autoclaved and used.  
Following transformation a rich medium was used to help recovery of bacteria. The 
medium of choice was SOC (Invitrogen, UK). The composition of SOC medium is 





Appendix II: Supplemental material 
pSFV1 with IRES in EcoRV and with duplication of the N-



























Supplemental data 1: The genomeic sequence of the SFV1(3F)-IRES-ZsGreen from 1 - 1690 
nt. 
SFV1(3F)-IRES-ZsGreen contains duplicated N-terminus of nsP1 (highlighted in blue). IRES 
element is located at 276 – 853 nt, between the EcoRV site between the duplicated N-terminus of 
nsP1 (highlighted in green).  
